0 4 4 5 5 activationdependent transcriptional regulation human fa promoter requires nfkappab p50p65 recruitment
1 8 8 7 8 activationdependent transcriptional regulation human fa promoter requires nfkappab p50p65 recruitment
1 8 8 7 8 activationdependent transcriptional regulation human fa promoter requires nfkappab p50p65 recruitment
0 5 5 13 15 using sequential deletion mutant human fa promoter transient transfection assay identified 47bp sequence position 306 260 relative atg required activationdriven fa upregulation
0 5 5 17 17 using sequential deletion mutant human fa promoter transient transfection assay identified 47bp sequence position 306 260 relative atg required activationdriven fa upregulation
0 5 5 11 12 using sequential deletion mutant human fa promoter transient transfection assay identified 47bp sequence position 306 260 relative atg required activationdriven fa upregulation
0 5 5 6 6 using sequential deletion mutant human fa promoter transient transfection assay identified 47bp sequence position 306 260 relative atg required activationdriven fa upregulation
1 17 17 18 19 electrophoretic mobility shift assay emsa supershift analysis region documented constitutive binding sp1 unactivated nuclear extract inducible binding p50p65 nfkappab heterodimers pi activation
0 6 6 7 7 functional contribution kappabsp1 composite site piinducible fa promoter activation verified using kappabsp1 concatamers 295 286 thymidine kinase promoterdriven reporter construct native promoter construct jurkat cell overexpressing ikappabalpha
0 5 5 6 6 sitedirected mutagenesis critical guanine nucleotide kappabsp1 element documented essential role site activationdependent fa promoter induction
0 12 12 13 13 sitedirected mutagenesis critical guanine nucleotide kappabsp1 element documented essential role site activationdependent fa promoter induction
0 12 12 10 10 interleukin10 inhibits expression interferon alpha interferon gamma induced gene suppressing tyrosine phosphorylation stat1
0 5 5 3 3 accomplished preventing ifninduced tyrosine phosphorylation stat1 component ifnalpha ifngammainduced dna binding complex
1 5 5 9 11 accomplished preventing ifninduced tyrosine phosphorylation stat1 component ifnalpha ifngammainduced dna binding complex
1 14 14 10 11 two tandem ap1 binding site dyad symmetry required enhancer activity dnaprotein complex formation member cfoscjun family
0 5 6 22 22 provide model megakaryocytic differentiation expression alpha2 integrin gene requires signaling via map kinase pathway activate two tandem ap1 binding site alpha2 integrin enhancer
0 2 2 3 5 kilobases 5 gata3 transcriptional initiation site
0 7 7 8 8 upstream regulatory element could confer tcell specificity gata3 promoter activity analysis region revealed 707base pair silencer drastically inhibited gata3 promoter activity nontcells
0 7 7 8 8 upstream regulatory element could confer tcell specificity gata3 promoter activity analysis region revealed 707base pair silencer drastically inhibited gata3 promoter activity nontcells
0 6 6 9 10 analyzed nature stat protein capable binding il2ralpha pim1 irf1 gas element cytokine stimulation observed ifnalphainduced binding stat1 stat3 stat4 stat5 element
0 8 8 9 10 analyzed nature stat protein capable binding il2ralpha pim1 irf1 gas element cytokine stimulation observed ifnalphainduced binding stat1 stat3 stat4 stat5 element
0 7 7 8 9 yet ifnalpha able activate binding stat5 highaffinity ifp53 gas site
0 4 4 2 2 ifnalpha enhanced tyrosine phosphorylation stat1 stat3 stat4 stat5a stat5b
0 5 5 2 2 ifnalpha enhanced tyrosine phosphorylation stat1 stat3 stat4 stat5a stat5b
0 6 6 2 2 ifnalpha enhanced tyrosine phosphorylation stat1 stat3 stat4 stat5a stat5b
0 7 7 2 2 ifnalpha enhanced tyrosine phosphorylation stat1 stat3 stat4 stat5a stat5b
0 8 8 2 2 ifnalpha enhanced tyrosine phosphorylation stat1 stat3 stat4 stat5a stat5b
0 10 10 11 11 evidence suppressed activity transcription factor nfat1 proximal binding element p0 il4 promoter associated enhanced il4 gene transcription cell atopic patient
0 26 26 19 20 series electrophoretic mobility shift assay protein extract highly polarized th2 clone atopics th1 clone control compared dnabinding activity two nfatbinding element p0 p1 crucial proximal human il4 promoter
0 26 26 22 22 series electrophoretic mobility shift assay protein extract highly polarized th2 clone atopics th1 clone control compared dnabinding activity two nfatbinding element p0 p1 crucial proximal human il4 promoter
0 26 26 21 21 series electrophoretic mobility shift assay protein extract highly polarized th2 clone atopics th1 clone control compared dnabinding activity two nfatbinding element p0 p1 crucial proximal human il4 promoter
0 26 26 27 27 series electrophoretic mobility shift assay protein extract highly polarized th2 clone atopics th1 clone control compared dnabinding activity two nfatbinding element p0 p1 crucial proximal human il4 promoter
1 6 6 3 4 proximal p0 site nfatcontaining complex devoid nfat2 readily inducible th1 clone hardly th2 clone
1 11 11 4 5 contrast th1 th2 clone nfatcontaining complex strongly inducible p1 site consisting nfat2 p0compatible nfat activity without apparent difference th1 th2 clone
0 3 3 15 16 finding suggest highlevel il4 production atopic th2 cell associated selective reduction suppressive nfat1 activity il4 p0 element patient multifactorial disease may putative systemic disorder level
1 4 4 0 0 complex consisted p50p50 homodimers p50p65 heterodimers
1 2 2 0 0 complex consisted p50p50 homodimers p50p65 heterodimers
1 2 2 0 0 complex consisted p50p50 homodimers p50p65 heterodimers
1 2 2 3 3 complex consisted p50p50 homodimers p50p65 heterodimers
1 2 2 5 5 complex consisted p50p50 homodimers p50p65 heterodimers
1 4 4 5 5 complex consisted p50p50 homodimers p50p65 heterodimers
1 9 9 3 4 nonrheumatoid arthritis binding nfkappa b synovial cell exclusively mediated p50p50 homodimers
0 6 6 10 12 involvement nfkappab p50p65 heterodimer activation human prointerleukin1beta gene two subregions upstream enhancer element
1 2 2 3 3 involvement nfkappab p50p65 heterodimer activation human prointerleukin1beta gene two subregions upstream enhancer element
0 8 9 5 6 region between3134 2729 bp upstream transcription site human prointerleukin 1beta proil1beta gene identified lpsresponsive enhancer element
1 20 20 12 12 result supershift analysis using specific antibody transcription factor suggested binding complex contained nfkappab component p50 p65 contain nfkappab protein p52 crel rel b ap1 protein cfo cjun creb cebpbeta nfil6
1 14 14 12 12 result supershift analysis using specific antibody transcription factor suggested binding complex contained nfkappab component p50 p65 contain nfkappab protein p52 crel rel b ap1 protein cfo cjun creb cebpbeta nfil6
1 25 25 23 23 result supershift analysis using specific antibody transcription factor suggested binding complex contained nfkappab component p50 p65 contain nfkappab protein p52 crel rel b ap1 protein cfo cjun creb cebpbeta nfil6
1 19 19 12 12 result supershift analysis using specific antibody transcription factor suggested binding complex contained nfkappab component p50 p65 contain nfkappab protein p52 crel rel b ap1 protein cfo cjun creb cebpbeta nfil6
1 26 26 23 23 result supershift analysis using specific antibody transcription factor suggested binding complex contained nfkappab component p50 p65 contain nfkappab protein p52 crel rel b ap1 protein cfo cjun creb cebpbeta nfil6
1 21 22 12 12 result supershift analysis using specific antibody transcription factor suggested binding complex contained nfkappab component p50 p65 contain nfkappab protein p52 crel rel b ap1 protein cfo cjun creb cebpbeta nfil6
0 4 4 5 6 phosphorylation traf2 inhibits binding cd40 cytoplasmic domain
0 6 6 7 8 traf2 signal transducing adaptor molecule bind cd40 cytoplasmic domain
0 9 9 13 14 furthermore phosphorylation status traf2 significant effect ability protein bind cd40 evidenced observation cd40 cytoplasmic domain interacted preferentially underphosphorylated traf2 phosphatase treatment significantly enhanced binding traf2 cd40
0 12 12 5 5 furthermore cocl2 also caused timedependent tyrosine phosphorylation mitogenactivated protein map kinase isoform erk2 without significantly affecting erk1 indicating erk2 preferred substrate upstream kinase mapk pathway
0 7 7 3 3 investigation focused localizing ciselements responsible regulation adult betalike globin gene delta beta immature primitive erythroid tissue
0 10 10 3 3 investigation focused localizing ciselements responsible regulation adult betalike globin gene delta beta immature primitive erythroid tissue
0 5 5 13 14 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 5 5 1 2 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 4 4 1 2 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 4 4 6 8 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 5 5 6 8 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 4 4 6 8 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 5 5 6 8 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 4 4 33 33 analyzed dna sequence included delta beta 5 flanking region extending approximately 500 50bp promoter region truncated delta beta 5 flanking region extending approximately 250 50 bp chimeric promoter construction consisted distal delta beta fragment fused proximal beta delta sequence
0 8 9 10 10 cat reporter construction appreciable level cat activity supported beta globin promoter low level activity delta promoter
0 14 14 10 10 cat reporter construction appreciable level cat activity supported beta globin promoter low level activity delta promoter
0 4 4 2 3 contrast deletion upstream portion delta promoter led 10 fold decrease expression
0 2 3 4 4 coupling upstream beta globin sequence approximately 500 250 bp truncated delta promoter fragment led complete extinction transcription activity consistent negative regulatory effect beta globin gene upstream element
0 6 7 1 2 fusion upstream portion delta promoter truncated beta globin promoter yielded modest increase promoter strength relative truncated beta gene promoter indicating presence positive transcriptional element upstream delta globin regulatory region
0 3 3 1 2 fusion upstream portion delta promoter truncated beta globin promoter yielded modest increase promoter strength relative truncated beta gene promoter indicating presence positive transcriptional element upstream delta globin regulatory region
0 25 26 21 23 fusion upstream portion delta promoter truncated beta globin promoter yielded modest increase promoter strength relative truncated beta gene promoter indicating presence positive transcriptional element upstream delta globin regulatory region
0 6 7 4 4 fusion upstream portion delta promoter truncated beta globin promoter yielded modest increase promoter strength relative truncated beta gene promoter indicating presence positive transcriptional element upstream delta globin regulatory region
0 6 6 4 4 fusion upstream portion delta promoter truncated beta globin promoter yielded modest increase promoter strength relative truncated beta gene promoter indicating presence positive transcriptional element upstream delta globin regulatory region
0 25 26 27 28 fusion upstream portion delta promoter truncated beta globin promoter yielded modest increase promoter strength relative truncated beta gene promoter indicating presence positive transcriptional element upstream delta globin regulatory region
0 10 11 19 19 sitedirected mutagenesis binding site repressor protein bp1 bp2 upstream portion beta globin gene flanking region led 46 fold increase promoter activity
0 10 11 8 9 sitedirected mutagenesis binding site repressor protein bp1 bp2 upstream portion beta globin gene flanking region led 46 fold increase promoter activity
0 10 11 10 14 sitedirected mutagenesis binding site repressor protein bp1 bp2 upstream portion beta globin gene flanking region led 46 fold increase promoter activity
0 3 3 4 4 dnase footprinting upstream deltaglobin region revealed protected sequence corresponding consensus binding site gata1 bp2
0 7 8 3 5 result confirm sequence upstream promoter region adult beta globin gene contribute factormediated suppression early development may modulate expression later stage
0 0 0 3 8 il2ralpha promoter containing nuclear factor kappa b nfkappab site transcriptionally induced
0 0 0 1 1 il2ralpha promoter containing nuclear factor kappa b nfkappab site transcriptionally induced
1 3 3 5 5 using antibody p50 p65 subunit nfkappab emsas involvement p50 p65 protein demonstrated
1 2 2 5 5 using antibody p50 p65 subunit nfkappab emsas involvement p50 p65 protein demonstrated
0 2 3 4 4 regulation megakaryocytic glycoprotein ix promoter oncogenic ets transcription factor fli1
1 0 2 7 7 glycoprotein gp ix subunit von willebrand receptor gpibvix mediates adhesion platelet subendothelium damaged blood vessel
1 0 2 4 6 glycoprotein gp ix subunit von willebrand receptor gpibvix mediates adhesion platelet subendothelium damaged blood vessel
0 2 2 6 7 previous characterization gpix promoter identified functional ets site disrupted reduced promoter activity
0 2 2 3 3 previous characterization gpix promoter identified functional ets site disrupted reduced promoter activity
0 4 4 5 5 study transient cotransfection several gpix promoterreporter construct 293t kidney fibroblast fli1 expression vector show oncogenic protein fli1 transactivate gpix promoter intact gpix ets site present
0 4 4 21 23 study transient cotransfection several gpix promoterreporter construct 293t kidney fibroblast fli1 expression vector show oncogenic protein fli1 transactivate gpix promoter intact gpix ets site present
0 3 3 3 5 addition fli1 binding gpix ets site identified antibody supershift experiment nuclear extract derived hematopoietic human erythroleukemia cell
0 7 7 11 11 comparative study showed fli1 also able transactivate gpibalpha lesser extent gpiib promoter
0 10 10 11 11 comparative study showed fli1 also able transactivate gpibalpha lesser extent gpiib promoter
0 14 14 21 22 previous study pertaining macrophage response lp identified novel dnabinding domain located 550 487 human tnfalpha promoter contains transcriptional activity lack known nfkappabbinding site
0 14 14 8 9 previous study pertaining macrophage response lp identified novel dnabinding domain located 550 487 human tnfalpha promoter contains transcriptional activity lack known nfkappabbinding site
0 14 14 15 15 previous study pertaining macrophage response lp identified novel dnabinding domain located 550 487 human tnfalpha promoter contains transcriptional activity lack known nfkappabbinding site
1 10 10 10 10 first showed viral binding induced number immunoregulatory gene il1beta a20 nfkappabp105p50 ikappabalpha unactivated monocyte neutralizing ab major hcmv glycoprotein gb ul55 gh ul75 inhibited induction gene
1 10 10 10 10 first showed viral binding induced number immunoregulatory gene il1beta a20 nfkappabp105p50 ikappabalpha unactivated monocyte neutralizing ab major hcmv glycoprotein gb ul55 gh ul75 inhibited induction gene
0 12 12 13 13 transient overexpression inactive mutant either raf1 jnk1 showed pathway involved kappa bdependent il6 promoter activity
0 7 7 8 8 interestingly shown nfkappa bmediated gene transcription context il6 promoter well dependent serine kinase activity interaction cjun protein
0 19 19 17 18 overexpression hematopoietic proteintyrosine phosphatase heptp result suppression lymphocyte activation measured cell antigen receptorinduced activation transcription factor binding 5 promoter interleukin2 gene
1 0 3 6 7 shp2interacting transmembrane adaptor protein sit novel disulfidelinked dimer regulating human cell activation
1 2 2 3 3 functional role grplslp76 complex suggested ability grpl act alone concert slp76 augment nfat activation jurkat cell
0 18 18 15 17 pg490 also inhibits pmastimulated activation chimeric transcription factor cterminal ta1 transactivation domain nfkappab p65 fused dna binding domain gal4
0 13 13 8 11 pg490 also inhibits pmastimulated activation chimeric transcription factor cterminal ta1 transactivation domain nfkappab p65 fused dna binding domain gal4
0 15 16 17 19 took advantage monoclonal model germinal center b cell differentiation igm igd cl01 cell define role gamma 3 evolutionarily conserved sequence ec germline transcriptional activation human c gamma 3 gene
0 0 1 8 10 gamma 3 ec lie upstream major gamma 3 transcription initiation site display 90 identity corresponding human gamma 1 gamma 2 gamma 4 region
0 15 15 21 21 targeted mutational analysis demonstrated tandem nfkappa brel binding motif critical gamma 3 ec responsiveness cd40l il4 stat6binding site additionally required il4 inducibility
1 1 1 2 2 thrombininduced p65 homodimer binding downstream nfkappa b site promoter mediates endothelial icam1 expression neutrophil adhesion
0 4 4 19 21 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 4 4 31 32 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 4 4 27 30 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 4 4 19 21 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 4 4 13 16 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 4 4 5 5 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 4 4 5 5 transient transfection endothelial cell icam1 promoter luciferase reporter gene icam1luc construct indicated deletion upstream nfkappa b site 533 base translation start site effect thrombin responsiveness whereas mutationdeletion downstream nfkappa b site 223 base translation start site prevented activation icam1 promoter indicating downstream nfkappa b site critical thrombin inducibility
0 14 14 10 13 gel supershift assay demonstrated thrombin induced binding nfkappa bp65 rel downstream nfkappa b site icam1 promoter
1 8 8 7 8 gel supershift assay demonstrated thrombin induced binding nfkappa bp65 rel downstream nfkappa b site icam1 promoter
0 14 14 15 15 gel supershift assay demonstrated thrombin induced binding nfkappa bp65 rel downstream nfkappa b site icam1 promoter
0 10 12 2 3 thrombin receptor activation peptide 14aminoacid peptide representing new nh2 terminus proteolytically activated receptor1 mimicked thrombin action inducing icam1 expression
0 10 12 8 9 thrombin receptor activation peptide 14aminoacid peptide representing new nh2 terminus proteolytically activated receptor1 mimicked thrombin action inducing icam1 expression
0 10 12 4 5 thrombin receptor activation peptide 14aminoacid peptide representing new nh2 terminus proteolytically activated receptor1 mimicked thrombin action inducing icam1 expression
0 5 5 13 16 data indicate thrombin activates endothelial icam1 expression polymorphonuclear leukocyte adhesion nfkappa bp65 binding downstream nfkappa b site icam1 promoter proteolytically activated receptor1 activation
1 11 11 10 11 data indicate thrombin activates endothelial icam1 expression polymorphonuclear leukocyte adhesion nfkappa bp65 binding downstream nfkappa b site icam1 promoter proteolytically activated receptor1 activation
0 5 5 18 18 data indicate thrombin activates endothelial icam1 expression polymorphonuclear leukocyte adhesion nfkappa bp65 binding downstream nfkappa b site icam1 promoter proteolytically activated receptor1 activation
1 3 3 3 3 ctla4 ligation inhibited cd3cd28induced il2 mrna accumulation inhibiting il2 transcription appears mediated part decreasing nfat accumulation nucleus
1 6 6 0 2 nfkappab binding complex composed transcriptionally active p65relap50 heterodimers result primarily targeted degradation ikappabalpha inhibitor sequesters relkappab cytoplasm
1 6 6 7 7 nfkappab binding complex composed transcriptionally active p65relap50 heterodimers result primarily targeted degradation ikappabalpha inhibitor sequesters relkappab cytoplasm
0 8 8 6 7 macrophage cell using reporter gene directed kappab sequence ikappabalpha il8 promoter region
0 9 9 6 7 macrophage cell using reporter gene directed kappab sequence ikappabalpha il8 promoter region
0 8 8 10 11 macrophage cell using reporter gene directed kappab sequence ikappabalpha il8 promoter region
0 9 9 10 11 macrophage cell using reporter gene directed kappab sequence ikappabalpha il8 promoter region
0 11 11 15 17 hiv1 reactivation resting peripheral blood mononuclear cell infected adult upon vitro cd4 crosslinking ligand cdr2loop extracellular domain 1
0 16 16 13 14 additionally virus reactivation resting pbmcs infected vitro hiv1 found specifically induced ligand cdr2loop domain 1 d1 cd4 virus envelope anticd4 monoclonal antibody
0 16 16 12 12 additionally virus reactivation resting pbmcs infected vitro hiv1 found specifically induced ligand cdr2loop domain 1 d1 cd4 virus envelope anticd4 monoclonal antibody
0 7 7 8 8 result indicate signaling event initiated pbmcs oligomerization cd4 d1cdr2loop trigger hiv1 upregulation infected individual
0 2 2 5 6 human mcm5 mcm6 promoter mutation e2f site failed promoter regulation following serum stimulation exogenous e2f expression
0 1 1 5 6 human mcm5 mcm6 promoter mutation e2f site failed promoter regulation following serum stimulation exogenous e2f expression
0 1 1 3 3 human mcm5 mcm6 promoter mutation e2f site failed promoter regulation following serum stimulation exogenous e2f expression
0 2 2 3 3 human mcm5 mcm6 promoter mutation e2f site failed promoter regulation following serum stimulation exogenous e2f expression
0 6 6 3 4 addition identified novel e2flike sequence human mcm6 promoter cooperates authentic e2f site e2fdependent regulation
0 6 6 7 7 addition identified novel e2flike sequence human mcm6 promoter cooperates authentic e2f site e2fdependent regulation
0 5 5 18 18 result demonstrated growthregulated expression mammalian mcm5 mcm6 gene presumably mcm member primarily regulated e2f binding multiple e2f site promoter
0 6 6 18 18 result demonstrated growthregulated expression mammalian mcm5 mcm6 gene presumably mcm member primarily regulated e2f binding multiple e2f site promoter
0 5 5 16 17 result demonstrated growthregulated expression mammalian mcm5 mcm6 gene presumably mcm member primarily regulated e2f binding multiple e2f site promoter
0 6 6 16 17 result demonstrated growthregulated expression mammalian mcm5 mcm6 gene presumably mcm member primarily regulated e2f binding multiple e2f site promoter
0 8 8 9 9 found two member nsaid sodium salicylate sulindac repress il1b promoter similar degree heat shock hsf1 overexpression
0 2 2 3 3 least case il1b promoter repression seem involve another factor whose activity affected nsaid nfkappab il1b promoter fragment used study nfkappab responsive bind specifically hsf1
0 2 2 3 3 least case il1b promoter repression seem involve another factor whose activity affected nsaid nfkappab il1b promoter fragment used study nfkappab responsive bind specifically hsf1
0 11 11 9 12 exposure nsaid complex effect hsp gene expression sulindac activated stress responsive hsp70b promoter sodium salicylate
0 11 11 12 12 exposure nsaid complex effect hsp gene expression sulindac activated stress responsive hsp70b promoter sodium salicylate
1 3 3 7 7 nuclear localization formation betacateninlymphoid enhancer factor 1 complex sufficient activation gene expression
1 3 6 7 7 nuclear localization formation betacateninlymphoid enhancer factor 1 complex sufficient activation gene expression
0 4 4 5 5 introduced small deletion within betacatenin delta19 disrupts binding lef1 ecadherin apc axin
1 0 0 2 2 betacatenin lef1 complex activate reporter gene expression transformed tlymphocyte cell line jurkat normal lymphocyte even though factor nuclear
1 1 1 2 2 betacatenin lef1 complex activate reporter gene expression transformed tlymphocyte cell line jurkat normal lymphocyte even though factor nuclear
0 11 11 8 9 different sequence requirement expression erythroid megakaryocytic cell within regulatory element upstream gata1 gene
0 4 4 5 6 kilobases upstream murine hematopoieticspecific gata1 ie promoter
1 12 12 3 7 composite motif bind multiprotein hematopoieticspecific transcription factor complex includes gata1 scltal1 e2a lmo2 ldb1
1 11 11 3 7 composite motif bind multiprotein hematopoieticspecific transcription factor complex includes gata1 scltal1 e2a lmo2 ldb1
1 13 13 3 7 composite motif bind multiprotein hematopoieticspecific transcription factor complex includes gata1 scltal1 e2a lmo2 ldb1
1 10 10 3 7 composite motif bind multiprotein hematopoieticspecific transcription factor complex includes gata1 scltal1 e2a lmo2 ldb1
0 7 7 8 8 slp76 vav function separate overlapping pathway augment interleukin2 promoter activity
0 6 6 12 13 following cell antigen receptor stimulation slp76 vav undergo tyrosine phosphorylation associate via sh2 domain vav phosphorylated tyrosine slp76
0 6 6 8 8 following cell antigen receptor stimulation slp76 vav undergo tyrosine phosphorylation associate via sh2 domain vav phosphorylated tyrosine slp76
0 5 6 7 7 furthermore slp76 vav synergistic effect interleukin il2 promoter activity cell
0 6 6 5 5 report show two tyrosine tyr113 tyr128 slp76 required binding vav vitro intact cell
0 6 6 7 7 additionally overexpression vav slp76 augments cd28induced il2 promoter activity
0 3 3 4 4 targeted remodeling human betaglobin promoter chromatin structure produce increased expression decreased silencing
0 9 9 19 19 determine whether possible artificially enhance opening chromatin structure minimal betaglobin promoter placed 101bp erythroidspecific dnase 1 hypersensitive siteforming element hsfe immediately upstream betaglobin promoter gene
0 9 9 10 10 determine whether possible artificially enhance opening chromatin structure minimal betaglobin promoter placed 101bp erythroidspecific dnase 1 hypersensitive siteforming element hsfe immediately upstream betaglobin promoter gene
0 17 17 13 13 hsfe induced area enhanced dnase 1 hypersensitivity extending transcriptional start site 300bp artificial promoter significantly increased proportion betaglobin promoter open chromatin configuration
0 14 14 9 10 result indicate relatively small cisacting element able enhance remodeling promoter chromatin structure resulting increased betaglobin gene expression
1 11 11 4 4 understand role nfkappa b complex cell development activation generated transgenic mouse rela crel complex selectively inhibited tlineage cell specific expression transdominant form kappa b alpha
1 12 12 4 4 understand role nfkappa b complex cell development activation generated transgenic mouse rela crel complex selectively inhibited tlineage cell specific expression transdominant form kappa b alpha
0 5 5 12 12 first stat4 required il12dependent transactivation irf1 reporter construct second stat4 binding irf1 promoter shown using emsa
0 7 7 3 4 binding yy1 oct1 novel element downregulates expression il5 human cell
0 6 6 8 8 objective study focus functional analysis human il5 hil5 promoter characterization ci regulatory element transcription factor involved suppression il5 transcription cell
0 10 10 6 6 result identified 5 protein binding region br located within proximal hil5 promoter
0 10 10 9 11 result identified 5 protein binding region br located within proximal hil5 promoter
0 10 10 11 11 result identified 5 protein binding region br located within proximal hil5 promoter
0 6 6 3 3 functional analysis indicates br involved control hil5 promoter activity
0 6 6 7 7 functional analysis indicates br involved control hil5 promoter activity
0 11 11 3 3 two region br3 br4 located position 102 73 previously described regulator il5 expression cell
0 11 11 2 2 two region br3 br4 located position 102 73 previously described regulator il5 expression cell
0 12 12 5 7 show br3 sequence contains novel negative regulatory element located position 90 79 hil5 promoter bind oct1 octamerlike yy1 nuclear factor
0 12 12 1 1 show br3 sequence contains novel negative regulatory element located position 90 79 hil5 promoter bind oct1 octamerlike yy1 nuclear factor
0 12 12 13 13 show br3 sequence contains novel negative regulatory element located position 90 79 hil5 promoter bind oct1 octamerlike yy1 nuclear factor
0 9 9 10 10 substitution mutation abolished binding protein br3 sequence significantly increased hil5 promoter activity activated cell
0 11 11 7 8 conclusion suggest oct1 yy1 octamerlike factor binding 9079 sequence within proximal il5 promoter involved suppression il5 transcription cell
0 11 11 7 8 conclusion suggest oct1 yy1 octamerlike factor binding 9079 sequence within proximal il5 promoter involved suppression il5 transcription cell
0 11 11 12 12 conclusion suggest oct1 yy1 octamerlike factor binding 9079 sequence within proximal il5 promoter involved suppression il5 transcription cell
0 4 4 3 3 dna binding transactivation domain pu
0 4 4 5 6 polymorphism affect oct1 binding tnf promoter region associated severe malaria see comment genetic variation cytokine promoter region postulated influence susceptibility infection molecular mechanism polymorphism might affect gene regulation unknown
0 31 31 17 17 systematic dna footprinting tnf encoding tumour necrosis factor tnf promoter region identified single nucleotide polymorphism snp cause helixturnhelix transcription factor oct1 bind novel region complex proteindna interaction alters gene expression human monocyte
0 19 21 6 6 stat1 activity evident stat binding sequence sbe present promoter gene upregulated monocyte macrophage maturation fcgammari icam1 promoter transcription factor ifn regulatory factor1
0 19 21 3 5 stat1 activity evident stat binding sequence sbe present promoter gene upregulated monocyte macrophage maturation fcgammari icam1 promoter transcription factor ifn regulatory factor1
0 14 14 6 6 stat1 activity evident stat binding sequence sbe present promoter gene upregulated monocyte macrophage maturation fcgammari icam1 promoter transcription factor ifn regulatory factor1
0 14 14 3 5 stat1 activity evident stat binding sequence sbe present promoter gene upregulated monocyte macrophage maturation fcgammari icam1 promoter transcription factor ifn regulatory factor1
0 15 15 8 8 stat1 activity evident stat binding sequence sbe present promoter gene upregulated monocyte macrophage maturation fcgammari icam1 promoter transcription factor ifn regulatory factor1
0 15 15 3 5 stat1 activity evident stat binding sequence sbe present promoter gene upregulated monocyte macrophage maturation fcgammari icam1 promoter transcription factor ifn regulatory factor1
0 4 4 9 9 molecular event leading enhanced stat1 activation cytokine responsiveness concerned y701 s727 stat1 phosphorylation
0 2 2 3 3 tissuespecific regulation ecto5nucleotidase promoter
0 6 6 1 2 isolated 5 region ecto5nucleotidase low km 5nt gene established 969base pair bp fragment confers cellspecific expression cat reporter gene correlate expression endogenous ecto5nt mrna enzymatic activity
0 6 6 2 4 summary identified tissuespecific regulatory region 5 ecto5nt core promoter requires presence functional cre site within basal promoter suppressive activity
0 6 6 7 8 summary identified tissuespecific regulatory region 5 ecto5nt core promoter requires presence functional cre site within basal promoter suppressive activity
0 4 4 1 3 within upstream promoter region bclx potential nfkappabbinding sequence found support nfkappabdependent transcriptional activation
0 4 4 6 7 within upstream promoter region bclx potential nfkappabbinding sequence found support nfkappabdependent transcriptional activation
0 4 5 6 6 oct1 also shown repress interleukin 8 promoter activity
0 5 9 10 10 cebpbeta gata1 synergistically regulate activity eosinophil granule major basic protein promoter implication cebpbeta activity eosinophil gene expression
0 1 1 5 10 analysis mbp promoter region identified cebp ccaatenhancerbinding protein consensus binding site 6 bp upstream functional gatabinding site mbp gene
0 1 1 5 10 analysis mbp promoter region identified cebp ccaatenhancerbinding protein consensus binding site 6 bp upstream functional gatabinding site mbp gene
0 1 1 2 3 analysis mbp promoter region identified cebp ccaatenhancerbinding protein consensus binding site 6 bp upstream functional gatabinding site mbp gene
0 17 17 12 13 electrophoretic mobility shift assay emsas showed recombinant cebpbeta protein could bind potential cebpbinding site bp 90 82 mbp promoter
0 17 17 14 16 electrophoretic mobility shift assay emsas showed recombinant cebpbeta protein could bind potential cebpbinding site bp 90 82 mbp promoter
0 17 17 18 18 electrophoretic mobility shift assay emsas showed recombinant cebpbeta protein could bind potential cebpbinding site bp 90 82 mbp promoter
0 9 9 7 8 furthermore demonstrated cebpbeta gata1 bind simultaneously cebp gatabinding site mbp promoter
0 9 9 10 10 furthermore demonstrated cebpbeta gata1 bind simultaneously cebp gatabinding site mbp promoter
0 11 11 12 12 determine functionality cebp gata binding site analyzed whether cebpbeta gata1 stimulate mbp promoter cebpbeta gata1 negative jurkat tcell line
0 14 14 15 15 expression fog riend ata bind gata1 act cofactor gatabinding protein decreased transactivation activity gata1 mbp promoter dosedependent manner
1 5 5 6 6 tnf major inducer nfkappab particularly p50p65 complex whereas il7 act cofactor sustaining expression p75 tnf receptor
0 13 13 18 18 report model cd28 costimulation using pma plus natural ligand cd80 resulted limited stimulation il2 evidenced cytokine production il2 promoter stimulation
0 9 9 0 0 promoter assay revealed cd28dependent effect nfkappab ap1 nfat intact il2 promoter
1 4 4 1 1 cd23induced nfkappab heterodimer composed p65p50 subunit
1 4 4 2 3 cd23induced nfkappab heterodimer composed p65p50 subunit
1 4 4 2 3 cd23induced nfkappab heterodimer composed p65p50 subunit
1 4 4 1 1 cd23induced nfkappab heterodimer composed p65p50 subunit
0 11 11 13 13 aml1 cbfalpha2 cooperates b cellspecific activating protein bsappax5 activation b cellspecific blk gene promoter
0 20 23 25 25 understand function aml1 b cell differentiation analyzed regulatory region b cellspecific gene potential aml1binding site identified putative aml1binding site promoter b cellspecific tyrosine kinase gene blk
0 20 23 25 25 understand function aml1 b cell differentiation analyzed regulatory region b cellspecific gene potential aml1binding site identified putative aml1binding site promoter b cellspecific tyrosine kinase gene blk
0 14 14 11 13 furthermore vitro binding analysis revealed aml1 runt dnabinding domain physically interacts paired dnabinding domain bsap b cellspecific transcription factor
0 5 5 5 8 furthermore vitro binding analysis revealed aml1 runt dnabinding domain physically interacts paired dnabinding domain bsap b cellspecific transcription factor
0 13 13 14 14 physical interaction aml1 bsap correlate functional cooperativity transfection study aml1 bsap synergistically activate blk promoter transcription 50fold
1 2 2 10 11 shown cmaf cmyb transcription factor physically interact myeloid cell form inhibitory complex hinder transactivation cmyb target gene direct binding myb consensus site
1 1 1 10 11 shown cmaf cmyb transcription factor physically interact myeloid cell form inhibitory complex hinder transactivation cmyb target gene direct binding myb consensus site
1 11 11 9 9 tnfalpha treatment induces rapid translocation 65 kd transcriptional activator nfkappab subunit rel whose binding nucleus occurs change intracellular ro
0 7 7 3 5 deletion substitution putative nfkappab binding site identified bclx promoter significantly decreased taxinduced transactivation
0 7 7 8 8 deletion substitution putative nfkappab binding site identified bclx promoter significantly decreased taxinduced transactivation
0 3 3 4 4 furthermore taxinduced transactivation bclx promoter also diminished mutant ikappabalpha specifically inhibits nfkappab activity
0 13 13 5 5 il4 activates gene expression inducing tyrosine phosphorylation homodimerization nuclear translocation latent transcription factor stat6 signal transducer activator transcription6
1 5 5 3 3 total protein content nfkappab subunit p65 mnc lysates also showed decrease following hydrocortisone injection
0 9 9 10 12 lymphoid cellspecific nuclear factor containing crellike protein preferentially interacts interleukin6 kappa brelated motif whose activity repressed lymphoid cell
1 1 1 6 6 show crel bind kappa b site homodimers well heterodimers p50
1 1 1 8 8 show crel bind kappa b site homodimers well heterodimers p50
1 9 9 8 8 show crel bind kappa b site homodimers well heterodimers p50
1 1 1 2 2 particular crel homodimer high affinity interleukin6 il6 beta interferon kappa b site
0 5 5 9 11 particular crel homodimer high affinity interleukin6 il6 beta interferon kappa b site
0 7 8 9 11 particular crel homodimer high affinity interleukin6 il6 beta interferon kappa b site
0 17 17 18 19 spite association p50 vitro however found lymphoid cellspecific nuclear factor vivo contains crel p50 epitope factor termed il6 kappa b binding factor ii appears contain crel homodimer preferentially recognizes several il6 kappa brelated kappa b motif
1 12 12 26 26 spite association p50 vitro however found lymphoid cellspecific nuclear factor vivo contains crel p50 epitope factor termed il6 kappa b binding factor ii appears contain crel homodimer preferentially recognizes several il6 kappa brelated kappa b motif
0 17 17 30 35 spite association p50 vitro however found lymphoid cellspecific nuclear factor vivo contains crel p50 epitope factor termed il6 kappa b binding factor ii appears contain crel homodimer preferentially recognizes several il6 kappa brelated kappa b motif
0 12 12 14 14 spite association p50 vitro however found lymphoid cellspecific nuclear factor vivo contains crel p50 epitope factor termed il6 kappa b binding factor ii appears contain crel homodimer preferentially recognizes several il6 kappa brelated kappa b motif
0 2 2 14 14 spite association p50 vitro however found lymphoid cellspecific nuclear factor vivo contains crel p50 epitope factor termed il6 kappa b binding factor ii appears contain crel homodimer preferentially recognizes several il6 kappa brelated kappa b motif
0 3 3 4 6 although previously shown il6 kappa b motif function potent il1tumor necrosis factorresponsive element nonlymphoid cell activity found repressed lymphoid cell jurkat tcell line
0 3 3 4 5 also present evidence il6 kappa b binding factor ii function repressor specific il6 kappa brelated kappa b motif lymphoid cell
0 3 3 12 17 also present evidence il6 kappa b binding factor ii function repressor specific il6 kappa brelated kappa b motif lymphoid cell
0 10 10 11 11 addition bsap found abundant dnabinding activity bcell nuclear extract interacts cd19 promoter
0 1 1 13 13 interleukin2 il2 gene expression controlled transcriptionally cooperative activity specific transactivating factor bind il2 enhancer
0 13 13 12 12 however csa fk506 inhibit appearance dna binding activity factor bind nfat ap1 site il2 enhancer
0 13 13 14 14 however csa fk506 inhibit appearance dna binding activity factor bind nfat ap1 site il2 enhancer
0 21 24 17 20 report interleukin 2 il2 act human blood monocyte enhancing binding activity transcription factor nfkappa b consensus sequence 5 regulatory enhancer region il2 receptor alpha chain p55
0 9 12 21 24 enhanced nfkappa b binding activity followed functional activation inducibility il2 receptor alpha chain mediated enhanced nfkappa b binding heterologous promoter containing nfkappa b consensus sequence 291 245 il2 receptor alpha chain gene activated
0 9 12 25 26 enhanced nfkappa b binding activity followed functional activation inducibility il2 receptor alpha chain mediated enhanced nfkappa b binding heterologous promoter containing nfkappa b consensus sequence 291 245 il2 receptor alpha chain gene activated
1 6 6 11 12 addition il2 capable increasing transcript level p50 gene coding p50 subunit nfkappa b transcription factor whereas mrna level p65 nfkappa b gene remained unchanged
0 2 5 6 7 regulation human tumor necrosis factor alpha promoter region macrophage cell b cell line
0 3 7 8 9 1311base pair human tumor necrosis factor tnf alpha promoter region fused luciferase luc reporter gene studied transient transfection system three tnf producing cell line u937 macrophage cell line mla 144 cell line 7296 b cell line
1 3 3 2 2 also true kbf p50 homodimer binding activity u937 cell
1 3 3 4 4 also true kbf p50 homodimer binding activity u937 cell
0 10 11 2 6 human genome erythroidspecific hypersensitive site hs2 enhancer regulates transcription downstream betalike globin gene 1050 kilobases away
1 3 3 8 10 protooncogene product cfo cjun heterodimerize leucine zipper form ap1 transcription factor
1 2 2 8 10 protooncogene product cfo cjun heterodimerize leucine zipper form ap1 transcription factor
0 5 5 2 3 previously found cisacting region spanning gmcsf promoter region position 95 27 confers inducibility reporter gene transient transfection assay
0 5 5 6 7 previously found cisacting region spanning gmcsf promoter region position 95 27 confers inducibility reporter gene transient transfection assay
0 8 8 3 5 kappa bmad3 mask nuclear localization signal nfkappa b p65 requires transactivation domain inhibit nfkappa b p65 dna binding
1 8 8 6 7 kappa bmad3 mask nuclear localization signal nfkappa b p65 requires transactivation domain inhibit nfkappa b p65 dna binding
1 8 8 6 7 kappa bmad3 mask nuclear localization signal nfkappa b p65 requires transactivation domain inhibit nfkappa b p65 dna binding
1 15 15 3 7 active nuclear form nfkappa b transcription factor complex composed two dna binding subunit nfkappa b p65 nfkappa b p50 share extensive nterminal sequence homology vrel oncogene product
1 18 18 3 7 active nuclear form nfkappa b transcription factor complex composed two dna binding subunit nfkappa b p65 nfkappa b p50 share extensive nterminal sequence homology vrel oncogene product
1 15 15 3 4 active nuclear form nfkappa b transcription factor complex composed two dna binding subunit nfkappa b p65 nfkappa b p50 share extensive nterminal sequence homology vrel oncogene product
1 2 2 0 1 nfkappa b p65 subunit provides transactivation activity complex serf intracellular receptor cytoplasmic inhibitor nfkappa b termed kappa b
1 3 3 1 2 contrast nfkappa b p50 alone fails stimulate kappa bdirected transcription based prior vitro study directly regulated kappa b
1 14 14 6 7 investigate molecular basis critical regulatory interaction nfkappa b kappa bmad3 series human nfkappa b p65 mutant identified functionally segregated dna binding kappa bmediated inhibition kappa binduced nuclear exclusion transcription factor
0 7 7 54 56 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
0 7 7 67 67 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
0 7 7 50 52 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
1 7 7 5 6 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
1 7 7 5 6 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
1 7 7 5 6 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
1 7 7 5 6 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
1 7 7 5 6 result vivo expression study performed nfkappa b p65 mutant revealed following 1 kappa bmad3 completely inhibits nfkappa b p65dependent transcriptional activation mediated human immunodeficiency virus type 1 kappa b enhancer human lymphocyte 2 binding kappa bmad3 nfkappa b p65 sufficient retarget nfkappa b p65 nucleus cytoplasm 3 selective deletion functional nuclear localization signal present rel homology domain nfkappa b p65 disrupts ability engage kappa bmad3 4 unique cterminus nfkappa b p65 attenuates nuclear localization contains sequence required kappa bmediated inhibition nfkappa b p65 dna binding activity
0 10 10 3 5 together finding suggest nuclear localization signal transactivation domain nfkappa b p65 constitute bipartite system critically involved inhibitory function kappa bmad3
1 10 10 8 9 together finding suggest nuclear localization signal transactivation domain nfkappa b p65 constitute bipartite system critically involved inhibitory function kappa bmad3
1 11 11 9 10 unexpectedly vivo study also demonstrate kappa bmad3 bind directly nfkappa b p50
0 15 15 9 10 however loss dna binding activity observed presumably reflecting unique cterminal domain distinct present nfkappa b p65
1 15 15 13 14 however loss dna binding activity observed presumably reflecting unique cterminal domain distinct present nfkappa b p65
1 5 5 0 1 nfkappa bdependent induction nfkappa b p50 subunit gene promoter underlies selfperpetuation human immunodeficiency virus transcription monocytic cell
0 5 5 8 8 nfkappa bdependent induction nfkappa b p50 subunit gene promoter underlies selfperpetuation human immunodeficiency virus transcription monocytic cell
0 8 8 1 1 activity promoter regulating synthesis p105 precursor nfkappa b p50 subunit enhanced cell
0 4 4 1 1 activity promoter regulating synthesis p105 precursor nfkappa b p50 subunit enhanced cell
1 8 8 6 7 activity promoter regulating synthesis p105 precursor nfkappa b p50 subunit enhanced cell
1 10 10 8 9 observation indicate chronic hiv infection u937 cell continuous nfkappa b p50p65 translocation result p105 promoter upregulation subsequent cytosolic nfkappa b accumulation ready translocation
1 10 10 8 9 observation indicate chronic hiv infection u937 cell continuous nfkappa b p50p65 translocation result p105 promoter upregulation subsequent cytosolic nfkappa b accumulation ready translocation
1 10 10 10 10 observation indicate chronic hiv infection u937 cell continuous nfkappa b p50p65 translocation result p105 promoter upregulation subsequent cytosolic nfkappa b accumulation ready translocation
1 10 10 10 10 observation indicate chronic hiv infection u937 cell continuous nfkappa b p50p65 translocation result p105 promoter upregulation subsequent cytosolic nfkappa b accumulation ready translocation
0 13 13 14 14 observation indicate chronic hiv infection u937 cell continuous nfkappa b p50p65 translocation result p105 promoter upregulation subsequent cytosolic nfkappa b accumulation ready translocation
0 13 14 15 15 result indicate defective recruitment nfkappa b may underlie nefs negative transcriptional effect hiv1 interleukin 2 promoter
1 5 5 11 11 novel mitogeninducible gene product related p50p105nfkappa b participates transactivation kappa b site
1 5 5 11 11 novel mitogeninducible gene product related p50p105nfkappa b participates transactivation kappa b site
1 9 9 6 6 p50b able form heteromeric kappa bbinding complex relb well p65 p50 two subunit nfkappa b
1 0 0 6 6 p50b able form heteromeric kappa bbinding complex relb well p65 p50 two subunit nfkappa b
1 9 9 13 14 p50b able form heteromeric kappa bbinding complex relb well p65 p50 two subunit nfkappa b
1 0 0 3 6 p50b able form heteromeric kappa bbinding complex relb well p65 p50 two subunit nfkappa b
1 7 7 3 6 p50b able form heteromeric kappa bbinding complex relb well p65 p50 two subunit nfkappa b
0 7 7 5 5 binding erythroid nonerythroid nuclear protein silencer human epsilonglobinencoding gene
0 16 16 9 11 previously reported presence transcriptional control element property silencer extending 392 177 bp relative cap site human epsilonglobinencoding gene cao et al
0 16 16 13 14 previously reported presence transcriptional control element property silencer extending 392 177 bp relative cap site human epsilonglobinencoding gene cao et al
0 2 2 3 3 data suggest il4 promoter activity normally downregulated nre via repression enhancer positive regulatory element
1 8 8 9 10 blockade dnabinding complex antifos mab demonstrated direct participation cfo ap1 complex induced antiaim mab
1 26 26 27 27 furthermore using dna template containing two copy prdii domain linked rabbit beta globin gene purified polypeptide specifically stimulated nfkappa b dependent transcription vitro reconstitution assay heterodimers p50 homodimers
0 7 7 2 4 oct2 transactivation remote enhancer position requires bcellrestricted activity
0 8 8 3 4 mutational analysis indicate carboxyterminal domain oct2 critical enhancer activation
0 14 14 0 2 glutaminerich activation domain present aminoterminal portion oct2 pou domain contribute marginally transactivation function distal position
0 5 5 6 6 nuclear transcription factor bind element il2 promoter
0 7 7 8 8 prior study identified several element contribute activity il2 promoter stimulated cell line jurkat
0 10 10 0 2 erythroid specific enhancer upstream gene encoding celltype specific transcription factor gata1
0 15 15 17 17 region upstream first exon highly conserved mouse man act erythroid specific enhancer transient assay linked gata1 sv40 promoter
1 7 7 6 7 activity enhancer almost completely dependent integrity dimeric gata1 binding site
1 10 10 1 2 two dnaprotein complex composed least four host protein p50 p55 p75 p85 share structural similarity vrel oncogene product
1 8 8 1 2 two dnaprotein complex composed least four host protein p50 p55 p75 p85 share structural similarity vrel oncogene product
1 9 9 13 14 dnaprotein crosslinking study revealed rapidly migrating b2 complex contains p50 p55 slowly migrating b1 complex composed p50 p55 p75 p85
1 10 10 6 7 dnaprotein crosslinking study revealed rapidly migrating b2 complex contains p50 p55 slowly migrating b1 complex composed p50 p55 p75 p85
1 9 9 6 7 dnaprotein crosslinking study revealed rapidly migrating b2 complex contains p50 p55 slowly migrating b1 complex composed p50 p55 p75 p85
1 12 12 13 14 sitedirected mutagenesis wildtype il2r alpha kappa b enhancer ggggaatctccc revealed binding p50 p55 b2 complex particularly sensitive alteration 5 triplet deoxyguanosine residue
1 11 11 13 14 sitedirected mutagenesis wildtype il2r alpha kappa b enhancer ggggaatctccc revealed binding p50 p55 b2 complex particularly sensitive alteration 5 triplet deoxyguanosine residue
0 3 4 5 7 sitedirected mutagenesis wildtype il2r alpha kappa b enhancer ggggaatctccc revealed binding p50 p55 b2 complex particularly sensitive alteration 5 triplet deoxyguanosine residue
1 7 7 2 3 contrast formation b1 complex reflecting binding p75 p85 critically depends upon 3 sequence enhancer element
1 6 6 2 3 contrast formation b1 complex reflecting binding p75 p85 critically depends upon 3 sequence enhancer element
0 4 6 1 3 activity kappa b enhancer interleukin2 receptor alpha chain somatic cell hybrid accompanied nuclear localization nfkappa b
1 8 8 3 4 two nuclear protein nfkappa b consisting subunit p50 p65 dnabinding subunit nfkappa b p50 also called kbf1 constitutively expressed localized nucleus human tcell line iarc 301
1 16 16 3 4 two nuclear protein nfkappa b consisting subunit p50 p65 dnabinding subunit nfkappa b p50 also called kbf1 constitutively expressed localized nucleus human tcell line iarc 301
0 5 9 0 2 kappa b enhancer gene encoding interleukin2 il2 receptor alpha chain il2r alpha functional hybrid expressing nuclear nfkappa b
0 1 2 4 5 human interferon beta ifnbeta regulatory element consists multiple enhanson domain target transcription factor involved inducible expression promoter
0 12 13 14 14 uninduced sendai virus induced hela extract used examine transcription vitro using series ifn beta promoter deletion
0 2 2 3 3 24fold increase ifnbeta promoter transcription observed sendai virus induced extract deletion prdi prdii element decreased induced level transcription
0 26 26 21 23 one induced transcript mad3 encodes protein 317 amino acid one domain containing five tandem repeat cdc10ankyrin motif 60 similar 46 identical ankyrin repeat region precursor nfkappa bkbf1 p50
1 9 9 10 12 vitro translated mad3 protein found specifically inhibit dnabinding activity p50p65 nfkappa b complex p50p50 kbf1 factor dnabinding protein
1 9 9 10 12 vitro translated mad3 protein found specifically inhibit dnabinding activity p50p65 nfkappa b complex p50p50 kbf1 factor dnabinding protein
1 9 9 15 15 vitro translated mad3 protein found specifically inhibit dnabinding activity p50p65 nfkappa b complex p50p50 kbf1 factor dnabinding protein
1 9 9 15 15 vitro translated mad3 protein found specifically inhibit dnabinding activity p50p65 nfkappa b complex p50p50 kbf1 factor dnabinding protein
0 6 6 4 5 nuclear factor nfgm2 interacts regulatory region gmcsf gene essential induction response tcell activation purification human tcell leukemia line jurkat cell similarity nfkappa b
0 6 6 3 4 demonstrated earlier study upstream region mouse gmcsf promoter position 95 73 essential transcriptional activation response pmaa23187
0 6 6 9 10 demonstrated earlier study upstream region mouse gmcsf promoter position 95 73 essential transcriptional activation response pmaa23187
0 6 6 3 7 demonstrated earlier study upstream region mouse gmcsf promoter position 95 73 essential transcriptional activation response pmaa23187
0 6 6 7 7 demonstrated earlier study upstream region mouse gmcsf promoter position 95 73 essential transcriptional activation response pmaa23187
1 4 4 1 1 purified nfgm2 consists 50 p50 65 kda p65 polypeptide binding activity specific gmcsf immunoglobulin kappa ggaaagtccc enhancer
0 12 12 16 16 purified nfgm2 consists 50 p50 65 kda p65 polypeptide binding activity specific gmcsf immunoglobulin kappa ggaaagtccc enhancer
1 2 2 5 6 electrophoretically purified p50 alone form proteindna complex mixture p50 associate preferentially p65 form nfgm2 complex
1 11 11 13 14 electrophoretically purified p50 alone form proteindna complex mixture p50 associate preferentially p65 form nfgm2 complex
1 1 1 7 8 addition p65 gave per se low affinity proteindna complex migrated slowly native nfgm2 complex
1 10 10 11 11 furthermore antiserum kbf1 identical 50 kda nfkappa b protein reacted p50 nfgm2 indicating nfgm2 polypeptide cannot immunologically differentiated 50 kda subunit nfkappa b
1 2 2 6 7 furthermore antiserum kbf1 identical 50 kda nfkappa b protein reacted p50 nfgm2 indicating nfgm2 polypeptide cannot immunologically differentiated 50 kda subunit nfkappa b
0 11 11 14 15 purified nfgm2 activated vitro transcription kappa b enhancer failed stimulate transcription gmcsf promoter harboring gm2 sequence
0 11 11 12 12 purified nfgm2 activated vitro transcription kappa b enhancer failed stimulate transcription gmcsf promoter harboring gm2 sequence
1 8 8 10 10 inhibition phorbol esterinduced monocytic differentiation dexamethasone associated downregulation cfo cjun ap1
1 9 9 10 10 inhibition phorbol esterinduced monocytic differentiation dexamethasone associated downregulation cfo cjun ap1
0 8 8 7 15 define effect dexamethasone molecular level prepared series deleted cjun promoter fragment linked chloramphenicol acetyltransferase cat gene
0 12 13 7 15 define effect dexamethasone molecular level prepared series deleted cjun promoter fragment linked chloramphenicol acetyltransferase cat gene
0 8 8 9 10 define effect dexamethasone molecular level prepared series deleted cjun promoter fragment linked chloramphenicol acetyltransferase cat gene
0 10 11 12 12 one base pair change abolishes cellrestricted activity kblike protoenhancer element interleukin 2 promoter
0 5 6 12 12 inducible cellspecific enhancer murine human interleukin 2 il2 gene contain kblike sequence gggatttcacc essential cisacting enhancer motif
0 5 6 10 11 inducible cellspecific enhancer murine human interleukin 2 il2 gene contain kblike sequence gggatttcacc essential cisacting enhancer motif
0 5 6 1 2 inducible cellspecific enhancer murine human interleukin 2 il2 gene contain kblike sequence gggatttcacc essential cisacting enhancer motif
0 5 6 13 16 inducible cellspecific enhancer murine human interleukin 2 il2 gene contain kblike sequence gggatttcacc essential cisacting enhancer motif
0 0 0 3 3 tcf1 consists two polypeptide 50 kd 105 kd former seems related 50 kd polypeptide nfkb
0 0 0 4 5 tcf1 consists two polypeptide 50 kd 105 kd former seems related 50 kd polypeptide nfkb
0 0 0 6 7 tcf1 consists two polypeptide 50 kd 105 kd former seems related 50 kd polypeptide nfkb
1 8 8 11 13 absence binding localized nfkappa b region hiv1 enhancer 65kda plus 50kda nfkappa b heterodimer preferentially lost
1 1 1 4 4 binding 65kda plus 50kda heterodimer hiv1 enhancer negatively regulated monocyte providing one mechanism restricting hiv1 gene expression
1 3 3 4 4 binding 65kda plus 50kda heterodimer hiv1 enhancer negatively regulated monocyte providing one mechanism restricting hiv1 gene expression
1 28 28 8 9 isolation relrelated human cdna potentially encodes 65kd subunit nfkappa b published erratum appears science 1991 oct 4254502811 dna probe spanned domain conserved among protooncogene crel drosophila morphogen dorsal p50 dna binding subunit nfkappa b generated jurkat cell complementary dna polymerase chain reaction pcr degenerate oligonucleotides
1 4 4 6 7 addition 65kd protein associated p50 subunit nfkappa b kappa b probe form complex electrophoretic mobility nfkappa bdna complex
1 21 21 10 12 one gene interest glycoprotein iib gpiib gene gpiib alpha subunit platelet cytoadhesin gpiibiiia produced megakaryocyte early stage differentiation whereas subunit complex gpiiia expressed cell
1 5 5 10 12 one gene interest glycoprotein iib gpiib gene gpiib alpha subunit platelet cytoadhesin gpiibiiia produced megakaryocyte early stage differentiation whereas subunit complex gpiiia expressed cell
0 3 6 22 24 minimal region human tumor necrosis factor alpha tnfalpha gene promoter necessary transcriptional induction phorbol ester pma human b lymphocyte cell line localized 52 89 nucleotide nt relative gene transcriptional start site
0 3 6 22 30 minimal region human tumor necrosis factor alpha tnfalpha gene promoter necessary transcriptional induction phorbol ester pma human b lymphocyte cell line localized 52 89 nucleotide nt relative gene transcriptional start site
0 3 6 9 9 minimal region human tumor necrosis factor alpha tnfalpha gene promoter necessary transcriptional induction phorbol ester pma human b lymphocyte cell line localized 52 89 nucleotide nt relative gene transcriptional start site
0 3 3 9 10 although three site tnfalpha promoter kappa 1 kappa 2 kappa 3 specifically bind transcription factor nfkappa b lymphoid nuclear extract tnfalpha mrna induction pma correlate nfkappa b binding activity displayed different b cell line
0 3 3 4 4 although three site tnfalpha promoter kappa 1 kappa 2 kappa 3 specifically bind transcription factor nfkappa b lymphoid nuclear extract tnfalpha mrna induction pma correlate nfkappa b binding activity displayed different b cell line
0 5 5 6 6 moreover kappa 1kappa 3 deleted tnfalpha promoter little effect gene inducibility pma
0 3 3 4 4 however functional truncated tnfalpha promoter indicating promoter context cell type specificity influence pma inducible function nfkappa b binding site
0 7 10 12 12 purification tcf1 alpha tcellspecific transcription factor activates tcell receptor c alpha gene enhancer contextdependent manner
0 11 12 13 13 tcf1 alpha originally identified purified binding site hiv1 promoter found bind tcr alpha enhancer promoter several gene expressed significantly earlier stage tcell development tcr alpha gene e
0 10 11 15 15 sequence related tcf1 alpha binding motif 5ggcaccctttga3 also found human tcr delta possibly tcr beta enhancer
0 13 14 15 15 sequence related tcf1 alpha binding motif 5ggcaccctttga3 also found human tcr delta possibly tcr beta enhancer
0 3 4 1 2 small 95bp fragment tcr alpha control region contains tcf1 alpha binding site juxtaposed campresponse element cre alpha 1 motif binding site distinct lymphoidspecific protein tcf2 alpha behaved potent tcellspecific enhancer vivo
0 3 4 13 14 small 95bp fragment tcr alpha control region contains tcf1 alpha binding site juxtaposed campresponse element cre alpha 1 motif binding site distinct lymphoidspecific protein tcf2 alpha behaved potent tcellspecific enhancer vivo
0 3 4 28 29 small 95bp fragment tcr alpha control region contains tcf1 alpha binding site juxtaposed campresponse element cre alpha 1 motif binding site distinct lymphoidspecific protein tcf2 alpha behaved potent tcellspecific enhancer vivo
0 3 4 10 11 small 95bp fragment tcr alpha control region contains tcf1 alpha binding site juxtaposed campresponse element cre alpha 1 motif binding site distinct lymphoidspecific protein tcf2 alpha behaved potent tcellspecific enhancer vivo
0 3 4 18 18 small 95bp fragment tcr alpha control region contains tcf1 alpha binding site juxtaposed campresponse element cre alpha 1 motif binding site distinct lymphoidspecific protein tcf2 alpha behaved potent tcellspecific enhancer vivo
0 3 4 5 6 small 95bp fragment tcr alpha control region contains tcf1 alpha binding site juxtaposed campresponse element cre alpha 1 motif binding site distinct lymphoidspecific protein tcf2 alpha behaved potent tcellspecific enhancer vivo
0 6 7 8 8 tcf1 alpha binding site also required tcr alpha enhancer activity transcriptionally active extract jurkat hela cell confirming tcf1 alpha tcellspecific transcription factor
0 10 11 8 9 curiously tcf1 alpha binding element inactive vivo removed neighboring element tcr alpha enhancer positioned one copy upstream heterologous promoter
0 10 11 12 12 curiously tcf1 alpha binding element inactive vivo removed neighboring element tcr alpha enhancer positioned one copy upstream heterologous promoter
0 18 19 20 20 thus transcriptional activity tcf1 alpha appears depend tcf2 alpha alpha 1 creb transcription factor context binding site within tcr alpha enhancer
0 7 7 4 6 novel tcell transactivator recognizes phorbol esterinducible element interleukin2 promoter
0 7 7 8 8 novel tcell transactivator recognizes phorbol esterinducible element interleukin2 promoter
0 0 1 4 4 interleukin 2 il2 gene promoter recognized several celltypespecific ubiquitous transcriptional regulator integrate information transmitted various signaling system leading il2 production tcell activation
0 23 23 10 10 using combination transfection proteindna binding vitro transcription method discovered novel tcellspecific transcriptional activator tcf1 tcell factor1 recognizes tcellspecific response element tce located within il2 promoter
0 23 23 17 19 using combination transfection proteindna binding vitro transcription method discovered novel tcellspecific transcriptional activator tcf1 tcell factor1 recognizes tcellspecific response element tce located within il2 promoter
0 23 23 24 24 using combination transfection proteindna binding vitro transcription method discovered novel tcellspecific transcriptional activator tcf1 tcell factor1 recognizes tcellspecific response element tce located within il2 promoter
1 3 3 0 0 ap1 polypeptide product cjun recognizes bind specific dna sequence stimulates transcription gene responsive certain growth factor phorbol ester 12otetradecanoylphorbol13acetate tpa
0 4 4 6 8 based result propose ntf otf2 interaction cognate dna element possibly proteinprotein level may critical bcellspecific expression interaction provide additional pathway regulating gene expression
0 5 5 0 2 tandem ap1binding site within human betaglobin dominant control region function inducible enhancer erythroid cell
0 5 5 10 11 tandem ap1binding site within human betaglobin dominant control region function inducible enhancer erythroid cell
0 5 5 6 8 tandem ap1binding site within human betaglobin dominant control region function inducible enhancer erythroid cell
0 11 11 1 1 powerful enhancer mapped 18bp dna segment located 11 kb 5 human epsilonglobin gene within dominant control locusactivating region
0 11 11 3 5 powerful enhancer mapped 18bp dna segment located 11 kb 5 human epsilonglobin gene within dominant control locusactivating region
0 11 11 14 15 powerful enhancer mapped 18bp dna segment located 11 kb 5 human epsilonglobin gene within dominant control locusactivating region
0 8 8 0 0 enhancer inducible k562 human erythroleukemia cell increasing linked gammaglobin promoterluciferase gene expression 170fold enhancerless construct
0 8 8 9 9 enhancer inducible k562 human erythroleukemia cell increasing linked gammaglobin promoterluciferase gene expression 170fold enhancerless construct
0 18 18 14 15 analyzed distribution nfat transcriptional activity among cell undergoing activation using construct three tandem copy nfatbinding site directs transcription lacz gene
0 6 6 7 7 similar construct controlled nfkappa b entire interleukin2 enhancer show bimodal expression pattern induction suggesting threshold set concentration transcription factor may common property inducible gene
0 17 18 19 19 expression highly specific protein inhibitor cyclic ampdependent protein kinase interleukin1 il1responsive cell blocked il1induced gene transcription driven kappa immunoglobulin enhancer human immunodeficiency virus long terminal repeat
1 13 13 6 6 report formation two distinct mitogeninducible dnabinding complex kappa b complex within hiv enhancer nfat1 complex within interleukin2 enhancer inhibited presence csa
0 21 22 14 15 effect tnfalpha gene expression examined transient expression assay using reporter chloramphenicol acetyltransferase plasmid linked regulatory element hiv long terminal repeat ltr beta interferon promoter
0 21 22 23 23 effect tnfalpha gene expression examined transient expression assay using reporter chloramphenicol acetyltransferase plasmid linked regulatory element hiv long terminal repeat ltr beta interferon promoter
0 11 11 16 18 addition phosphorothioate oligonucleotides contained octamer consensus jurkat leukemia cell inhibited interleukin2 il2 secretion degree similar observed mutated octamer site il2 enhancer
0 11 11 20 20 addition phosphorothioate oligonucleotides contained octamer consensus jurkat leukemia cell inhibited interleukin2 il2 secretion degree similar observed mutated octamer site il2 enhancer
0 8 9 10 10 c1 c2 protein also bind similar sequence found interleukin2receptor alphasubunit enhancer
0 7 7 8 8 sp1 transcription factor bound three different region cd14 promoter
0 22 22 3 4 mutation major sp1 binding site 110 bp decreased tissuespecific promoter activity result together transactivation experiment demonstrate sp1 play critical role tissuespecific expression cd14 monocytic cell
1 9 9 4 7 tolerance lipopolysaccharide involves mobilization nuclear factor kappa b predominance p50 homodimers
1 9 9 10 10 tolerance lipopolysaccharide involves mobilization nuclear factor kappa b predominance p50 homodimers
1 18 18 1 3 resolution nfkappa b complex gel shift analysis show binding protein mobilized naive mono mac 6 cell consists mainly p50p65 heterodimers tolerant cell p50 homodimer predominant
1 18 18 1 3 resolution nfkappa b complex gel shift analysis show binding protein mobilized naive mono mac 6 cell consists mainly p50p65 heterodimers tolerant cell p50 homodimer predominant
1 18 18 1 3 resolution nfkappa b complex gel shift analysis show binding protein mobilized naive mono mac 6 cell consists mainly p50p65 heterodimers tolerant cell p50 homodimer predominant
1 18 18 19 19 resolution nfkappa b complex gel shift analysis show binding protein mobilized naive mono mac 6 cell consists mainly p50p65 heterodimers tolerant cell p50 homodimer predominant
1 18 18 19 19 resolution nfkappa b complex gel shift analysis show binding protein mobilized naive mono mac 6 cell consists mainly p50p65 heterodimers tolerant cell p50 homodimer predominant
1 18 18 23 23 resolution nfkappa b complex gel shift analysis show binding protein mobilized naive mono mac 6 cell consists mainly p50p65 heterodimers tolerant cell p50 homodimer predominant
1 10 10 7 8 tolerant blood monocyte also upregulate cd14 mobilize nfkappa b predominance p50 homodimers
1 10 10 11 11 tolerant blood monocyte also upregulate cd14 mobilize nfkappa b predominance p50 homodimers
0 4 4 5 6 critical issue concern mechanism cd14 transmembrane domain transduces signal following lp binding
0 2 2 2 5 recently cloned cd14 5 upstream sequence demonstrated tissuespecific promoter activity
0 10 10 10 13 using stable transfection monocytoid u937 cell line series deletion mutant cd14 5 upstream sequence coupled reporter gene construct show bp 128 70 critical region induction cd14 expression
0 9 9 10 10 one gene product overexpressed jurkat cell specifically induced transcription interleukin2 enhancer activating tcellspecific transcription factor nfat nfil2a
0 5 5 1 3 since kappa b motif present vcam1 intercellular adhesion molecule1 icam1 promoter used pdtc study regulatory mechanism vcam1 icam1 induction subsequent monocyte adhesion tnftreated human umbilical vein endothelial cell huvecs
0 6 8 1 3 since kappa b motif present vcam1 intercellular adhesion molecule1 icam1 promoter used pdtc study regulatory mechanism vcam1 icam1 induction subsequent monocyte adhesion tnftreated human umbilical vein endothelial cell huvecs
0 5 5 10 10 since kappa b motif present vcam1 intercellular adhesion molecule1 icam1 promoter used pdtc study regulatory mechanism vcam1 icam1 induction subsequent monocyte adhesion tnftreated human umbilical vein endothelial cell huvecs
0 4 4 0 2 serum response element sre cfo regulatory region participates induction transcription various growth factor phorbol ester subsequent squelching transcription
0 4 4 3 3 serum response element sre cfo regulatory region participates induction transcription various growth factor phorbol ester subsequent squelching transcription
0 4 4 5 6 serum response element sre cfo regulatory region participates induction transcription various growth factor phorbol ester subsequent squelching transcription
0 3 3 12 13 demonstrate deletion human udg promoter sequence expression e2f1 activates udg promoter several e2f site
0 3 3 2 5 demonstrate deletion human udg promoter sequence expression e2f1 activates udg promoter several e2f site
0 3 3 4 4 demonstrate deletion human udg promoter sequence expression e2f1 activates udg promoter several e2f site
1 10 10 11 11 major putative downstream site e2f located first exon serf target e2f1dp1 complex binding vitro
1 10 10 11 11 major putative downstream site e2f located first exon serf target e2f1dp1 complex binding vitro
1 6 6 9 12 addition integrin ligation lead nuclear translocation p50 p65 subunit nfkappa b transcription factor activation reporter gene driven promoter containing nfkappa b site increased level mrna immediateearly gene including cytokine interleukin il1 beta
1 7 7 9 12 addition integrin ligation lead nuclear translocation p50 p65 subunit nfkappa b transcription factor activation reporter gene driven promoter containing nfkappa b site increased level mrna immediateearly gene including cytokine interleukin il1 beta
0 14 14 9 10 component tyrosine phosphorylated subsequent cell adhesion include paxillin pp125fak sh2 domain containing tyrosine kinase syk
0 7 7 5 5 contrast integrin ligation antibody induces tyrosine phosphorylation syk fak paxillin
0 9 9 5 5 adhering cell pretreatment cytochalasin suppresses tyrosine phosphorylation fak paxillin syk il1 beta message induction unaffected
0 6 6 7 7 distinct signaling property identify functionally different cd4 epitope
0 2 2 16 16 investigated effect cd4 triggering cell activating signal lymphoma model using monoclonal antibody mab recognize different cd4 epitope
1 12 12 3 5 supershift analysis revealed nfkappa b complex costimulated cd4 cell contained large amount p50 substantial amount p65 marginal level crel protein
1 15 15 3 5 supershift analysis revealed nfkappa b complex costimulated cd4 cell contained large amount p50 substantial amount p65 marginal level crel protein
0 10 12 15 16 significantly csa completely suppressed induction nfat endothelial cell inhibited activity granulocytemacrophage colonystimulating factor gmcsf gene regulatory element use nfat 60
0 3 3 15 15 csa also suppressed eselectin vascular cell adhesion molecule1 vcam1 expression endothelial cell even though eselectin promoter activated nfkappa b rather nfat
0 13 13 10 11 effect csa endothelial cell also detected chromatin structure level dnasel hypersensitive site within gmcsf enhancer eselectin promoter suppressed csa
0 13 13 14 14 effect csa endothelial cell also detected chromatin structure level dnasel hypersensitive site within gmcsf enhancer eselectin promoter suppressed csa
0 15 15 16 16 effect csa endothelial cell also detected chromatin structure level dnasel hypersensitive site within gmcsf enhancer eselectin promoter suppressed csa
0 5 5 1 2 n cterminal sequence control degradation mad3i kappa b alpha response inducer nfkappa b activity
0 5 5 0 0 n cterminal sequence control degradation mad3i kappa b alpha response inducer nfkappa b activity
0 5 7 8 11 result show deletion c terminus kappa b alpha molecule amino acid 279 abolishes constitutive ligandinducible phosphorylation inhibits ligandinducible degradation
0 0 0 10 12 vdr dnabinding mutant unable either bind element vitro repress vivo vdr dnabinding domain alone however bound element also could repress il2 expression
1 12 12 15 15 combining partially purified protein vitro observed loss bound nfatpap1dna complex upon inclusion vdr vdrretinoid x receptor
1 5 5 16 16 order addition offrate experiment indicate vdrretinoid x receptor heterodimer block nfatpap1 complex formation stably associate nfat1 element
0 0 0 1 2 interferongamma activation sequence mediates transcriptional regulation igg fc receptor type ic gene interferongamma
0 8 10 8 12 transient transfections cat reporter gene construct containing various fc gamma ric promoter sequence u937 cell revealed 20bp region surrounding transcription start site 7 13 capable mediating transcription initiation ifngamma responsive element gire present within 74 bp upstream transcription initiation site
0 8 10 11 11 gel shift experiment showed stat1 alpha protein bound fc gamma ric gire response ifngamma treatment u937 cell
0 5 5 6 7 fc gamma ric gire homologous ifngamma activation sequence gas guanylate binding protein x box element class ii mhc gene
0 10 11 12 12 expression vector cotransfected chloramphenicol acetyl transferase cat reporter gene regulated thymidine kinase promoter containing gal4 dna binding site nih 3t3 293 k562 jurkat cell line
0 14 14 15 17 expression vector cotransfected chloramphenicol acetyl transferase cat reporter gene regulated thymidine kinase promoter containing gal4 dna binding site nih 3t3 293 k562 jurkat cell line
0 0 0 8 9 mzf1 represses cat reporter gene expression via gal4 binding site nonhematopoietic cell line nih 3t3 293
0 11 11 4 4 mzf1 binding site present promoter several gene expressed myeloid differentiation including cd34 promoter
0 8 8 9 9 recombinant mzf1 protein specifically bind consensus binding site cd34 promoter mobility shift assay
0 8 8 9 9 mzf1 expression vector cotransfected luciferase reporter plasmid regulated cd34 promoter nonhematopoietic hematopoietic cell line
0 1 1 10 11 activation cd34 expression hematopoietic cell line dependent presence intact mzf1 binding site
0 3 3 4 4 cell typespecific regulation cd34 promoter mzf1 suggests presence tissuespecific regulatorsadapters differential mzf1 modification determine mzf1 transcriptional regulatory function
1 15 16 3 5 cell line investigated nfkappa b complex induced following cd30 engagement shown contain p50 nfkappa b1 p65 rela possibly transcription factor
1 12 14 3 5 cell line investigated nfkappa b complex induced following cd30 engagement shown contain p50 nfkappa b1 p65 rela possibly transcription factor
1 11 11 0 1 nfkappa b elevation result phenotypic abnormality mouse lacking kappa b alpha p50 subunit nfkappa b show dramatically delayed onset abnormality
1 6 6 5 5 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 6 6 5 5 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 12 12 10 11 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 12 12 10 11 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 6 6 6 6 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 6 6 6 6 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 12 12 12 12 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 12 12 12 12 triggering complement receptor cr1 cd35 cr3 cd11bcd18 induces nuclear translocation nfkappa b p50p65 human monocyte enhances viral replication hivinfected monocytic cell
1 12 12 8 9 effect lp tnfalpha mediated ability induce nuclear translocation dnabinding heterodimer nfkappa b p50p65 bind specific sequence hivlong terminal repeat
1 12 12 10 11 effect lp tnfalpha mediated ability induce nuclear translocation dnabinding heterodimer nfkappa b p50p65 bind specific sequence hivlong terminal repeat
1 12 12 10 11 effect lp tnfalpha mediated ability induce nuclear translocation dnabinding heterodimer nfkappa b p50p65 bind specific sequence hivlong terminal repeat
1 12 12 8 9 effect lp tnfalpha mediated ability induce nuclear translocation dnabinding heterodimer nfkappa b p50p65 bind specific sequence hivlong terminal repeat
1 12 12 12 12 effect lp tnfalpha mediated ability induce nuclear translocation dnabinding heterodimer nfkappa b p50p65 bind specific sequence hivlong terminal repeat
1 12 12 12 12 effect lp tnfalpha mediated ability induce nuclear translocation dnabinding heterodimer nfkappa b p50p65 bind specific sequence hivlong terminal repeat
1 9 9 9 9 present study demonstrates triggering complement receptor cr1 cd35 cr3 cd11bcd18 enhances viral replication hivinfected human monocytic cell
1 9 9 9 9 present study demonstrates triggering complement receptor cr1 cd35 cr3 cd11bcd18 enhances viral replication hivinfected human monocytic cell
1 9 9 7 8 observed stimulation cr1 cr3 induces nuclear translocation nfkappa b p50p65 infected cell
1 9 9 9 9 observed stimulation cr1 cr3 induces nuclear translocation nfkappa b p50p65 infected cell
1 9 9 9 9 observed stimulation cr1 cr3 induces nuclear translocation nfkappa b p50p65 infected cell
1 3 3 1 2 translocation nfkappa b p50p65 also observed following stimulation cr1 cr3 uninfected peripheral blood monocyte hivseronegative donor
1 3 3 3 3 translocation nfkappa b p50p65 also observed following stimulation cr1 cr3 uninfected peripheral blood monocyte hivseronegative donor
1 3 3 3 3 translocation nfkappa b p50p65 also observed following stimulation cr1 cr3 uninfected peripheral blood monocyte hivseronegative donor
1 5 5 3 4 tnfalpha mediate translocation nfkappa b p50p65 induced triggering complement receptor
1 5 5 3 4 tnfalpha mediate translocation nfkappa b p50p65 induced triggering complement receptor
1 5 5 5 5 tnfalpha mediate translocation nfkappa b p50p65 induced triggering complement receptor
0 4 4 5 5 nuclear factoril6 activates human il4 promoter cell
0 10 10 5 6 positive regulatory element prei strong enhancer element essential expression human il4 gene
0 13 13 14 14 overexpression nfil6 enhanced expression chloramphenicol acetyl transferase reporter gene linked preithymidine kinase human il4 promoter 10fold jurkat cell
0 7 7 8 8 result demonstrate nfil6 involved transcriptional activation human il4 promoter cell
0 6 6 2 5 although removal first 67 amino acid p95vav activates transforming potential nih 3t3 cell region appears required function cell
0 7 9 10 12 activation nfkappa b phosphatase inhibitor involves phosphorylation kappa b alpha phosphatase 2asensitive site
1 5 5 5 7 action phosphatase inhibitor associated activation rela
1 16 16 1 3 50 nfkappa b heterodimer affected agent block induction kappa b alpha phosphorylation tumor necrosis factor alpha tnfalpha
0 10 10 11 13 interleukin 4 activates signal transducer activator transcription stat protein interacts interferongamma activation sitelike sequence upstream epsilon exon human b cell line
1 18 18 29 30 characteristic signal transducer activator transcription stat protein determined whether antibody stat protein interfere gel mobility shift found antibody il4 stat also known stat6 antibody stat protein interfere formation il4 naf complex
0 10 10 11 13 cotransfection jak3 il4 stat cos7 cell produced intracellular activity bound ifngamma activation sitelike sequence comigrated il4 naf electrophoretic mobility shift assay
1 2 2 16 16 cotransfection jak3 il4 stat cos7 cell produced intracellular activity bound ifngamma activation sitelike sequence comigrated il4 naf electrophoretic mobility shift assay
0 2 3 13 15 determine platelet thromboxane receptor transcriptional control isolated characterized human genomic dna clone containing 5 flanking region thromboxane receptor gene
0 4 5 2 3 exonintron structure 5 portion thromboxane receptor gene determined initially comparing nucleotide sequence 5 flanking genomic clone novel human uterine thromboxane receptor cdna extended mrna 141 bp upstream previously identified human placental cdna
0 0 1 5 7 thromboxane receptor gene neither tata caat consensus site
0 0 1 4 4 thromboxane receptor gene neither tata caat consensus site
0 5 6 2 4 promoter function 5 flanking region thromboxane receptor gene evaluated transfection thromboxane receptor gene promoterchloramphenicol acetyltransferase cat chimera plasmid plateletlike k562 cell
0 0 1 2 2 thromboxane receptor promoter activity assessed cat expression relatively weak significantly enhanced phorbol ester treatment
0 16 17 12 15 functional analysis 5 deletion construct transfected k562 cell gel mobility shift localized major phorbol esterresponsive motif thromboxane receptor gene promoter cluster activator protein2 ap2 binding consensus site located approximately 1
0 4 4 27 28 test hypothesis studied several tat mutant including two stop codon mutant one deletion mutant using replicationcompetent hiv1 construct carrying wildtype mutant ltrs modification nfkappa b andor sp1 binding site
0 8 8 10 10 regulation transcription human erythropoietin receptor gene protein binding gata1 sp1 motif
0 5 5 9 11 used deletion analysis transfection assay reporter gene construct examine transcription control element 5 flanking region human epor gene
0 5 5 12 14 used deletion analysis transfection assay reporter gene construct examine transcription control element 5 flanking region human epor gene
0 2 2 3 3 150 bp hepor promoter exhibited high low activity erythroid ocim1 k562 cell respectively reflecting high low level constitutive hepor expression
0 7 7 3 3 interestingly mutated sp1 site resulting marked decrease hepor promoter activity could restore transactivation increasing gata1 level ocim1 cell
0 7 7 8 8 interestingly mutated sp1 site resulting marked decrease hepor promoter activity could restore transactivation increasing gata1 level ocim1 cell
0 4 4 5 5 data suggest gata1 transactivate epor promoter level hepor gene expression depend gata1 alone
0 0 0 1 1 interleukin2 promoter activity epsteinbarr virustransformed b lymphocyte controlled nuclear factorchi b
0 10 10 9 9 transient transfections using reporter construct multiple transcription factor binding site il2 promoter distal nuclear factor nfat proximal nfat ap1octamer ups nfchi b tced site performed
0 10 10 8 11 transient transfections using reporter construct multiple transcription factor binding site il2 promoter distal nuclear factor nfat proximal nfat ap1octamer ups nfchi b tced site performed
0 10 10 11 11 transient transfections using reporter construct multiple transcription factor binding site il2 promoter distal nuclear factor nfat proximal nfat ap1octamer ups nfchi b tced site performed
0 0 0 1 1 il2 promoter bearing defective nfchi b site completely inactive ebvtransformed b cell still activity jurkat cell
0 8 8 11 11 seven ebvb cell clone line differing capacity secrete il2 activity il2 promoter correlated well status il2 secretion
1 24 24 16 18 electrophoretic mobility shift assay using protein extract ebvb cell il2 nfchi b probe revealed constitutive generation chi b complex il2secreting cell consisting mainly heterodimeric p50p65 complex
1 24 24 16 18 electrophoretic mobility shift assay using protein extract ebvb cell il2 nfchi b probe revealed constitutive generation chi b complex il2secreting cell consisting mainly heterodimeric p50p65 complex
1 24 24 18 18 electrophoretic mobility shift assay using protein extract ebvb cell il2 nfchi b probe revealed constitutive generation chi b complex il2secreting cell consisting mainly heterodimeric p50p65 complex
1 24 24 18 18 electrophoretic mobility shift assay using protein extract ebvb cell il2 nfchi b probe revealed constitutive generation chi b complex il2secreting cell consisting mainly heterodimeric p50p65 complex
0 2 2 2 5 result demonstrate il2 nfchi b site indispensable activity il2 promoter ebvtransformed b cell whereas transcription factor appear le important il2 expression cell
0 2 2 9 9 result demonstrate il2 nfchi b site indispensable activity il2 promoter ebvtransformed b cell whereas transcription factor appear le important il2 expression cell
1 9 9 5 5 case transcriptional factor nfkappa b heterodimer consisting two subunit p50 p65 encoded two distinct gene rel family
1 10 10 5 5 case transcriptional factor nfkappa b heterodimer consisting two subunit p50 p65 encoded two distinct gene rel family
1 10 10 1 4 case transcriptional factor nfkappa b heterodimer consisting two subunit p50 p65 encoded two distinct gene rel family
1 9 9 1 4 case transcriptional factor nfkappa b heterodimer consisting two subunit p50 p65 encoded two distinct gene rel family
0 7 7 10 11 cterminal domain precursor rapidly degraded forming mature p50 subunit consisted nterminal region molecule
0 3 4 7 8 regulatory element human interleukin 2 gene promoter binding site zinc finger protein sp1 egr1
0 3 4 0 1 regulatory element human interleukin 2 gene promoter binding site zinc finger protein sp1 egr1
0 3 4 6 6 regulatory element human interleukin 2 gene promoter binding site zinc finger protein sp1 egr1
0 8 8 9 9 prior study identified several transcription factor contribute activity il2 promoter stimulated lymphocyte
0 5 5 2 3 describe novel regulatory element within il2 promoter located immediately upstream nuclear factor activated cell nfat domain
0 5 5 6 6 describe novel regulatory element within il2 promoter located immediately upstream nuclear factor activated cell nfat domain
0 6 6 2 3 jurkat cell zip site serf activator il2 gene expression combination zip nfat binding site required maximal il2 promoter activity
0 6 6 17 17 jurkat cell zip site serf activator il2 gene expression combination zip nfat binding site required maximal il2 promoter activity
0 6 6 7 7 result suggest critical role zip site il2 promoter activity
0 3 3 4 6 begun examine structure b2 subunit promoter region
1 1 1 2 3 formation nfat1 transcriptional complex il2 promoter essential il2 transcription
0 4 4 5 5 formation nfat1 transcriptional complex il2 promoter essential il2 transcription
0 6 6 7 8 using cell line stably transfected trimer nfat1 regulatory element linked lacz reporter gene screened inhibitor nfat1mediated betagalactosidase activity
0 2 2 12 13 similar inhibition nfat1mediated gene expression observed second cell line stably transfected nfat1 regulatory element linked reporter gene scd8
0 2 2 13 14 although detected il2 mrna aldtreated cell nucleus cell contain protein capable binding three regulatory sequence il2 promoter region nfat nf kappa b ap1
0 2 2 16 17 although detected il2 mrna aldtreated cell nucleus cell contain protein capable binding three regulatory sequence il2 promoter region nfat nf kappa b ap1
0 10 11 9 9 previously unrecognized element located downstream start site transcription first exon dr alpha gene defined enhances promoter activity eightfold positiondependent manner
0 10 11 2 2 previously unrecognized element located downstream start site transcription first exon dr alpha gene defined enhances promoter activity eightfold positiondependent manner
0 10 11 5 7 previously unrecognized element located downstream start site transcription first exon dr alpha gene defined enhances promoter activity eightfold positiondependent manner
0 14 15 16 16 mutation dnabinding site abolished binding nuclear factor human b cell nuclear extract decreased activity dr alpha promoter basal level
0 6 7 17 19 significant sequence homology element found dna dr beta dp alpha beta dq alpha gene always located downstream transcriptional start site
0 11 12 17 19 significant sequence homology element found dna dr beta dp alpha beta dq alpha gene always located downstream transcriptional start site
0 4 6 1 3 coupling signal response domain kappa b alpha multiple pathway nfkappa b activation
0 11 13 4 5 alanine substitution introduced two serine residue positioned within nterminal regulatory region kappa b alpha also yielded constitutive repressor escaped taxinduced turnover potently inhibited immune activation pathway nfkappa b induction including initiated antigen cytokine receptor
0 11 13 8 10 alanine substitution introduced two serine residue positioned within nterminal regulatory region kappa b alpha also yielded constitutive repressor escaped taxinduced turnover potently inhibited immune activation pathway nfkappa b induction including initiated antigen cytokine receptor
0 8 10 4 7 together vivo study define critical signal response domain kappa b alpha coordinately control biologic activity kappa b alpha nfkappa b response viral immune stimulus
0 8 10 4 10 together vivo study define critical signal response domain kappa b alpha coordinately control biologic activity kappa b alpha nfkappa b response viral immune stimulus
0 1 3 10 11 human plateletactivating factor receptor pafr gene transcribed two distinct promoter promoter 1 promoter 2 generate two transcript designated pafr transcript 1 pafr transcript 2 though open reading frame identical
0 4 4 9 9 human plateletactivating factor receptor pafr gene transcribed two distinct promoter promoter 1 promoter 2 generate two transcript designated pafr transcript 1 pafr transcript 2 though open reading frame identical
0 4 4 9 9 human plateletactivating factor receptor pafr gene transcribed two distinct promoter promoter 1 promoter 2 generate two transcript designated pafr transcript 1 pafr transcript 2 though open reading frame identical
0 1 3 9 9 human plateletactivating factor receptor pafr gene transcribed two distinct promoter promoter 1 promoter 2 generate two transcript designated pafr transcript 1 pafr transcript 2 though open reading frame identical
0 1 3 12 13 human plateletactivating factor receptor pafr gene transcribed two distinct promoter promoter 1 promoter 2 generate two transcript designated pafr transcript 1 pafr transcript 2 though open reading frame identical
0 9 9 5 8 positive negative regulatory element identified proximal 5 flanking region il3 gene
0 9 9 2 3 positive negative regulatory element identified proximal 5 flanking region il3 gene
0 8 12 5 13 p50 nfkappa b protein bound kappa b element interleukin2 receptor il2r alpha chain promoter resting cell
0 8 12 13 13 p50 nfkappa b protein bound kappa b element interleukin2 receptor il2r alpha chain promoter resting cell
1 9 9 9 9 however immediately tcrcd3 crosslinking approximately 1 h immediate binding p50
1 0 0 0 0 p50
1 20 20 1 1 rel heterodimers also detected bound sequence early time point 716 h early remained active later time point 40 h late activation
1 1 1 7 7 predominance p50 nfkappa b moiety possibly p50 homodimers closely related specie rather p50p56 heterodimer nfkappa b predominant nfkappa b specie lymphocytic monocytic cell demonstrated nucleus u1 cell
1 12 12 13 13 predominance p50 nfkappa b moiety possibly p50 homodimers closely related specie rather p50p56 heterodimer nfkappa b predominant nfkappa b specie lymphocytic monocytic cell demonstrated nucleus u1 cell
0 6 6 3 6 thus experiment demonstrate cterminal region hiv1 tat required suppress mnsod expression induce prooxidative condition reflected drop reduced glutathione gsh gshoxidized gsh gssg ratio
1 0 1 0 0 pebp2 alpha pebp2 alpha b gene encode dnabinding subunit murine transcription factor pebp2 implicated tcellspecific transcriptional regulator
1 2 4 0 0 pebp2 alpha pebp2 alpha b gene encode dnabinding subunit murine transcription factor pebp2 implicated tcellspecific transcriptional regulator
0 1 2 3 3 transcription il2r alpha promoter inhibited either elf1 hmgiy binding site mutated
0 0 0 18 20 elf1 physically associated hmgi nfkappa b p50 crel vitro suggesting proteinprotein interaction might functionally coordinate action upstream downstream positive regulatory element
0 6 7 9 9 recent study identified calcineurin key enzyme interleukin il2 il4 promoter activation
0 8 8 9 9 recent study identified calcineurin key enzyme interleukin il2 il4 promoter activation
0 17 17 18 18 gamma bcamk delta camai known exhibit constitutive ca2independent activity cotransfected alone combination jurkat cell plasmid containing intact il2 promoter driving expression chloramphenicol acetyltransferase reporter gene
0 3 3 4 4 cotransfection gamma bcamk il2 promoter construct downregulated transcription response stimulation ionomycin phorbol myristate acetate pma
0 4 4 5 5 inhibitory effect camk ii il2 promoter associated decreased transcription ap1 nfat transactivating pathway
0 4 4 5 5 condition delta camai superinduced il2 promoter activity approximately twofold increase
0 5 5 6 6 similar result obtained construct containing il4 promoter also used
0 3 4 2 2 either serine32 serine36 kappa balpha mutated protein undergo signalinduced phosphorylation degradation nfkappa b could activated
0 3 4 1 1 either serine32 serine36 kappa balpha mutated protein undergo signalinduced phosphorylation degradation nfkappa b could activated
0 7 7 6 6 substitution promoter generated entire xbox x1 x2boxes hladra replaced analogous region hladqb
0 7 7 5 5 substitution promoter generated entire xbox x1 x2boxes hladra replaced analogous region hladqb
0 22 22 23 23 regulation transcription interleukin2 gene blymphocytes since b cell clone immortalized ebv virus induced produce interleukin2 typical cell cytokine studied role different element il2 promoter clone transfection
0 16 16 17 19 removal carboxy terminus enables erp interact variety etsbinding site including e74 site igh enhancer pi site lck promoter ets site suggesting carboxyterminal negative regulatory domain
1 6 6 1 3 gp160induced nfkappa b complex consists p65 p50 crel protein
1 5 5 1 3 gp160induced nfkappa b complex consists p65 p50 crel protein
1 11 11 12 12 secretion il2 tnfalpha surface expression il2r dnabinding activity nfkappa b ap1 fosjun complex response phorbol myristate acetate tnfalpha immobilized antibody cd3 monitored
0 2 2 4 4 inhibition mediated nef phosphorylation thr15 gtpbinding activity mutation critical site alter inhibition
1 7 7 14 16 second abnormality kappa bbinding activity cell patient rela member rel homology family part normal nfkappa b complex induced nucleus following activation
1 11 11 11 11 hela cell well b cell tnfalpha rapidly induced nuclear translocation primarily p50p65 crel
1 11 11 11 11 hela cell well b cell tnfalpha rapidly induced nuclear translocation primarily p50p65 crel
1 9 9 14 14 fact cellular nfkappa b activity phosphorylationdependent dna binding activity p65containing nfkappa b enhanced phosphorylation vitro
0 10 11 7 9 appa b protein cytoplasmic store nucleus bound kappa b sequence il2r alpha promoter either p50
0 10 11 12 12 appa b protein cytoplasmic store nucleus bound kappa b sequence il2r alpha promoter either p50
1 14 14 14 14 appa b protein cytoplasmic store nucleus bound kappa b sequence il2r alpha promoter either p50
1 1 1 1 1 65 p50
1 1 1 1 1 65 p50
1 0 0 0 0 name
1 14 14 15 15 protease inhibitor block lipopolysaccharide induction tissue factor gene expression human monocytic cell preventing activation crelp65 heterodimers
1 14 14 15 15 protease inhibitor block lipopolysaccharide induction tissue factor gene expression human monocytic cell preventing activation crelp65 heterodimers
0 9 9 6 8 transcriptional regulation mediated binding crelp65 heterodimers kappa blike site tf promoter
1 4 4 5 5 transcriptional regulation mediated binding crelp65 heterodimers kappa blike site tf promoter
1 4 4 5 5 transcriptional regulation mediated binding crelp65 heterodimers kappa blike site tf promoter
0 9 9 10 10 transcriptional regulation mediated binding crelp65 heterodimers kappa blike site tf promoter
1 3 3 4 4 nuclear translocation cytosolic crelp65 heterodimers member nfkappa brel family requires dissociation proteolytic degradation inhibitor protein kappa b alpha
0 5 5 10 10 tpck tlck inhibited lp induction tf protein tf mrna tf promoter activity dosedependent manner
1 9 9 10 10 inhibitor specifically prevented degradation kappa b alpha nuclear translocation crelp65 heterodimers
1 7 7 8 8 taken together data indicated inhibiting nuclear translocation crelp65 heterodimers prevented lp induction tf gene transcription monocytic cell
1 5 5 6 6 stimulation plus clone liberated classical p50p65 complex cytoplasmic pool whereas minus clone produced apparently novel fastermigrating complex judged electrophoretic mobility shift assay
1 6 6 1 2 surprising fastermigrating complex composed also p50 p65
1 11 11 12 12 htlvi tax expression lead constitutive nuclear expression biologically active nfkappa b crel complex however biochemical mechanism underlying response remains poorly understood
0 4 4 17 20 demonstrate tax induction nuclear crel expression activated rela p65 subunit nfkappa b activates transcription crel gene intrinsic kappa b enhancer element
1 7 7 10 11 demonstrate tax induction nuclear crel expression activated rela p65 subunit nfkappa b activates transcription crel gene intrinsic kappa b enhancer element
0 5 5 2 3 distinct dnasei hypersensitive site associated tal1 transcription erythroid tcell line
0 3 3 3 5 methylation study indicated tal15 gcrich region behaves like cpg island hypomethylated normal cell methylated de novo transcriptionally inactive allele established cell line
0 7 7 3 4 five major dnasei hypersensitive site h mapped tal1 locus
0 9 9 10 11 h iv v exclusively observed erythroidmegakaryocytic cell line express tal1 promoter 1a 1b
0 16 16 17 18 h ii weak hematopoietic cell line absent hela greatly enhanced jurkat suggesting region might implicated cisactivation tal1 promoter 1b cell line
0 13 13 16 17 h iii weak hel jurkat greatly enhanced du528 tcell line bear 114 initiate tal1 transcription within exon 4
0 8 8 9 9 result suggest distinct regulatory element associated use different tal1 promoter
1 1 1 2 2 functional mycmax heterodimer required activationinduced apoptosis cell hybridoma
1 1 1 2 2 functional mycmax heterodimer required activationinduced apoptosis cell hybridoma
1 10 10 8 8 coexpression reciprocally mutant myc protein capable forming functional heterodimers mutant max compensate dominant negative activity restore activationinduced apoptosis
1 3 3 8 8 coexpression reciprocally mutant myc protein capable forming functional heterodimers mutant max compensate dominant negative activity restore activationinduced apoptosis
0 1 1 2 2 transactivation tp1 promoter bamhi c promoter already investigated detail appears mediated via proteinprotein interaction direct binding ebna2 type ebv type 1 dna
0 3 4 2 2 transactivation tp1 promoter bamhi c promoter already investigated detail appears mediated via proteinprotein interaction direct binding ebna2 type ebv type 1 dna
0 5 5 3 4 various report delineated cisacting element lmp promoter ebna2 mediates transactivation
0 5 5 6 6 various report delineated cisacting element lmp promoter ebna2 mediates transactivation
0 3 3 1 2 determined proteinbinding region lmp promoter within 42 bp fragment encompassing nucleotide 135 176 relative lmp transcriptional start site
0 3 3 14 17 determined proteinbinding region lmp promoter within 42 bp fragment encompassing nucleotide 135 176 relative lmp transcriptional start site
0 3 3 6 8 determined proteinbinding region lmp promoter within 42 bp fragment encompassing nucleotide 135 176 relative lmp transcriptional start site
0 3 3 10 12 determined proteinbinding region lmp promoter within 42 bp fragment encompassing nucleotide 135 176 relative lmp transcriptional start site
0 10 10 11 11 however analysis sucrose gradient fraction gel retardation assay provided evidence lmp promoterbinding protein form complex higher mr ebna2positive cell extract
0 10 10 11 11 deduce result ebna2positive cell might indeed contain specific complex bound lmp promoter however labile detected standard gel retardation assay
0 5 11 12 12 identification region directs monocytic activity colonystimulating factor 1 macrophage colonystimulating factor receptor promoter bind pebp2cbf aml1
0 3 4 8 9 demonstrated monocytespecific expression csf1 receptor regulated level transcription tissuespecific promoter whose activity stimulated monocytebcellspecific transcription factor pu
1 16 16 4 5 competition supershift experiment indicate mono b contains member polyomavirus enhancerbinding protein 2corebinding factor pebp2cbf family includes aml1 gene product mono distinct complex preferentially expressed monocytic cell
0 18 18 15 16 study element role class ii gene regulation cdna library screened oligonucleotide probe containing element nearby j element human dpa gene
0 9 9 10 10 antisense cdna clone 18 inhibited expression reporter construct containing dpa promoter indicating functional importance expression class ii gene
0 6 6 14 14 understand mechanism prl regulates biphasic expression irf1 cloned rat irf1 gene functionally characterized irf1 promoter
0 3 3 5 6 phase prl response irf1 gene different region irf1 5flanking promoter dna
0 3 3 10 10 phase prl response irf1 gene different region irf1 5flanking promoter dna
0 2 2 24 26 expression human prl hprl gene extrapituitary site uterus decidualized endometrial stroma myometrium cell hematopoietic lineage directed alternative promoter located approximately 6 kilobases kb upstream pituitaryspecific start site
0 2 2 20 23 expression human prl hprl gene extrapituitary site uterus decidualized endometrial stroma myometrium cell hematopoietic lineage directed alternative promoter located approximately 6 kilobases kb upstream pituitaryspecific start site
0 2 2 16 17 expression human prl hprl gene extrapituitary site uterus decidualized endometrial stroma myometrium cell hematopoietic lineage directed alternative promoter located approximately 6 kilobases kb upstream pituitaryspecific start site
0 18 18 12 15 order delineate tissuespecific mechanism governing control nonpituitary prl gene expression cloned sequenced 3 kb 5flanking dna upstream deciduallymphoid dprl promoter
0 18 18 19 19 order delineate tissuespecific mechanism governing control nonpituitary prl gene expression cloned sequenced 3 kb 5flanking dna upstream deciduallymphoid dprl promoter
0 9 9 10 10 experiment also show activated pr confer direct transcriptional control dprl promoter
0 3 3 4 4 compared activity transfected dprl promoter prlsecreting nonsecreting lymphoid cell found 3 kb 5flanking region dprl promoter contain element restricting expression lymphocyte produce prl allowed expression fusion reporter gene irrespective status endogenous prl gene
0 12 12 4 7 sharp contrast endometrial cell 3 kb 5flanking dna conferred strong transcriptional activation dprl promoter decidualized endometrial stromal cell actively secreting prl allow transcription undifferentiated nonprlsecreting endometrial stromal cell
0 12 12 13 13 sharp contrast endometrial cell 3 kb 5flanking dna conferred strong transcriptional activation dprl promoter decidualized endometrial stromal cell actively secreting prl allow transcription undifferentiated nonprlsecreting endometrial stromal cell
0 0 0 4 6 egr1 promoter contains six ccat6gg carg motif
0 16 16 18 20 treatment u937 tur cell okadaic acid inhibitor serinethreonine protein phosphatase 1 2a associated induction monocytic differentiation egr1 transcription 5most carg element
0 8 8 4 4 since finding supported involvement serinethreonine protein phosphorylation regulation egr1 expression studied activation 40 ribosomal protein s6 serinethreonine kinase pp70s6k pp90rsk
1 5 5 6 6 mobility shift assay nfkappa b p50p50 homodimer observed complex formed kappa b sequence unstimulated spb21 cell
1 9 9 10 10 cell stimulated anticd3 mab pmaa23187 complex formation nfkappa b p50p65 heterodimer kappa b sequence induced
1 9 9 10 10 cell stimulated anticd3 mab pmaa23187 complex formation nfkappa b p50p65 heterodimer kappa b sequence induced
1 8 8 9 9 interestingly pge2 dibutyryl bt2camp abolished binding nfkappa b p50p65 heterodimer kappa b sequence cell stimulated anticd3 mab pmaa23187
1 8 8 9 9 interestingly pge2 dibutyryl bt2camp abolished binding nfkappa b p50p65 heterodimer kappa b sequence cell stimulated anticd3 mab pmaa23187
1 6 6 3 4 stimulus induced appearance nfkappa b component crel p65 rela p50 nfkappa b1 nfkappa b dna binding activity nucleus
1 9 9 3 4 stimulus induced appearance nfkappa b component crel p65 rela p50 nfkappa b1 nfkappa b dna binding activity nucleus
1 7 7 3 4 stimulus induced appearance nfkappa b component crel p65 rela p50 nfkappa b1 nfkappa b dna binding activity nucleus
0 2 5 8 8 nonlymphoid cell epidermal growth factor receptor displayed increased tyrosine phosphorylation within second uv irradiation
0 8 9 10 10 sodium salicylate aspirin also inhibited nfkappa bdependent transcription ig kappa enhancer human immunodeficiency virus hiv long terminal repeat ltr transfected cell
0 3 3 7 9 positive negative regulation il2 gene expression role multiple regulatory site
0 6 6 1 3 several cisacting regulatory site required induction il2 gene stimulation
0 8 8 3 5 study analysed function cisacting regulatory site context native il2 enhancer promoter sequence
0 8 8 9 9 study analysed function cisacting regulatory site context native il2 enhancer promoter sequence
0 17 17 14 14 result study suggest nfat 276 261 distal octamer 256 248 proximal octamer 75 66 site act enhancer il2 gene transcription presence cellular stimulation also silencing effect il2 gene expression resting cell
0 1 1 16 16 increase il2 gene expression triggered cd28 involves kappa blike sequence 5regulatory region il2 promoter called cd28responsive element
0 1 1 7 9 increase il2 gene expression triggered cd28 involves kappa blike sequence 5regulatory region il2 promoter called cd28responsive element
0 1 1 10 11 increase il2 gene expression triggered cd28 involves kappa blike sequence 5regulatory region il2 promoter called cd28responsive element
0 1 1 13 13 increase il2 gene expression triggered cd28 involves kappa blike sequence 5regulatory region il2 promoter called cd28responsive element
0 14 14 18 19 sequence homology single nucleotide mutation anticd28 ab stimulation study established nfkappa blike sequence promoter il8 gene functioned cd28 response element
0 14 14 13 13 sequence homology single nucleotide mutation anticd28 ab stimulation study established nfkappa blike sequence promoter il8 gene functioned cd28 response element
0 14 14 10 12 sequence homology single nucleotide mutation anticd28 ab stimulation study established nfkappa blike sequence promoter il8 gene functioned cd28 response element
0 14 14 13 15 sequence homology single nucleotide mutation anticd28 ab stimulation study established nfkappa blike sequence promoter il8 gene functioned cd28 response element
0 11 11 12 12 transient transfection assay revealed two signal pma camp required optimal activation il5 promoter
0 2 2 5 6 p sequence il4 gene defined responsive element pma calcium ionophore a23187 share sequence similarity nf kappa b nfactivated cell binding site
0 2 2 0 1 p sequence il4 gene defined responsive element pma calcium ionophore a23187 share sequence similarity nf kappa b nfactivated cell binding site
0 2 2 19 20 p sequence il4 gene defined responsive element pma calcium ionophore a23187 share sequence similarity nf kappa b nfactivated cell binding site
1 5 5 7 7 electromobility shift assay nfkappa b p65 p65p50 heterodimer nfat bound p sequence
1 6 6 7 7 electromobility shift assay nfkappa b p65 p65p50 heterodimer nfat bound p sequence
0 1 1 7 8 understand gata3 gene regulation cloned human gene 5 end mouse gata3 gene
0 2 2 8 10 show human gata3 gene contains six exon distributed 17 kb dna
0 11 11 8 8 two human gata3 zinc finger encoded two separate exon highly conserved gata1 structural homology two gene found
0 2 2 6 8 human mouse gata3 transcription unit start major initiation site
0 2 2 2 4 human mouse gata3 transcription unit start major initiation site
0 6 6 12 13 finally show dna fragment containing human gata3 transcription unit 3 kb upstream initiation site 4 kb downstream polyadenylation site display tcell specificity
0 6 6 17 18 finally show dna fragment containing human gata3 transcription unit 3 kb upstream initiation site 4 kb downstream polyadenylation site display tcell specificity
0 6 6 7 8 finally show dna fragment containing human gata3 transcription unit 3 kb upstream initiation site 4 kb downstream polyadenylation site display tcell specificity
0 10 10 8 8 characterization nfp nuclear factor interacts regulatory p sequence 5cgaaaatttcc3 human interleukin4 gene relationship nfkappa b nfat
0 10 10 6 7 characterization nfp nuclear factor interacts regulatory p sequence 5cgaaaatttcc3 human interleukin4 gene relationship nfkappa b nfat
0 3 3 7 8 p sequence human interleukin4 il4 gene defined responsive element phorbol 12myristate 13acetate calcium ionophore a23187 jurkat cell share sequence similarity nfkappa b nfat binding site
0 3 3 0 1 p sequence human interleukin4 il4 gene defined responsive element phorbol 12myristate 13acetate calcium ionophore a23187 jurkat cell share sequence similarity nfkappa b nfat binding site
0 3 3 23 24 p sequence human interleukin4 il4 gene defined responsive element phorbol 12myristate 13acetate calcium ionophore a23187 jurkat cell share sequence similarity nfkappa b nfat binding site
1 2 2 4 4 nfkappa b p65 p65p50 heterodimer bound p sequence electrophoretic mobility shift assay emsa activated transcription p sequence expression plasmid cotransfected p sequencedriven reporter plasmid jurkat cell
1 3 3 4 4 nfkappa b p65 p65p50 heterodimer bound p sequence electrophoretic mobility shift assay emsa activated transcription p sequence expression plasmid cotransfected p sequencedriven reporter plasmid jurkat cell
0 6 6 4 5 transcriptional regulatory element associated nucleasehypersensitive site pol gene human immunodeficiency virus type 1
0 8 8 6 7 result identify transcriptional regulatory element associated nucleasehypersensitive site pol gene hiv1 suggest activity may controlled complex interplay cisregulatory element
0 8 8 6 7 result identify transcriptional regulatory element associated nucleasehypersensitive site pol gene hiv1 suggest activity may controlled complex interplay cisregulatory element
1 3 3 11 11 vsrcinduced complex comprised p50 p65 component nfkappa b determined supershift immunoblot analysis
1 4 4 11 11 vsrcinduced complex comprised p50 p65 component nfkappa b determined supershift immunoblot analysis
1 3 3 6 7 vsrcinduced complex comprised p50 p65 component nfkappa b determined supershift immunoblot analysis
1 4 4 6 7 vsrcinduced complex comprised p50 p65 component nfkappa b determined supershift immunoblot analysis
0 5 11 1 4 function nfkappa brel binding site major histocompatibility complex class ii invariant chain promoter dependent cellspecific binding different nfkappa brel subunit
0 5 11 12 12 function nfkappa brel binding site major histocompatibility complex class ii invariant chain promoter dependent cellspecific binding different nfkappa brel subunit
0 3 7 6 6 promoter human major histocompatibility complex class iiassociated invariantchain gene ii contains two nfkappa brel binding site located 109 118 ii kappa b1 163 172 ii kappa b2 transcription start site
0 3 7 24 26 promoter human major histocompatibility complex class iiassociated invariantchain gene ii contains two nfkappa brel binding site located 109 118 ii kappa b1 163 172 ii kappa b2 transcription start site
0 3 7 17 18 promoter human major histocompatibility complex class iiassociated invariantchain gene ii contains two nfkappa brel binding site located 109 118 ii kappa b1 163 172 ii kappa b2 transcription start site
0 3 7 22 23 promoter human major histocompatibility complex class iiassociated invariantchain gene ii contains two nfkappa brel binding site located 109 118 ii kappa b1 163 172 ii kappa b2 transcription start site
0 3 7 0 0 promoter human major histocompatibility complex class iiassociated invariantchain gene ii contains two nfkappa brel binding site located 109 118 ii kappa b1 163 172 ii kappa b2 transcription start site
0 3 7 19 21 promoter human major histocompatibility complex class iiassociated invariantchain gene ii contains two nfkappa brel binding site located 109 118 ii kappa b1 163 172 ii kappa b2 transcription start site
1 18 18 14 15 electrophoretic mobility supershift assay determine member nfkappa brel family transcription factor bind site vitro dnabinding complex contain p50 p52 p65 crel correlate positive regulation whereas presence p50 correlate negative regulation
1 17 17 14 15 electrophoretic mobility supershift assay determine member nfkappa brel family transcription factor bind site vitro dnabinding complex contain p50 p52 p65 crel correlate positive regulation whereas presence p50 correlate negative regulation
1 20 20 14 15 electrophoretic mobility supershift assay determine member nfkappa brel family transcription factor bind site vitro dnabinding complex contain p50 p52 p65 crel correlate positive regulation whereas presence p50 correlate negative regulation
1 19 19 14 15 electrophoretic mobility supershift assay determine member nfkappa brel family transcription factor bind site vitro dnabinding complex contain p50 p52 p65 crel correlate positive regulation whereas presence p50 correlate negative regulation
1 5 5 21 23 although postulated pituitary endocrine cell pancreatic endocrine betacells share identical pane2a complex nativewestern analysis pituitary endocrine betacells detect pan protein distinct cell typespecific complex
1 5 5 11 11 although postulated pituitary endocrine cell pancreatic endocrine betacells share identical pane2a complex nativewestern analysis pituitary endocrine betacells detect pan protein distinct cell typespecific complex
1 10 10 11 11 although postulated pituitary endocrine cell pancreatic endocrine betacells share identical pane2a complex nativewestern analysis pituitary endocrine betacells detect pan protein distinct cell typespecific complex
1 9 9 4 5 ap1 complex consists distinct protein heterodimers encoded protooncogene cfo cjun mrna whose gene expression induced tpa cyclic amp growth factor
1 8 8 4 5 ap1 complex consists distinct protein heterodimers encoded protooncogene cfo cjun mrna whose gene expression induced tpa cyclic amp growth factor
1 8 8 0 1 ap1 complex consists distinct protein heterodimers encoded protooncogene cfo cjun mrna whose gene expression induced tpa cyclic amp growth factor
1 9 9 0 1 ap1 complex consists distinct protein heterodimers encoded protooncogene cfo cjun mrna whose gene expression induced tpa cyclic amp growth factor
1 6 6 10 11 gene encoding 105kda protein p105 precursor p50 subunit transcription factor nfkappa b also encodes p70 kappa b protein kappa b gamma identical cterminal 607 amino acid p105
0 24 24 21 23 one 63kda isoform termed kappa b gamma1 lack 59 amino acid cterminal ankyrin repeat 7 novel 35amino acid c terminus encoded alternative reading frame p105 gene
0 4 6 16 19 one 63kda isoform termed kappa b gamma1 lack 59 amino acid cterminal ankyrin repeat 7 novel 35amino acid c terminus encoded alternative reading frame p105 gene
0 24 24 16 19 one 63kda isoform termed kappa b gamma1 lack 59 amino acid cterminal ankyrin repeat 7 novel 35amino acid c terminus encoded alternative reading frame p105 gene
0 2 4 6 9 55kda isoform kappa b gamma2 lack 190 cterminal amino acid p70i kappa b gamma
0 10 13 6 9 55kda isoform kappa b gamma2 lack 190 cterminal amino acid p70i kappa b gamma
0 2 2 16 17 earlier study il2 gene expression showed overexpression calcineurin cn ca2calmodulindependent protein phosphatase stimulate transcription il2 promoter nfatbinding site
0 2 2 15 15 earlier study il2 gene expression showed overexpression calcineurin cn ca2calmodulindependent protein phosphatase stimulate transcription il2 promoter nfatbinding site
0 14 14 15 15 study obtained evidence transfection cdna cn catalytic cn b regulatory subunit also augments transcription gmcsf promoter recovers transcription inhibited csa
0 3 3 15 15 multimerizing regulatory element gmcsf promoter found one target site cn action conserved lymphokine element 0 cle0 located position 54 40
0 3 3 11 14 multimerizing regulatory element gmcsf promoter found one target site cn action conserved lymphokine element 0 cle0 located position 54 40
0 3 3 1 2 multimerizing regulatory element gmcsf promoter found one target site cn action conserved lymphokine element 0 cle0 located position 54 40
0 3 3 4 4 multimerizing regulatory element gmcsf promoter found one target site cn action conserved lymphokine element 0 cle0 located position 54 40
0 7 7 15 16 result suggest cn involved coordinated induction gmcsf il2 gene cle0 sequence gmcsf gene functional analogue nfatbinding site il2 promoter mediates signal downstream cell activation
0 7 7 18 18 result suggest cn involved coordinated induction gmcsf il2 gene cle0 sequence gmcsf gene functional analogue nfatbinding site il2 promoter mediates signal downstream cell activation
0 10 12 14 14 intricate arrangement binding site ets family transcription factor regulates activity alpha 4 integrin gene promoter
0 6 7 9 9 activity construct containing 5 deletion mutant alpha 4 gene promoter compared transfection assay cell line express alpha 4 cell line
1 6 7 7 8 deletion 5most ets site effect binding gabp alphagabp beta eliminated
0 19 20 22 22 conclude although neither two 5most ets site alone bind nuclear protein appear act modulators control pattern ets protein bind alpha 4 gene promoter
1 10 10 11 11 lipopolysaccharide induction tissue factor gene expression monocytic cell mediated binding crelp65 heterodimers kappa blike site
1 10 10 11 11 lipopolysaccharide induction tissue factor gene expression monocytic cell mediated binding crelp65 heterodimers kappa blike site
0 15 15 11 11 report characterization nuclear complex human monocytic cell bound kappa blike site 5cggagtttcc3 5flanking region human tf gene
0 15 15 8 10 report characterization nuclear complex human monocytic cell bound kappa blike site 5cggagtttcc3 5flanking region human tf gene
0 15 15 12 13 report characterization nuclear complex human monocytic cell bound kappa blike site 5cggagtttcc3 5flanking region human tf gene
1 9 9 12 12 vitro binding study demonstrated tf site bound translated crel p65 homodimers p50p65 heterodimers p50 homodimers
1 8 8 10 10 vitro binding study demonstrated tf site bound translated crel p65 homodimers p50p65 heterodimers p50 homodimers
1 9 9 10 10 vitro binding study demonstrated tf site bound translated crel p65 homodimers p50p65 heterodimers p50 homodimers
1 3 3 4 4 fact lowionicstrength condition tf complex migrate translated p50p65 dimer instead comigrated crelp65 dimer
1 7 7 8 8 fact lowionicstrength condition tf complex migrate translated p50p65 dimer instead comigrated crelp65 dimer
1 7 7 8 8 fact lowionicstrength condition tf complex migrate translated p50p65 dimer instead comigrated crelp65 dimer
1 11 11 8 8 fact lowionicstrength condition tf complex migrate translated p50p65 dimer instead comigrated crelp65 dimer
1 7 7 8 8 fact lowionicstrength condition tf complex migrate translated p50p65 dimer instead comigrated crelp65 dimer
1 10 10 18 18 antibody nfkappa b rel protein uv crosslinking study revealed presence crel p65 absence p50 tf complex showed crelp65 heterodimers selectively bound tf kappa blike site
1 11 11 18 18 antibody nfkappa b rel protein uv crosslinking study revealed presence crel p65 absence p50 tf complex showed crelp65 heterodimers selectively bound tf kappa blike site
0 14 14 22 24 antibody nfkappa b rel protein uv crosslinking study revealed presence crel p65 absence p50 tf complex showed crelp65 heterodimers selectively bound tf kappa blike site
1 5 5 6 6 taken together result demonstrated binding crelp65 heterodimers novel kappa blike site mediated lp induction tf gene expression monocytic cell
1 5 5 6 6 taken together result demonstrated binding crelp65 heterodimers novel kappa blike site mediated lp induction tf gene expression monocytic cell
0 10 10 14 14 investigate effect human immunodeficiency virus type 1 hiv1 tat interleukin2 il2 expression used il2 promoterchloramphenicol acetyltransferase construct il2secreting jurkat cell model system
0 8 8 9 9 transient expression hiv1 tat induced five eightfold increase il2 promoter activity jurkat cell stimulated phytohemagglutinin phorbol myristate acetate
0 6 6 7 7 nfkappa b site position 206 195 il2 promoter required sufficient tat effect
0 3 4 5 5 demonstrate human monocytic mcsf receptor promoter directs reporter gene activity tissuespecific fashion
0 2 3 4 4 bind activates mcsf receptor promoter
0 5 6 7 7 nuclear extract bind specific site mcsf receptor promoter upstream major transcription initiation site
0 2 3 4 4 binding decrease mcsf receptor promoter activity significantly macrophage cell line
0 1 2 3 3 transactivates mcsf receptor promoter nonmacrophage cell
0 4 4 29 30 present study analysis interleukin2 il2 gene activation show naive human helper cell cord blood cd4 cell adult cd4cd45ro cell regulate il2 transcription mechanism involving silencer activator acting purinerich il2 promoter element nfat binding site
1 17 19 13 16 part high affinity ige receptor mast cell basophil langerhans cell possibly cell component low affinity receptor igg fc gamma riiia cd16 natural killer cell macrophage part cell antigen receptor subset cell
1 20 20 13 16 part high affinity ige receptor mast cell basophil langerhans cell possibly cell component low affinity receptor igg fc gamma riiia cd16 natural killer cell macrophage part cell antigen receptor subset cell
0 8 8 6 7 investigated protein binding characteristic functional importance act1activating region il3 promoter
0 8 8 9 9 investigated protein binding characteristic functional importance act1activating region il3 promoter
0 10 10 12 13 region bind inducible tcellspecific factor 5 end site necessary expression il3 absence upstream element
0 8 8 6 7 characteristic make act1 site analogous activating arre1 site il2 promoter
0 0 3 8 8 human prointerleukin 1 beta gene requires dna sequence proximal distal transcription start site tissuespecific induction
0 0 3 9 9 human prointerleukin 1 beta gene requires dna sequence proximal distal transcription start site tissuespecific induction
0 1 2 14 15 ligated proil1 beta cap siteproximal region located 131 12 proil1 beta simian virus 40 enhancer element functioned efficiently monocyte hela cell normally competent il1 beta expression
0 2 2 3 3 ligated murine cfo promoter however proil1 beta enhancer inducible phorbol myristate acetatestimulated hela cell suggesting existence proil1 beta promoterproximal requirement tissue specificity
0 5 6 7 7 ligated murine cfo promoter however proil1 beta enhancer inducible phorbol myristate acetatestimulated hela cell suggesting existence proil1 beta promoterproximal requirement tissue specificity
0 5 6 3 3 ligated murine cfo promoter however proil1 beta enhancer inducible phorbol myristate acetatestimulated hela cell suggesting existence proil1 beta promoterproximal requirement tissue specificity
0 0 0 11 11 l gene produce erythroid rpk hepatic lpk isozymes alternative use two promoter
0 4 4 3 4 report characterization ci transacting element involved tissuespecific activity l gene erythroid promoter
0 4 4 2 2 report characterization ci transacting element involved tissuespecific activity l gene erythroid promoter
0 4 4 11 11 report characterization ci transacting element involved tissuespecific activity l gene erythroid promoter
0 0 0 7 8 rpk dna fragment extending 870 54 relative cap site confers erythroid specificity reporter gene
0 13 13 7 8 mutation deletion site indicate association ccaccsp1 gata binding site drive efficient tissuespecific expression rpk minimal promoter
0 13 13 14 15 mutation deletion site indicate association ccaccsp1 gata binding site drive efficient tissuespecific expression rpk minimal promoter
0 8 8 4 4 finally cotransfection experiment study element involved hgata1 transactivation rpk promoter hela cell
0 29 29 34 35 using transfection reporter gene assay specifically designed primary lymphocyte conjunction gel retardation assay western blot analysis uv crosslinking study found cjun cfo octamerbinding protein play major role transcriptional activation il3 gene via interaction two specific region contained within il3 5flanking sequence
0 29 29 34 35 using transfection reporter gene assay specifically designed primary lymphocyte conjunction gel retardation assay western blot analysis uv crosslinking study found cjun cfo octamerbinding protein play major role transcriptional activation il3 gene via interaction two specific region contained within il3 5flanking sequence
0 29 29 39 40 using transfection reporter gene assay specifically designed primary lymphocyte conjunction gel retardation assay western blot analysis uv crosslinking study found cjun cfo octamerbinding protein play major role transcriptional activation il3 gene via interaction two specific region contained within il3 5flanking sequence
0 5 5 3 4 additionally region base 107 59 il3 promoter containing putative ap2 sp1 binding motif appears necessary basal level expression il3 gene
0 5 5 11 12 additionally region base 107 59 il3 promoter containing putative ap2 sp1 binding motif appears necessary basal level expression il3 gene
0 3 5 6 6 transcriptional activation human zeta 2 globin promoter alpha globin regulatory element hs40 functional role specific nuclear factordna complex
0 7 8 9 10 transcriptional activation human zeta 2 globin promoter alpha globin regulatory element hs40 functional role specific nuclear factordna complex
0 5 7 8 8 studied functional interaction human embryonic zeta 2 globin promoter alpha globin regulatory element hs40 located 40 kb upstream zeta 2 globin gene
0 9 11 12 12 shown transient expression assay hs40 behaved authentic enhancer highlevel zeta 2 globin promoter activity k562 cell erythroid cell line embryonic andor fetal origin
0 5 7 20 20 although sequence located 559 88 zeta 2 globin gene dispensable expression enhancerless plasmid required hs40 enhancermediated activity zeta 2 globin promoter
0 4 6 7 7 sitedirected mutagenesis demonstrated hs40 enhancerzeta 2 globin promoter interaction mediated two gata1 factor binding motif located 230 104 respectively
0 22 24 25 25 bal 31 deletion mapping data suggested one gata1 motif one gt motif two nfe2ap1 motif together formed functional core hs40 erythroidspecific activation zeta 2 globin promoter
1 13 13 17 17 therefore examined effect ec cell nuclear factor known regulate il2 transcription including cjun cfostwo component transcription factor ap1 nfat others
1 12 12 17 17 therefore examined effect ec cell nuclear factor known regulate il2 transcription including cjun cfostwo component transcription factor ap1 nfat others
0 13 13 10 12 gelshift analysis reveals constitutive presence nuclear factor resting pbl bind proximal ap1 site il2 promoter contain immunoreactive cjun cfo protein
0 13 13 14 14 gelshift analysis reveals constitutive presence nuclear factor resting pbl bind proximal ap1 site il2 promoter contain immunoreactive cjun cfo protein
1 5 5 1 1 contrast ap1 phaactivated cell contains cjun low level cfo
1 8 8 1 1 contrast ap1 phaactivated cell contains cjun low level cfo
1 7 7 9 9 strikingly costimulation ec result dramatic increase 15fold cfo content ap1
0 7 7 16 16 asked whether dexamethasone dex cyclosporin csa inhibit il2 gene transcription interfering activity nuclear protein bind il2 promoter
0 12 12 13 13 correlate change nuclear factor binding vitro transcriptional activity vivo define structural requirement il2 promoter repression used transient dna transfections
0 7 7 12 12 jurkat cell transfected plasmid containing either intact il2 promoter ap1 nfat nfkb motif
1 0 0 12 13 e2a gene encodes transcription factor helixloophelix family implicated cellspecific gene expression part dimeric complex interact e box enhancer element
1 7 7 5 5 result consistent view dnabinding activity lef1bcf1 homodimer e2a protein selective appearance putative cellspecific transcription factor b lymphoid cell seems attributable least part elevated e2a protein concentration cell
1 7 7 6 6 result consistent view dnabinding activity lef1bcf1 homodimer e2a protein selective appearance putative cellspecific transcription factor b lymphoid cell seems attributable least part elevated e2a protein concentration cell
0 7 7 8 8 recombinant polypeptide formed sequencespecific complex ebfbinding site mb1 promoter
0 7 7 8 8 recombinant polypeptide formed sequencespecific complex ebfbinding site mb1 promoter
0 2 2 12 14 transcription human betaglobin gene cluster depends upon upstream regulatory sequence collectively termed locus control region
0 2 2 7 9 transcription human betaglobin gene cluster depends upon upstream regulatory sequence collectively termed locus control region
0 17 18 14 15 elucidate role individual gata factor erythropoiesis conditional allele gata1 gata2 gata3 prepared fusing factor hormonebinding domain human estrogen receptor er
0 24 24 22 23 determine whether defect patient lymphocyte involved transacting factor common affected lymphokine gene examined ability nuclear factor patient lymphocyte bind response element present regulatory region il2
0 24 24 19 20 determine whether defect patient lymphocyte involved transacting factor common affected lymphokine gene examined ability nuclear factor patient lymphocyte bind response element present regulatory region il2
0 9 9 7 8 contrast binding nuclear factor activated cell nfat response element il2 enhancer nfatlike response element present il4 enhancer abnormal
0 15 15 11 13 contrast binding nuclear factor activated cell nfat response element il2 enhancer nfatlike response element present il4 enhancer abnormal
0 9 9 10 10 contrast binding nuclear factor activated cell nfat response element il2 enhancer nfatlike response element present il4 enhancer abnormal
0 15 15 10 10 contrast binding nuclear factor activated cell nfat response element il2 enhancer nfatlike response element present il4 enhancer abnormal
0 24 24 25 26 ascertain whether abnormal nfat binding activity related impaired function transfected patient control lymphocyte construct containing reporter gene encoding chloramphenicol acetyl transferase cat control entire il2 regulatory region multimers individual enhancer sequence
0 12 12 7 9 contrast cat gene expression directed multimer oct1 proximal oct1pbinding site equivalent patient control
0 15 15 8 9 phenomenon due mutually exclusive binding nfatp nfkappa b p sequence element located 69 bp upstream il4 transcription initiation site
0 15 15 12 14 phenomenon due mutually exclusive binding nfatp nfkappa b p sequence element located 69 bp upstream il4 transcription initiation site
0 15 15 16 18 phenomenon due mutually exclusive binding nfatp nfkappa b p sequence element located 69 bp upstream il4 transcription initiation site
0 1 1 2 2 human il4 promotermediated transcription downregulated jurkat cell stimulated nfkappa bactivating cytokine tumor necrosis factor alpha suppressed relaoverexpressing cell
0 10 10 16 17 contrast protein kinase c stimulation rela overexpression affect activity human il4 promoter containing mouse p sequence higheraffinity site nfatp loweraffinity site rela
0 10 10 13 15 contrast protein kinase c stimulation rela overexpression affect activity human il4 promoter containing mouse p sequence higheraffinity site nfatp loweraffinity site rela
0 10 10 19 20 contrast protein kinase c stimulation rela overexpression affect activity human il4 promoter containing mouse p sequence higheraffinity site nfatp loweraffinity site rela
0 10 10 11 11 contrast protein kinase c stimulation rela overexpression affect activity human il4 promoter containing mouse p sequence higheraffinity site nfatp loweraffinity site rela
0 7 7 3 4 essential sufficient interaction pou domain either oct1 oct2
0 7 7 3 4 essential sufficient interaction pou domain either oct1 oct2
0 8 8 6 7 gal4 dna binding domain reveals nh2 coohterminal domain bob
0 8 8 6 7 gal4 dna binding domain reveals nh2 coohterminal domain bob
0 8 8 5 5 gal4 dna binding domain reveals nh2 coohterminal domain bob
0 0 0 0 3 gal4 dna binding domain reveals nh2 coohterminal domain bob
0 4 4 0 1 polymorphic nucleotide within human il4 promoter mediate overexpression gene
0 4 4 5 5 polymorphic nucleotide within human il4 promoter mediate overexpression gene
0 4 4 5 5 support model report human il4 promoter exists multiple allelic form exhibit distinct transcriptional activity il4positive cell
0 22 22 5 6 nucleotide substitution within recently described oap40 element located upstream nfat site p sequence appears largely responsible increased promotor strength particular allelic form il4 promoter
0 22 22 23 23 nucleotide substitution within recently described oap40 element located upstream nfat site p sequence appears largely responsible increased promotor strength particular allelic form il4 promoter
0 5 5 1 2 identification allelic nucleotide result overexpression il4 gene provides specific target comprehensive screening atopic nonatopic individual may provide clue genetic predisposition atopy
0 6 6 0 0 promoter 5 flanking sequence controlling human b29 gene expression
0 11 11 6 9 better understand regulation pivotal gene analyzed human genomic dna sequence upstream b29 atg start codon transcriptional control activity
0 1 1 6 7 human b29 gene lack either tata caat box transcription initiated multiple site
0 3 3 10 12 minimal promoter human b29 gene contained within 193bp region 5 multiple start site
0 3 3 0 1 minimal promoter human b29 gene contained within 193bp region 5 multiple start site
0 3 3 7 8 minimal promoter human b29 gene contained within 193bp region 5 multiple start site
0 9 9 10 10 motif strikingly conserved sequence placement relative previously characterized murine b29 promoter
0 6 6 7 8 additional upstream gene segment dramatically affected b29 minimal promoter activity
0 4 4 7 7 newly identified motif called b29 conserved sequence bcs found upstream human murine b29 promoter appears stimulate b29 transcription novel mechanism
0 4 4 7 7 newly identified motif called b29 conserved sequence bcs found upstream human murine b29 promoter appears stimulate b29 transcription novel mechanism
0 4 4 5 6 newly identified motif called b29 conserved sequence bcs found upstream human murine b29 promoter appears stimulate b29 transcription novel mechanism
0 4 4 13 13 newly identified motif called b29 conserved sequence bcs found upstream human murine b29 promoter appears stimulate b29 transcription novel mechanism
0 6 6 7 7 single bcs little effect either minimal b29 promoter heterologous promoter
0 12 12 13 14 instead bcs stimulated transcription counteracting 5 negative regulatory dna sequence block activity b29 minimal promoter absence
0 2 2 10 11 finding indicate b29 gene expression controlled complex interplay positive negative regulatory element
0 9 9 10 10 expression constitutively active raf1 mek1 jurkat cell enhanced stimulation il2 promoterdriven transcription stimulated calcium ionophore pma together calcium ionophore expression protein sufficient stimulate nfat activity
0 5 5 6 6 expression mek1interfering mutant inhibited stimulation il2 promoterdriven transcription blocked ability constitutively active ra raf1 costimulate nfat activity calcium ionophore
0 9 9 10 10 expression map kinasespecific phosphatase mkp1 block erk activation inhibited il2 promoter nfatdriven transcription stimulated calcium ionophore pma addition mkp1 neutralized transcriptional enhancement caused active raf1 mek1 expression
0 6 8 9 9 identification ionomycincyclosporin aresponsive element within human cell receptor gamma enhancer
0 7 9 11 11 report identification importance sequence noncytokine gene human cell receptor gamma tcrg enhancer
0 13 13 14 14 result sitedirected mutation electrophoretic mobility shift assay strongly suggest sequence mediates ionomycininduced activation tcrg enhancer
0 13 13 15 15 analyzed expression ap1 nfkappa b nfat octamer binding transcription factor known involved regulation il2 gene promoter activity
1 9 9 21 21 contrast anergic cd4 cell contained severely reduced level ap1 fosjuncontaining nfat complex expressed significant amount nfkappa b oct binding protein sea stimulation
1 9 9 21 21 contrast anergic cd4 cell contained severely reduced level ap1 fosjuncontaining nfat complex expressed significant amount nfkappa b oct binding protein sea stimulation
1 7 7 1 3 resolution nfkappa b complex demonstrated predominant expression p50p65 heterodimers activated cd4 cell anergic cell mainly expressed transcriptionally inactive p50 homodimer
1 7 7 1 3 resolution nfkappa b complex demonstrated predominant expression p50p65 heterodimers activated cd4 cell anergic cell mainly expressed transcriptionally inactive p50 homodimer
1 7 7 8 8 resolution nfkappa b complex demonstrated predominant expression p50p65 heterodimers activated cd4 cell anergic cell mainly expressed transcriptionally inactive p50 homodimer
1 7 7 8 8 resolution nfkappa b complex demonstrated predominant expression p50p65 heterodimers activated cd4 cell anergic cell mainly expressed transcriptionally inactive p50 homodimer
1 7 7 19 19 resolution nfkappa b complex demonstrated predominant expression p50p65 heterodimers activated cd4 cell anergic cell mainly expressed transcriptionally inactive p50 homodimer
1 2 2 3 4 presence p65 p50 nfkappa b component lpsactivated thp1 cell confirmed specific antibody induction supershifts mobility assay
0 2 2 15 17 investigate regulation il13 gene expression cell isolated sequenced human il13 gene analyzed 5flanking region potential transcriptional activation element examined expression nontransformed tlineage cell population
0 2 2 12 13 investigate regulation il13 gene expression cell isolated sequenced human il13 gene analyzed 5flanking region potential transcriptional activation element examined expression nontransformed tlineage cell population
0 11 11 9 10 il13 gene 5 flank region included segment sequence homology p element il4 promoter involved transcriptional activation cell
0 0 0 1 4 il13 gene 5 flank region included segment sequence homology p element il4 promoter involved transcriptional activation cell
0 11 11 12 12 il13 gene 5 flank region included segment sequence homology p element il4 promoter involved transcriptional activation cell
0 1 1 2 4 mutation il13 p element site significantly reduced il13 promoter activity response tcell activation
0 1 1 8 8 mutation il13 p element site significantly reduced il13 promoter activity response tcell activation
0 2 2 4 6 oligonucleotides containing il13 il4 p element site specifically bound transcriptional activator protein nuclear factoractivated cell preformed nfatp incubated nuclear protein extract activated cell
0 3 3 4 6 oligonucleotides containing il13 il4 p element site specifically bound transcriptional activator protein nuclear factoractivated cell preformed nfatp incubated nuclear protein extract activated cell
0 11 11 9 10 primed cell contain higher level nuclear nfatp capable binding p element il4 il13 promoter freshlyisolated cell nfatbinding p element attractive candidate mediate coordinate expression two cytokine gene
0 12 12 9 10 primed cell contain higher level nuclear nfatp capable binding p element il4 il13 promoter freshlyisolated cell nfatbinding p element attractive candidate mediate coordinate expression two cytokine gene
0 11 11 13 13 primed cell contain higher level nuclear nfatp capable binding p element il4 il13 promoter freshlyisolated cell nfatbinding p element attractive candidate mediate coordinate expression two cytokine gene
0 12 12 13 13 primed cell contain higher level nuclear nfatp capable binding p element il4 il13 promoter freshlyisolated cell nfatbinding p element attractive candidate mediate coordinate expression two cytokine gene
0 4 4 13 13 analyze mechanism lead expression il1alpha htlviinfected cell line studied regulatory region human il1alpha promoter involved activation il1alpha gene
0 9 9 10 10 cotransfection assay tax protein htlvi htlvii specifically activated transcription il1alpha promoter uninfected jurkat cell line
0 14 14 15 15 mutant tax protein deficient transactivation gene nuclear factor nfkappab pathway unable induce transcriptional activity il1alpha promotercat construct rescued exogenous provision p65p50 nfkappab
1 20 20 8 8 mutant tax protein deficient transactivation gene nuclear factor nfkappab pathway unable induce transcriptional activity il1alpha promotercat construct rescued exogenous provision p65p50 nfkappab
1 20 20 8 8 mutant tax protein deficient transactivation gene nuclear factor nfkappab pathway unable induce transcriptional activity il1alpha promotercat construct rescued exogenous provision p65p50 nfkappab
0 2 2 3 4 found two il1alpha kappablike site position 1065 1056 646 655 specifically formed complex nfkappabcontaining nuclear extract mt2 cell nfkappab bound higher affinity 3 nfkappab binding site 5 nfkappab site
0 8 8 4 6 moreover deletion either 5 3 nfkappab site reduced il1alpha promoter activity mt2 cell transactivation il1alpha promoter exogenous nfkappab tax jurkat cell
0 8 8 3 3 moreover deletion either 5 3 nfkappab site reduced il1alpha promoter activity mt2 cell transactivation il1alpha promoter exogenous nfkappab tax jurkat cell
0 8 8 9 9 moreover deletion either 5 3 nfkappab site reduced il1alpha promoter activity mt2 cell transactivation il1alpha promoter exogenous nfkappab tax jurkat cell
0 8 8 9 9 moreover deletion either 5 3 nfkappab site reduced il1alpha promoter activity mt2 cell transactivation il1alpha promoter exogenous nfkappab tax jurkat cell
0 9 9 16 17 study included structural comparison promoter human mouse inducible synthase inos gene transfection assay human mouse inos promoter region response lp ifngamma electrophoretic mobility shift assay kappa b response element
0 4 4 5 5 two explanation hyporesponsiveness human inos promoter lp ifngamma found 1 multiple inactivating nucleotide substitution human counterpart enhancer element shown regulate lpsifngamma induced expression mouse inos gene 2 absence one nuclear factor human macrophage e
0 15 15 13 14 focus preferentially found adjacent nucleolus nuclear periphery represent site active transcription binding gata1 consensus site betaglobin locus
1 7 7 8 8 together result indicate occupancy viral enhancer nfkappab p50p65 heterodimers required ongoing transcription integrated hiv provirus monocyte even cell chronically infected permanently producing functional hiv tat protein
0 4 4 15 16 like ikappabalpha taxmediated breakdown ikappabbeta transfected lymphocyte blocked either cellpermeable proteasome inhibitor mutation ikappabbeta two serine residue present within nterminal region
0 8 8 2 3 single egr1 binding motif demonstrated bp 301 human cd44 promoter
0 8 8 9 9 single egr1 binding motif demonstrated bp 301 human cd44 promoter
0 2 2 3 5 identified region cmyb 5 flanking sequence increased cmyb expression tcell activation
0 4 4 5 7 protein footprint visible region cmyb 5 flanking sequence activated cell unactivated cell
0 4 4 9 10 structural functional characterization human cd36 gene promoter identification proximal pebp2cbf site
0 4 4 6 6 structural functional characterization human cd36 gene promoter identification proximal pebp2cbf site
0 5 5 12 12 study molecular mechanism control transcription cd36 gene monocytic cell isolated analyzed cd36 promoter
0 3 3 5 6 used oligonucleotide probe betacasein irf1 gene promoter isre probe detect stat protein nuclear extract acute leukemia cell bandshift assay
0 4 4 5 6 used oligonucleotide probe betacasein irf1 gene promoter isre probe detect stat protein nuclear extract acute leukemia cell bandshift assay
0 8 8 9 10 specific dna protein complex formation observed probe betacasein irf1 gene promoter isre oligonucleotide probe cell extract acute lymphoblastic leukemia acute myeloid leukemia aml investigated
1 8 8 15 16 lpsstimulated monocyte showed increased expression p105 mrna precursor p50 subunit transcription factor nuclear factorkappa b nfkappa b effect noticed expression p65 mrna
1 8 8 10 14 lpsstimulated monocyte showed increased expression p105 mrna precursor p50 subunit transcription factor nuclear factorkappa b nfkappa b effect noticed expression p65 mrna
1 10 10 11 12 electrophoretic mobility shift assay emsas demonstrated unstimulated monocyte predominantly expressed p50 nfkappa b
1 5 5 2 2 demonstrated uncoupling ap1 binding activity p62cfos p39cjun ap1 activity expressed strongly g1 g2mphase enriched sample sphase enriched sample hl60 cell level nuclear p62cfos p39cjun constant
0 4 4 0 2 cell typespecific enhancer human b7
0 2 2 3 4 identification tissuespecific deoxyribonuclease hypersensitive site approximately 3kb upstream transcription start site led characterization cell typespecific enhancer region
0 0 0 4 6 p45 subunit nfe2 contains basicleucine zipper domain dimerizes small maf family protein form functional nfe2 complex
1 0 0 2 2 p45 subunit nfe2 contains basicleucine zipper domain dimerizes small maf family protein form functional nfe2 complex
0 1 1 7 8 although p45 mrna transcribed two different promoter anfe2 promoter fnfe2 promoter erythroid megakaryocytic lineage cell p45 mrna transcribed anfe2 promoter
0 1 1 9 10 although p45 mrna transcribed two different promoter anfe2 promoter fnfe2 promoter erythroid megakaryocytic lineage cell p45 mrna transcribed anfe2 promoter
0 1 1 8 9 expression p45 megakaryocytic lineage cell p45 mrna transcribed anfe2 promoter
0 4 4 7 8 nfkappabrel binding site within gmcsf promoter termed kappab element appears important controlling expression reporter gene assay response number stimulus cell
0 4 4 0 2 nfkappabrel binding site within gmcsf promoter termed kappab element appears important controlling expression reporter gene assay response number stimulus cell
0 4 4 5 5 nfkappabrel binding site within gmcsf promoter termed kappab element appears important controlling expression reporter gene assay response number stimulus cell
0 6 6 4 5 15base oligonucleotide gm3 targeted purinerich region gmcsf proximal promoter overlap kappab element
0 6 6 10 11 15base oligonucleotide gm3 targeted purinerich region gmcsf proximal promoter overlap kappab element
0 6 6 7 8 15base oligonucleotide gm3 targeted purinerich region gmcsf proximal promoter overlap kappab element
0 16 16 17 17 gm3 also caused selective inhibition human tcell lymphotrophic virus1 tax transactivatorinduced luciferase activity reporter construct driven gmcsf promoter jurkat cell
0 3 3 1 2 conclude kappab element gmcsf promoter play central role transcriptional activation endogenous gmcsf gene
0 3 3 1 2 conclude kappab element gmcsf promoter play central role transcriptional activation endogenous gmcsf gene
0 3 3 4 4 conclude kappab element gmcsf promoter play central role transcriptional activation endogenous gmcsf gene
0 2 2 13 14 tissuespecific expression interleukin3 il3 mediated via cisacting element located within 315 base pair transcription start
0 2 2 6 7 tissuespecific expression interleukin3 il3 mediated via cisacting element located within 315 base pair transcription start
0 7 7 6 6 achieved part positive activity ap1 elf1 site il3 promoter
0 7 7 8 8 achieved part positive activity ap1 elf1 site il3 promoter
0 9 9 17 21 contribution cellspecific expression promoter site assessed transient expression assay il3 promoter construct linked luciferase gene focusing initially core binding factor cbf site footprinted vivo upon cell activation
0 6 6 2 4 finally novel positive regulatory element mapped il3 promoter nucleotide 180 210 lead increased expression cell
0 6 6 7 7 finally novel positive regulatory element mapped il3 promoter nucleotide 180 210 lead increased expression cell
0 5 5 14 15 together result demonstrate cell expression il3 specified activity single tissuespecific element instead involves multiple interacting element provide specific positive regulation cell specific negative regulation fibroblast
0 6 6 6 6 octamer binding factor coactivator activate murine pu
0 5 5 5 5 1995 oncogene 11 15491560 demonstrate pu
0 2 2 2 4 show murine pu
0 2 2 2 2 show murine pu
0 15 15 15 16 also demonstrate two site contribute promoter activity b cell sp1 binding site adjacent octamer site pu
0 13 13 13 13 finally show b cell coactivator obf1bob1ocab expressed b cell myeloid cell obf1bob1ocab transactivate pu
0 4 4 7 10 order better characterize human gammac promoter define minimal tissuespecific promoter region progressive 5deletion construct segment extending 1053 base pair upstream major transcription start site generated tested promoter activity various hematopoietic nonhematopoietic cell type
0 8 8 3 5 contains two potential ets binding site conserved murine gammac promoter gene one found essential functional promoter activity determined mutational analysis
0 4 4 5 5 result indicate already reported il2rbeta promoter gabinding protein essential component gammac basal promoter activity
0 10 10 11 12 result indicate already reported il2rbeta promoter gabinding protein essential component gammac basal promoter activity
0 11 11 17 18 transient expression luciferase reporter gene linked serially deleted sequence 5flanking region il9 gene revealed several positive negative regulatory element involved basal inducible expression il9 gene c5mj2 cell
0 15 15 16 16 within region nfkappab site 59 50 adjacent 20base pair upstream sequence demonstrated play critical role il9 promoter activity
0 3 3 16 17 structurefunction analysis various oct2a effector region context gal4 dnabinding domain revealed oct2a contains two functionally different activation domain n c terminus
0 3 3 4 5 structurefunction analysis various oct2a effector region context gal4 dnabinding domain revealed oct2a contains two functionally different activation domain n c terminus
0 7 7 7 9 structurefunction analysis various oct2a effector region context gal4 dnabinding domain revealed oct2a contains two functionally different activation domain n c terminus
0 8 8 6 7 recently identified repression domain located within n terminus oct2a amino acid 299
0 8 8 2 3 recently identified repression domain located within n terminus oct2a amino acid 299
0 8 8 9 11 recently identified repression domain located within n terminus oct2a amino acid 299
0 6 6 8 10 study present deletion analysis nterminal region oct2a determine minimal repression domain
0 4 4 13 13 recombinant nfat1 mediate transcription interleukin2 interleukin4 tumor necrosis factor alpha granulocytemacrophage colonystimulating factor promoter cell suggesting nfat1 contributes csasensitive transcription gene immune response
0 5 5 13 13 recombinant nfat1 mediate transcription interleukin2 interleukin4 tumor necrosis factor alpha granulocytemacrophage colonystimulating factor promoter cell suggesting nfat1 contributes csasensitive transcription gene immune response
0 6 9 13 13 recombinant nfat1 mediate transcription interleukin2 interleukin4 tumor necrosis factor alpha granulocytemacrophage colonystimulating factor promoter cell suggesting nfat1 contributes csasensitive transcription gene immune response
0 10 12 13 13 recombinant nfat1 mediate transcription interleukin2 interleukin4 tumor necrosis factor alpha granulocytemacrophage colonystimulating factor promoter cell suggesting nfat1 contributes csasensitive transcription gene immune response
0 0 0 11 12 nfat1 posse two transactivation domain whose sequence conserved nfatfamily protein conserved dnabinding domain mediates recruitment cooperating nuclear transcription factor even expressed absence region protein
0 0 0 3 4 nfat1 posse two transactivation domain whose sequence conserved nfatfamily protein conserved dnabinding domain mediates recruitment cooperating nuclear transcription factor even expressed absence region protein
0 0 0 22 22 nfat1 posse two transactivation domain whose sequence conserved nfatfamily protein conserved dnabinding domain mediates recruitment cooperating nuclear transcription factor even expressed absence region protein
0 11 11 17 18 approximately 40 diffuse large cell lymphoma associated chromosomal translocation deregulate expression bcl6 gene juxtaposing heterologous promoter bcl6 coding domain
1 7 7 12 13 using dna sequence selected ability bind recombinant bcl6 vitro show bcl6 present dnabinding complex nuclear extract various bcell line
0 7 9 10 10 eta neither bound kappa3 element nfatbinding site tumor necrosis factoralpha promoter activated tumor necrosis factoralpha promoter cotransfection assay
0 7 9 10 10 eta neither bound kappa3 element nfatbinding site tumor necrosis factoralpha promoter activated tumor necrosis factoralpha promoter cotransfection assay
0 3 3 6 7 study region upstream cp analyzed presence ci element involved regulating activity ebna gene promoter established vitro immortalized lymphoblastoid cell line lcls
0 5 5 7 7 deletion ebna2dependent enhancer located upstream cp resulted ca
0 4 4 13 13 extensive deletion sequence upstream cp including ebna2dependent enhancer resulted nearly complete loss cp activity
0 23 23 6 7 loss activity shown correlate deletion two ccaat box proximal ccaat box located bp 61 65 distal ccaat box located bp 253 257 upstream cp
0 23 23 12 14 loss activity shown correlate deletion two ccaat box proximal ccaat box located bp 61 65 distal ccaat box located bp 253 257 upstream cp
0 23 23 8 10 loss activity shown correlate deletion two ccaat box proximal ccaat box located bp 61 65 distal ccaat box located bp 253 257 upstream cp
0 23 23 20 21 loss activity shown correlate deletion two ccaat box proximal ccaat box located bp 61 65 distal ccaat box located bp 253 257 upstream cp
0 5 5 12 13 sitedirected mutagenesis ci element demonstrated cp activity highly dependent presence properly positioned ccaat box dependence distal ccaat box apparent proximal ccaat box deleted mutated
0 12 12 13 15 work report anergic cell defective ability upregulate protein binding transactivation two critical il2 dna enhancer element nfat nuclear factor activated cell sequence bind heterotrimeric nfatp fo jun protein complex activator protein1 ap1 bind fo jun heterodimers
1 24 24 27 28 work report anergic cell defective ability upregulate protein binding transactivation two critical il2 dna enhancer element nfat nuclear factor activated cell sequence bind heterotrimeric nfatp fo jun protein complex activator protein1 ap1 bind fo jun heterodimers
1 26 26 27 28 work report anergic cell defective ability upregulate protein binding transactivation two critical il2 dna enhancer element nfat nuclear factor activated cell sequence bind heterotrimeric nfatp fo jun protein complex activator protein1 ap1 bind fo jun heterodimers
1 24 24 23 24 work report anergic cell defective ability upregulate protein binding transactivation two critical il2 dna enhancer element nfat nuclear factor activated cell sequence bind heterotrimeric nfatp fo jun protein complex activator protein1 ap1 bind fo jun heterodimers
1 25 25 35 35 work report anergic cell defective ability upregulate protein binding transactivation two critical il2 dna enhancer element nfat nuclear factor activated cell sequence bind heterotrimeric nfatp fo jun protein complex activator protein1 ap1 bind fo jun heterodimers
1 26 26 35 35 work report anergic cell defective ability upregulate protein binding transactivation two critical il2 dna enhancer element nfat nuclear factor activated cell sequence bind heterotrimeric nfatp fo jun protein complex activator protein1 ap1 bind fo jun heterodimers
0 15 15 10 10 ebna transcription initiated one three ebna promoter qp contrast cp wp silent thus resulting lack ebna2 mrna
0 15 15 9 9 ebna transcription initiated one three ebna promoter qp contrast cp wp silent thus resulting lack ebna2 mrna
0 1 1 2 2 recently egr1 promoter shown highly responsive diverse biochemical signal generated antigen cytokine cell immune system
0 7 7 14 15 result suggest new option hiv gene therapy bcl2 muteins noncleavable alteration surrounding hiv protease cleavage site
0 10 11 4 4 ligand activation cerbb induced tyrosine phosphorylation dnabinding reporter gene transcription stat 5b erythroblast
1 12 12 3 5 agerelated decline induction nf kappa b could attributed alteration composition subunit p50 p65 found predominant subunit induced nf kappa b cell young well elderly donor
1 11 11 3 5 agerelated decline induction nf kappa b could attributed alteration composition subunit p50 p65 found predominant subunit induced nf kappa b cell young well elderly donor
1 5 5 3 4 similarly p105 precursor nfkappa b p50 subunit also posttranslationally processed proteasome
1 4 4 6 7 identified physical interaction tax hsn3 subunit human proteasome
1 4 4 7 7 identified physical interaction tax hsn3 subunit human proteasome
1 5 5 6 6 raise intriguing possibility physical association hsn3 proteasome subunit htlvi tax coupled independent interaction tax either p100 p65i kappa b alpha target cytoplasmic nfkappa brel complex proteasome processing
0 6 6 4 4 attenuated function variant form helixloophelix protein id3 generated alternative splicing mechanism
0 21 21 18 19 variant id3l protein functionally distinguishable conventional id3 since vitro dna mobility shift assay greatly impaired ability abrogate binding basic helixloophelix protein e47 e box recognition sequence
0 7 7 8 8 fold expression stimulated anergic condition whole mouse il2 enhancer construct showed reduction 4
0 9 9 8 10 180 site required transactivation possible confirm mutation normal mouse il2 enhancer site absolutely essential anergy induction
0 9 9 10 10 180 site required transactivation possible confirm mutation normal mouse il2 enhancer site absolutely essential anergy induction
0 12 12 2 3 two interferonstimulated response element isre flank multiple transcription start site region identifying mnda tataless interferonregulated gene
0 12 12 4 4 two interferonstimulated response element isre flank multiple transcription start site region identifying mnda tataless interferonregulated gene
0 2 2 3 3 demonstrate human gmcsf promoter enhancer also encompass binding site corebinding factor cbf
0 2 2 4 4 demonstrate human gmcsf promoter enhancer also encompass binding site corebinding factor cbf
0 0 0 4 4 gmcsf promoter cbf site tgtggtca located 51 bp upstream transcription start site also overlap yy1 binding site
0 0 0 15 16 gmcsf promoter cbf site tgtggtca located 51 bp upstream transcription start site also overlap yy1 binding site
0 0 0 9 11 gmcsf promoter cbf site tgtggtca located 51 bp upstream transcription start site also overlap yy1 binding site
0 0 0 6 8 gmcsf promoter cbf site tgtggtca located 51 bp upstream transcription start site also overlap yy1 binding site
0 0 0 0 3 gmcsf promoter cbf site tgtggtca located 51 bp upstream transcription start site also overlap yy1 binding site
1 0 0 1 1 aml1 cbf beta gene encode cbf ability influence cell growth differentiation implicated protooncogenes acute myeloid leukemia
0 6 6 7 10 furthermore cell two molecule nfatp bind tnfalpha promoter element kappa 3 association atf2 jun protein bound immediately adjacent cyclic amp response element cre site
0 20 20 14 15 instead atf2 jun protein bind composite kappa 3cre site nfatp bind newly identified second nfat site centered 76 nucleotide relative tnfalpha transcription start site
0 20 20 21 23 instead atf2 jun protein bind composite kappa 3cre site nfatp bind newly identified second nfat site centered 76 nucleotide relative tnfalpha transcription start site
0 5 5 13 14 consistent result quantitative dnase footprinting tnfalpha promoter using increasing amount recombinant nfatp demonstrated 76 site bind nfatp higher affinity kappa 3 site
0 5 5 6 6 consistent result quantitative dnase footprinting tnfalpha promoter using increasing amount recombinant nfatp demonstrated 76 site bind nfatp higher affinity kappa 3 site
0 6 6 10 10 two previously unrecognized nfatpbinding site proximal tnfalpha promoter also identified analysis
0 6 6 7 7 two previously unrecognized nfatpbinding site proximal tnfalpha promoter also identified analysis
0 3 7 1 2 analysis ligandbinding domain human retinoic acid receptor alpha sitedirected mutagenesis
0 9 10 13 16 study examined functional role cysteine arginine residue ligandbinding domain hrar alpha hrar alphalbd amino acid 154 462
0 9 10 13 16 study examined functional role cysteine arginine residue ligandbinding domain hrar alpha hrar alphalbd amino acid 154 462
0 9 10 5 6 study examined functional role cysteine arginine residue ligandbinding domain hrar alpha hrar alphalbd amino acid 154 462
0 9 10 4 4 study examined functional role cysteine arginine residue ligandbinding domain hrar alpha hrar alphalbd amino acid 154 462
0 9 10 16 16 study examined functional role cysteine arginine residue ligandbinding domain hrar alpha hrar alphalbd amino acid 154 462
0 3 4 1 2 change cysteine residue hrar alphalbd significant influence binding alltrans ra 9cis ra
0 3 4 11 11 change cysteine residue hrar alphalbd significant influence binding alltrans ra 9cis ra
0 5 6 11 11 result conclude electrostatic interaction retinoids rar alphalbd play significant role ligand binding
0 16 18 3 3 proximal sequence element psebinding transcription factor ptf bind pse rna polymerase ii rna polymerase iiitranscribed mammalian small nuclear rna snrna gene essential transcription
1 11 12 3 4 previously reported purification human ptf complex four subunit molecular cloning characterization ptf gamma delta subunit
1 13 14 3 4 previously reported purification human ptf complex four subunit molecular cloning characterization ptf gamma delta subunit
1 1 2 6 7 native ptf beta either protein fraction ptfoct1dna complex recognized polyclonal antibody raised recombinant ptf beta
1 5 6 5 7 along previous demonstration physical interaction ptf gammaptf delta tbp involvement tfiiib90 transcription class iii snrna gene result consistent notion tbpcontaining complex related tfiiib required transcription class iii snrna gene act weak interaction foursubunit ptf
1 6 7 5 7 along previous demonstration physical interaction ptf gammaptf delta tbp involvement tfiiib90 transcription class iii snrna gene result consistent notion tbpcontaining complex related tfiiib required transcription class iii snrna gene act weak interaction foursubunit ptf
0 12 12 13 13 mutation cre site result loss creb binding also lead loss functional activity bcl2 promoter transienttransfection assay
0 4 4 5 5 presence active cre site bcl2 promoter implies regulation bcl2 expression linked signal transduction pathway b cell
0 2 2 3 3 cre site bcl2 promoter appears play major role induction bcl2 expression activation mature b cell rescue immature b cell apoptosis
0 1 1 2 2 murine e3 promoter harbor single bipartite retinoic acid response element transient transfection assay conferred ra sensitivity
0 10 11 10 14 early study murine cell line indicated transcriptional transactivation function encoded glucocorticoid receptor gr nterminal domain required glucocorticoidmediated apoptosis
0 3 3 4 6 better understand contribution gr nterminal transactivation domain mediating murine thymocyte apoptosis stably transfected gr gr variant androgen receptor ar receptornegative s49 murine thymoma cell
0 6 6 8 10 analysis gr chimeric receptor containing potent vp16 e1a viral transactivation domain place gr n terminus revealed even low level expression receptor resulted enhanced steroid sensitivity mmtv induction thus supporting role transactivation apoptosis
0 7 7 8 10 analysis gr chimeric receptor containing potent vp16 e1a viral transactivation domain place gr n terminus revealed even low level expression receptor resulted enhanced steroid sensitivity mmtv induction thus supporting role transactivation apoptosis
1 1 2 5 5 human tafii 105 cell typespecific tfiid subunit related htafii130
1 2 2 6 6 property suggest tafii105 cell typespecific subunit tfiid may responsible mediating transcription subset activator b cell
0 9 9 4 4 study designed determine potential ciselements involved transcriptional regulation mouse perforin gene
0 6 6 3 3 dnase hypersensitive site dhs mapping revealed perforin locus contained six dhs within 7
0 6 6 12 13 dnase hypersensitive site dhs mapping revealed perforin locus contained six dhs within 7
0 6 6 3 3 dnase hypersensitive site dhs mapping revealed perforin locus contained six dhs within 7
0 5 5 3 4 confirm importance three cisacting element perforin gene expression point mutation introduced proximal gc box eb gt box pfp5a
0 14 14 5 6 result suggest combination three proximal cisacting element may constitute minimal region responsible ctlspecific expression perforin
0 18 19 20 20 activation tgfbeta 2 transcription correlate loss binding activity 80 kda glial labile repressor protein glrp responsive region within tfgbeta 2 promoter
0 1 1 2 2 bound btk promoter
0 7 8 10 10 novel immunosuppressive factor bovine colostrum block activation interleukin 2 gene enhancer nfat site
0 13 13 20 20 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 13 13 21 21 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 13 13 22 22 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 13 13 23 23 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 15 15 20 20 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 15 15 21 21 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 15 15 23 23 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 15 15 18 19 promoter region lacked tata box contained potential binding site transcriptional factor including two sp1 cre myb nfkb located position 153 178 286 875 1011 respectively
0 4 4 10 12 analyze regulatory mechanism controlling p27kip1 gene expression characterized 5flanking region nt 1609 178
0 4 4 8 9 analyze regulatory mechanism controlling p27kip1 gene expression characterized 5flanking region nt 1609 178
0 4 5 6 6 novel sp1 site human interleukin1 beta promoter confers preferential transcriptional activity keratinocytes
0 5 5 21 21 investigate mechanism transcriptional activation interleukin1beta il1beta nonmonocytic cell constructed series reporter plasmid bacterial chloramphenicol acetyltransferase gene linked various part human il1beta promoter performed transient transfection experiment
0 6 6 4 4 observation suggest sofarunrecognized sp1 site human il1beta promoter may participate transcriptional regulation gene keratinocytes
0 6 6 7 7 observation suggest sofarunrecognized sp1 site human il1beta promoter may participate transcriptional regulation gene keratinocytes
0 12 13 14 15 examine transcriptional regulation cytokine gene cd15 engagement cat plasmid reporter construct containing il1 beta promoterenhancer sequence introduced mm6
0 14 14 9 9 v3bh10 neither blocked radiolabeled il2 binding il2 receptor affected tyrosyl phosphorylation several cellular protein p120 p98 p96 p54 p38 immediately induced il2 stimulation
0 15 15 9 9 v3bh10 neither blocked radiolabeled il2 binding il2 receptor affected tyrosyl phosphorylation several cellular protein p120 p98 p96 p54 p38 immediately induced il2 stimulation
0 16 16 9 9 v3bh10 neither blocked radiolabeled il2 binding il2 receptor affected tyrosyl phosphorylation several cellular protein p120 p98 p96 p54 p38 immediately induced il2 stimulation
0 17 17 9 9 v3bh10 neither blocked radiolabeled il2 binding il2 receptor affected tyrosyl phosphorylation several cellular protein p120 p98 p96 p54 p38 immediately induced il2 stimulation
0 18 18 9 9 v3bh10 neither blocked radiolabeled il2 binding il2 receptor affected tyrosyl phosphorylation several cellular protein p120 p98 p96 p54 p38 immediately induced il2 stimulation
0 4 4 2 3 thus binding v3 loop gp120 cell surface molecule appears affect intracellular il2 signaling lead suppression il2induced cell growth
0 5 5 7 7 glycationdependent reactive oxygen speciesmediated suppression insulin gene promoter activity hit cell
0 11 11 7 7 result reporter gene analysis revealed insulin gene promoter sensitive glycation control betaactin gene promoter approximately 50 80 insulin gene promoter activity lost cell kept 3 presence 40 60 mm dribose respectively
0 5 5 7 7 result reporter gene analysis revealed insulin gene promoter sensitive glycation control betaactin gene promoter approximately 50 80 insulin gene promoter activity lost cell kept 3 presence 40 60 mm dribose respectively
0 8 8 9 9 differential interaction nuclear factor prei enhancer element human il4 promoter different cell subset
0 8 8 2 3 previously identified enhancer element prei essential function human il4 promoter
0 8 8 4 4 previously identified enhancer element prei essential function human il4 promoter
0 5 5 11 12 investigate mechanism responsible tissuespecific expression il4 gene analyzed nuclear factor binding prei site compared binding activity factor il4 promoter th1 th2 cell
0 5 5 18 18 investigate mechanism responsible tissuespecific expression il4 gene analyzed nuclear factor binding prei site compared binding activity factor il4 promoter th1 th2 cell
1 11 11 7 7 il4producing th0like human jurkat mouse el4 cell pos1 designated pos1a contains nfil6beta jun
1 11 11 7 7 mouse th2 d10 cell human th2 clone pos1 designated pos1b contains nfil6beta jun nfatcp
0 8 8 2 2 finding suggest prei may play role differential regulation il4 gene expression level
0 2 2 10 11 impaired induction cfoscjun gene transcriptional regulatory protein binding distinct cfoscjun promoter element activated human cell aging
0 2 2 10 11 impaired induction cfoscjun gene transcriptional regulatory protein binding distinct cfoscjun promoter element activated human cell aging
1 3 3 4 4 activation transcriptional factor cfoscjun ap1 essential normal cell responsiveness often impaired cell aging
0 15 15 16 18 using electrophoretic mobility shift assay level nuclear regulatory protein recognizing ap1 consensus tre motif proximal cjun trelike promoter element cfo serum response element sre determined resting stimulated cell
0 19 19 20 22 using electrophoretic mobility shift assay level nuclear regulatory protein recognizing ap1 consensus tre motif proximal cjun trelike promoter element cfo serum response element sre determined resting stimulated cell
0 14 14 18 20 although stimulation cell young subject resulted coordinated increase nuclear protein complex binding ap1 tre cjun tre cfo sre dna sequence motif agerelated reduction activation ap1 accompanied decreased level cjun tre cfo sre binding complex
0 16 16 18 20 although stimulation cell young subject resulted coordinated increase nuclear protein complex binding ap1 tre cjun tre cfo sre dna sequence motif agerelated reduction activation ap1 accompanied decreased level cjun tre cfo sre binding complex
1 17 17 1 3 furthermore nuclear protein complex binding sre motif induced activated cell young elderly subject contained serum response factor elk1 pointing toward agerelated defect activation transcriptional regulatory protein distinct cjunap1
1 27 27 27 27 furthermore nuclear protein complex binding sre motif induced activated cell young elderly subject contained serum response factor elk1 pointing toward agerelated defect activation transcriptional regulatory protein distinct cjunap1
1 1 1 5 5 addition rfx1 bind simultaneously likely heterodimer transcription factor mibp1 nre gamma
1 8 8 5 5 addition rfx1 bind simultaneously likely heterodimer transcription factor mibp1 nre gamma
0 2 5 6 6 characterization human plateletendothelial cell adhesion molecule1 promoter identification gata2 binding element required optimal transcriptional activity
0 5 5 7 8 examine factor controlling vascularspecific expression pecam1 cloned 5flanking region pecam1 gene analyzed transcriptional activity
0 2 2 3 4 5serially truncated pecam1 promoter segment cloned front luciferase reporter drove transcription lineage orientationspecific manner
0 20 20 21 21 mutational analysis showed optimal transcriptional activity required gata sequence position 24 gelshift assay showed gata2 transcription factor gata1 bound region pecam1 promoter
0 3 3 8 10 primer extension analysis cebpepsilon mrna detected single major transcription start site approximately 200 bp upstream start codon
0 3 3 15 16 primer extension analysis cebpepsilon mrna detected single major transcription start site approximately 200 bp upstream start codon
0 6 6 12 15 western blot immunoprecipitation study using rabbit anticebpepsilon antibody raised nterminal portion cebpepsilon amino acid 1 115 showed cebpepsilon 32kda nuclear phosphoprotein
0 6 6 9 10 western blot immunoprecipitation study using rabbit anticebpepsilon antibody raised nterminal portion cebpepsilon amino acid 1 115 showed cebpepsilon 32kda nuclear phosphoprotein
0 0 1 3 3 ferritin hchain gene promoter regulation analyzed hemetreated friend leukemia cell flcs monocytetomacrophage differentiation
0 3 4 14 18 show minimum region ferritin hgene promoter able confer transcriptional regulation heme flcs reporter gene 77 nucleotide upstream tata box
0 3 4 14 16 show minimum region ferritin hgene promoter able confer transcriptional regulation heme flcs reporter gene 77 nucleotide upstream tata box
0 3 4 17 18 show minimum region ferritin hgene promoter able confer transcriptional regulation heme flcs reporter gene 77 nucleotide upstream tata box
0 3 4 5 5 show minimum region ferritin hgene promoter able confer transcriptional regulation heme flcs reporter gene 77 nucleotide upstream tata box
0 7 8 0 1 ccaat element present reverse orientation promoter region ferritin hchain gene necessary binding gene activity since single point mutation able abolish binding hrf transcriptional activity transfected cell
0 11 12 20 20 demonstrate upon stimulation lipopolysaccharide taxol phorbol myristate acetate interleukin1 doublestranded rna kappab alpha degraded result absence induced phosphorylation serine 32 36
1 6 6 10 10 neither mutation kappab alpha mutation p50 rela two major subunit nfkappab cell line account phosphorylation defect
1 5 5 10 10 neither mutation kappab alpha mutation p50 rela two major subunit nfkappab cell line account phosphorylation defect
0 4 5 6 7 well culminating inducible phosphorylation kappab alpha serine 32 36 stimulus inactive 1
1 2 2 3 3 constitutive expression p50 homodimer freshly isolated human monocyte decrease vitro vivo differentiation possible mechanism influencing human immunodeficiency virus replication monocyte mature macrophage
1 9 9 10 10 freshly isolated monocyte constitutively expressed high level transcriptionally inactive p50 homodimer decreased time culture favor transcriptionally active p50p65 p50relb heterodimers
1 9 9 19 19 freshly isolated monocyte constitutively expressed high level transcriptionally inactive p50 homodimer decreased time culture favor transcriptionally active p50p65 p50relb heterodimers
1 17 17 19 19 freshly isolated monocyte constitutively expressed high level transcriptionally inactive p50 homodimer decreased time culture favor transcriptionally active p50p65 p50relb heterodimers
1 9 9 19 19 freshly isolated monocyte constitutively expressed high level transcriptionally inactive p50 homodimer decreased time culture favor transcriptionally active p50p65 p50relb heterodimers
1 18 18 19 19 freshly isolated monocyte constitutively expressed high level transcriptionally inactive p50 homodimer decreased time culture favor transcriptionally active p50p65 p50relb heterodimers
1 4 4 4 4 mdms am constitutively expressed p50p65 p50relb although lower level
1 4 4 4 4 mdms am constitutively expressed p50p65 p50relb although lower level
1 5 5 5 5 mdms am constitutively expressed p50p65 p50relb although lower level
1 6 6 6 6 hiv infection fresh monocyte failed induce p50p65 seen mdms
1 1 1 2 2 replacement p50 homodimers transcriptionally active heterodimers following time culture may partially explain progressive increase susceptibility monocyte hiv infection vitro culture
0 0 0 19 19 il2 superinduction tat occurred transcriptional level mediated cd28responsive element il2 promoter exclusively dependent 29 amino acid encoded second exon tat
0 0 0 10 10 il2 superinduction tat occurred transcriptional level mediated cd28responsive element il2 promoter exclusively dependent 29 amino acid encoded second exon tat
0 3 3 4 4 observation implicated crel il2 promoter factor experimental support obtained transient transfection experiment
0 2 2 0 1 cellspecific enhancer interleukin3 locus activated cooperatively oct nfat element within dnase ihypersensitive site
0 0 0 4 8 il3 enhancer spanned inducible cyclosporin asensitive dnase ihypersensitive site found cell
0 0 0 1 1 il3 enhancer spanned inducible cyclosporin asensitive dnase ihypersensitive site found cell
1 7 7 0 1 nfkappa b1 gene encodes 105kd protein precursor p50 component nfkappa b
1 1 1 3 4 nuclear rela crel protein complex differentially distributed within human thymocytes
1 2 2 3 4 nuclear rela crel protein complex differentially distributed within human thymocytes
1 11 11 3 4 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 10 10 3 4 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 10 10 3 4 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 10 10 12 12 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 10 10 12 12 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 10 10 12 12 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 11 11 12 12 present report identified nfkappa b protein extracted human thymocyte nucleus p50p65 p50crel complex
1 4 4 4 4 detection suggested preferential activation p50crel medullary thymocytes whereas p50p65 present cortical medullary region human thymus lobule
1 4 4 8 8 detection suggested preferential activation p50crel medullary thymocytes whereas p50p65 present cortical medullary region human thymus lobule
1 8 8 8 8 detection suggested preferential activation p50crel medullary thymocytes whereas p50p65 present cortical medullary region human thymus lobule
1 2 2 11 12 observation suggest p65 crel complex play distinct role gene expression form nfkappa b play critical role late stage intrathymic maturation cell
1 2 2 4 4 observation suggest p65 crel complex play distinct role gene expression form nfkappa b play critical role late stage intrathymic maturation cell
1 3 3 4 4 observation suggest p65 crel complex play distinct role gene expression form nfkappa b play critical role late stage intrathymic maturation cell
0 7 7 3 4 alteration single serine basic domain epsteinbarr virus zebra protein separate function transcriptional activation disruption latency
0 7 7 2 2 alteration single serine basic domain epsteinbarr virus zebra protein separate function transcriptional activation disruption latency
0 5 5 13 14 therefore initiation ebv lytic cycle zebra protein requires function addition transcriptional activation change serine 186 alanine dnabinding domain zebra abolished additional function uncovered new role zebra protein disruption ebv latency
0 5 5 16 17 therefore initiation ebv lytic cycle zebra protein requires function addition transcriptional activation change serine 186 alanine dnabinding domain zebra abolished additional function uncovered new role zebra protein disruption ebv latency
0 13 13 11 12 additional function required initiation lytic viral life cycle likely require phosphorylation serine 186 zebra protein may influence either dna recognition transcriptional activation lytic viral promoter chromatinized viral episome
0 1 1 2 2 human tf promoter contains binding site transcription factor ap1 crelp65 egr1 sp1
1 9 9 9 9 human tf promoter contains binding site transcription factor ap1 crelp65 egr1 sp1
1 9 9 9 9 human tf promoter contains binding site transcription factor ap1 crelp65 egr1 sp1
1 4 4 5 5 two ap1 site bound cfoscjun heterodimers unstimulated lpsstimulated cell
0 3 3 13 15 maximal lp induction tf promoter required two ap1 site kappa b site within lp response element
0 10 10 16 17 synergistic transactivation lp response element drosophila schneider cell coexpression cfo cjun crel p65 cjun p65 required transactivation domain cjun p65
1 2 2 2 2 data indicated cfoscjun crelp65 sp1 regulate tf gene expression human monocytic cell
1 2 2 2 2 data indicated cfoscjun crelp65 sp1 regulate tf gene expression human monocytic cell
1 3 3 3 3 data indicated cfoscjun crelp65 sp1 regulate tf gene expression human monocytic cell
1 3 3 3 3 data indicated cfoscjun crelp65 sp1 regulate tf gene expression human monocytic cell
1 3 3 2 2 dominantnegative mutant nfkappab p50 bind dna fails interact ets protein inhibits synergistic activation hiv1 hiv2 enhancer nfkappab p50 p65 ets1 suggesting physical interaction ets nfkappab protein required transcriptional activity hiv1 hiv2 enhancer
1 18 18 2 2 dominantnegative mutant nfkappab p50 bind dna fails interact ets protein inhibits synergistic activation hiv1 hiv2 enhancer nfkappab p50 p65 ets1 suggesting physical interaction ets nfkappab protein required transcriptional activity hiv1 hiv2 enhancer
1 8 9 10 10 proteolytic degradation posttranslationally modified ikappa b known mediated 26 proteasome complex
1 5 5 6 6 constitutive dna binding activity consisting p50 homodimers detected nuclear extract cell type
1 3 3 1 4 additional complex composed p50relap65 heterodimers appeared nuclear extract 7day mdms
1 3 3 1 4 additional complex composed p50relap65 heterodimers appeared nuclear extract 7day mdms
1 3 3 1 4 additional complex composed p50relap65 heterodimers appeared nuclear extract 7day mdms
1 3 3 4 4 additional complex composed p50relap65 heterodimers appeared nuclear extract 7day mdms
1 3 3 4 4 additional complex composed p50relap65 heterodimers appeared nuclear extract 7day mdms
1 3 3 4 4 additional complex composed p50relap65 heterodimers appeared nuclear extract 7day mdms
1 7 7 8 8 result suggest macrophage differentiation result expression active p50relap65 heterodimers capacity activate target gene expression
1 7 7 8 8 result suggest macrophage differentiation result expression active p50relap65 heterodimers capacity activate target gene expression
1 7 7 8 8 result suggest macrophage differentiation result expression active p50relap65 heterodimers capacity activate target gene expression
1 12 12 13 13 parallel induction kappa b alpha synthesis may allow continuous presence cytoplasmic reservoir p50relap65 complex readily available inducermediated stimulation
1 12 12 13 13 parallel induction kappa b alpha synthesis may allow continuous presence cytoplasmic reservoir p50relap65 complex readily available inducermediated stimulation
0 1 1 29 31 human il5 promoterenhancerluciferase gene construct transfected tcell clone transcribed either tcr il2r stimulation clearly downregulated dexamethasone indicating approximately 500bp human il5 gene segment located 5 upstream coding region contains activationinducible enhancer element responsible regulation gc
0 1 1 30 31 human il5 promoterenhancerluciferase gene construct transfected tcell clone transcribed either tcr il2r stimulation clearly downregulated dexamethasone indicating approximately 500bp human il5 gene segment located 5 upstream coding region contains activationinducible enhancer element responsible regulation gc
0 1 1 24 25 human il5 promoterenhancerluciferase gene construct transfected tcell clone transcribed either tcr il2r stimulation clearly downregulated dexamethasone indicating approximately 500bp human il5 gene segment located 5 upstream coding region contains activationinducible enhancer element responsible regulation gc
0 1 1 21 22 human il5 promoterenhancerluciferase gene construct transfected tcell clone transcribed either tcr il2r stimulation clearly downregulated dexamethasone indicating approximately 500bp human il5 gene segment located 5 upstream coding region contains activationinducible enhancer element responsible regulation gc
0 4 4 5 6 promoter function analysis show saa promoter sequence 280 226 confer lp responsiveness
0 2 2 9 11 oncogenic form notch1 lacking either primary binding site rbpjkappa nuclear localization sequence retain ability associate rbpjkappa activate transcription
0 2 2 5 8 oncogenic form notch1 lacking either primary binding site rbpjkappa nuclear localization sequence retain ability associate rbpjkappa activate transcription
0 2 2 5 7 oncogenic form notch1 lacking either primary binding site rbpjkappa nuclear localization sequence retain ability associate rbpjkappa activate transcription
0 2 2 13 13 unlike fullsized notch1 two truncated form protein either lacking major portion extracellular domain deltae consisting intracellular domain icn found activate transcription cultured cell presumably rbpjkappa response element within dna
0 8 8 13 13 transcriptional activation required presence weak rbpjkappabinding site within notch1 ankyrin repeat region intracellular domain
0 8 8 9 11 transcriptional activation required presence weak rbpjkappabinding site within notch1 ankyrin repeat region intracellular domain
0 8 8 9 10 data consistent notch1 oncogenesis transcriptional activation independent association rbpjkappa promoter site
0 7 7 8 8 chloramphenicol acetyltransferase expression construct containing region human collagenase1 promoter stably transiently transfected u937 cell reporter activity assessed various time onset phorbol 12myristate 13acetate pmamediated differentiation
0 15 15 3 3 rapid strong induction promoter activity lost construct mutant ap1 element however 1696 h postpma mutant collagenase1 promoter displayed ap1 independent pmamediated transactivation
1 9 9 10 10 celltocell contact activates vitro binding nuclear factor kappab nfkappab p50p65 heterodimer hiv1 kappab oligonucleotide
1 9 9 10 10 celltocell contact activates vitro binding nuclear factor kappab nfkappab p50p65 heterodimer hiv1 kappab oligonucleotide
0 1 1 20 21 found nfatx1 dna binding activity interaction ap1 polypeptide dependent central rel similarity region transcriptional activation reduced deletion either nterminal domain cterminal domain suggesting presence intrinsic transcriptional activation motif region
0 1 1 24 27 found nfatx1 dna binding activity interaction ap1 polypeptide dependent central rel similarity region transcriptional activation reduced deletion either nterminal domain cterminal domain suggesting presence intrinsic transcriptional activation motif region
0 1 1 18 19 found nfatx1 dna binding activity interaction ap1 polypeptide dependent central rel similarity region transcriptional activation reduced deletion either nterminal domain cterminal domain suggesting presence intrinsic transcriptional activation motif region
0 1 1 9 12 found nfatx1 dna binding activity interaction ap1 polypeptide dependent central rel similarity region transcriptional activation reduced deletion either nterminal domain cterminal domain suggesting presence intrinsic transcriptional activation motif region
0 6 6 4 5 also show calcineurin associated nterminal domain nfatx1 multiple docking site caused reduction size indicative dephosphorylation nfatx1
0 6 6 7 7 itk cellspecific tyrosine kinase required cd2mediated interleukin2 promoter activation human cell line jurkat
0 13 13 11 11 stimulation either cd2 cell receptor tcrcd3 tcells monoclonal antibodymediated crosslinking induced tyrosine phosphorylation itk maximal early 1 min stimulation
0 0 0 2 2 interleukin2 il2 promoter activity stimulated crosslinking cd2 tcrcd3 cd28 antibody significantly reduced transient expression itk mutant lacking kinase activity
0 7 7 3 3 reduction paralleled decrease tyrosine phosphorylation endogenous wildtype itk
0 9 9 4 4 show engagement cd40 induces tyrosine phosphorylation activation jak3 well stat3
0 7 7 4 4 show engagement cd40 induces tyrosine phosphorylation activation jak3 well stat3
0 3 3 8 9 jak3 constitutively associated cd40 interaction requires prolinerich sequence membraneproximal region cd40
0 3 3 6 7 jak3 constitutively associated cd40 interaction requires prolinerich sequence membraneproximal region cd40
0 4 8 9 9 structure function analysis human myeloid cell nuclear differentiation antigen promoter evidence role sp1 cmyb pu
0 3 3 14 16 method based coamplification vdr cdna internal standard consisting known concentration human vdr cdna mutated bglii restriction site interassay coefficient variation 11
0 7 8 9 9 approach generated luciferase reporter construct containing element cd95 ligand promoter
0 7 8 27 27 next effort determine critical transcription factor regulate cd95 ligand expression demonstrate cyclosporin asensitive nuclear factorat response element promoter region gene critical optimal cd95 ligand reporter activity stimulated cell
0 4 4 5 6 investigated mechanism transactivation mediated ciita activation domain studying role process transcription initiation elongation
0 12 12 13 14 specifically altered specificity tbp tata box binding protein assay used analyze response ciita activation domain mutation tbp known disrupt interaction associated general factor
0 11 11 12 13 tbp mutant defective interaction tbpassociated factor tafii250 also failed mediate transactivation ciita activation domain
0 6 6 6 9 expression plasmid encoding region rfx5 fused gal4 dna binding domain activated transcription reporter construct containing gal4 site cotransfection assay raji human b cell line
0 7 7 4 6 complex promoter specificity determined dna binding domain rfx5 general transcription apparatus recruited acidic activation domain ciita
0 15 15 12 14 complex promoter specificity determined dna binding domain rfx5 general transcription apparatus recruited acidic activation domain ciita
0 1 1 7 9 demonstrate elf1 constitutively localized nucleus dependent presence amino acid 86265
0 1 1 11 13 analysis gal4elf1 fusion protein revealed nterminal 86 amino acid elf1 contain transcriptional activation domain activity attenuated internal repression domain
0 3 3 13 14 human cytomegalovirus induces interleukin8 production human monocytic cell line thp1 acting concurrently ap1 nfkappabbinding site interleukin8 gene
0 2 2 7 8 functional analysis il8 gene revealed ap1 nfkappab factorbinding element involved conferring responsiveness cmv
0 6 6 7 7 ets1 nfkappab ap1 synergistically transactivate human gmcsf promoter
0 10 10 0 1 cisacting element nfkappab ap1 etslike binding motif identified promoter region gmcsf gene important essential transcriptional activity following cell activation
0 10 10 18 18 cisacting element nfkappab ap1 etslike binding motif identified promoter region gmcsf gene important essential transcriptional activity following cell activation
1 3 3 11 12 result suggest constitutive ets1 inducible nfkappab ap1 cooperate part higher order transcriptional complex activated cell
0 3 3 1 2 comparison transactivation domain stat5 stat6 lymphoid cell mammary epithelial cell
0 4 4 2 3 deletion analysis carboxylterminal region stat6 recombination region heterologous dna binding domain allowed delimitation characterization transactivation domain stat6
0 7 7 1 2 potency transactivation domain stat5 stat6 viral protein vp16 compared
0 4 4 1 2 potency transactivation domain stat5 stat6 viral protein vp16 compared
0 3 3 1 2 potency transactivation domain stat5 stat6 viral protein vp16 compared
0 5 5 3 4 preb cell baf3 transactivation domain stat6 il4 regulated independently dna binding function
0 6 8 13 14 immediateearly gene product egr1 regulates human interleukin2 receptor betachain promoter noncanonical egr sp1 binding site
0 6 8 9 9 immediateearly gene product egr1 regulates human interleukin2 receptor betachain promoter noncanonical egr sp1 binding site
0 10 10 3 4 characterized factor bind enhancer region located nucleotide 170 139 human il2rbeta promoter
0 14 14 15 17 paper demonstrate pif egr1 based recognition antiegr1 antiserum gel mobility shift assay even though il2rbeta dna binding motif differed substantially canonical egr1 binding site
0 5 5 6 6 jurkat cell site required maximal il2rbeta promoter activity helas3 cell transfection egr1 could drive activity reporter construct containing site
1 12 12 3 4 supershift specific antibody nfkappa b subunit confirmed inducible retarded band observed emsa p65p50 heterodimer nfkappa brel protein
1 12 12 3 4 supershift specific antibody nfkappa b subunit confirmed inducible retarded band observed emsa p65p50 heterodimer nfkappa brel protein
1 12 12 13 13 supershift specific antibody nfkappa b subunit confirmed inducible retarded band observed emsa p65p50 heterodimer nfkappa brel protein
1 13 13 9 11 response required least 120 min evident supershift experiment revealed nfkappa b complex contains rela p50
1 14 14 9 11 response required least 120 min evident supershift experiment revealed nfkappa b complex contains rela p50
1 12 12 6 7 expected lp strongly induced formation two nfkappa b dnabinding activity one identified relap50
1 12 12 6 7 expected lp strongly induced formation two nfkappa b dnabinding activity one identified relap50
1 12 12 12 12 expected lp strongly induced formation two nfkappa b dnabinding activity one identified relap50
1 12 12 12 12 expected lp strongly induced formation two nfkappa b dnabinding activity one identified relap50
0 6 6 8 8 gatabinding protein gata4 selectively regulates human il5 gene promoter il5 producing cell express multiple gatabinding protein
0 4 4 7 7 using atl16t cell express il5 mrna identified region within human il5 gene promoter regulates il5 gene transcription
0 14 14 10 12 report describe cloning human gata4 hgata4 show hgata4 selectively interacts 70 gata site within il5 proximal promoter region
0 7 7 8 8 cotransfection experiment revealed hgata4 pmaa23187 stimulation necessary il5 promoter activation
1 6 6 11 12 however using atl16t nuclear extract demonstrated gata4 gatabinding protein form specific dnaprotein complex 70 gata site
1 4 4 17 17 since coexpression dominant negative cfo abolished responsiveness tpa conclude activated transcription dra gene depends interaction x2 box nfx2 contains cfo
0 28 28 4 4 previously identified new binding site transcription factor downstream transcription start site nt 465 720 three ap1 site ii iii ap3like motif ap3l downstream binding factor dbf site juxtaposed sp1 site
0 11 11 3 6 report identification characterization simple tandem repeat dna polymorphism gene encoding hnf3alpha 3beta 3gamma 4gamma 6 mapping hnf6 chromosome band 15q21
0 12 12 3 6 report identification characterization simple tandem repeat dna polymorphism gene encoding hnf3alpha 3beta 3gamma 4gamma 6 mapping hnf6 chromosome band 15q21
0 10 10 3 6 report identification characterization simple tandem repeat dna polymorphism gene encoding hnf3alpha 3beta 3gamma 4gamma 6 mapping hnf6 chromosome band 15q21
1 1 1 3 3 included p50p50 p50p65 dimer recognized specific antibody emsa
1 1 1 3 3 included p50p50 p50p65 dimer recognized specific antibody emsa
1 2 2 3 3 included p50p50 p50p65 dimer recognized specific antibody emsa
1 13 13 11 12 aim identifying genetic target transcription factor stably transfected cdna encoding ebf covalent homodimer e47 individually together immature hematopoietic baf3 cell lack factor
0 8 8 5 6 multiple functionally important ebf e47 binding site identified lambda5 promoterenhancer region indicating lambda5 direct genetic target transcription factor
0 8 8 9 10 multiple functionally important ebf e47 binding site identified lambda5 promoterenhancer region indicating lambda5 direct genetic target transcription factor
0 5 5 6 6 differential interaction nuclear factor leukocytespecific pp52 promoter b cell
0 9 11 7 8 previously detected tissuespecific promoter preceding exon encoding n terminus pp52 leukocyte protein
0 0 0 16 17 pp52 promoter contains initiator specifying unique 5 terminus pp52 mrna tandem pair ets sp1 motif lone cebp motif
0 0 0 3 3 pp52 promoter contains initiator specifying unique 5 terminus pp52 mrna tandem pair ets sp1 motif lone cebp motif
0 0 0 14 14 pp52 promoter contains initiator specifying unique 5 terminus pp52 mrna tandem pair ets sp1 motif lone cebp motif
0 0 0 6 7 pp52 promoter contains initiator specifying unique 5 terminus pp52 mrna tandem pair ets sp1 motif lone cebp motif
0 0 0 1 1 pp52 promoter contains initiator specifying unique 5 terminus pp52 mrna tandem pair ets sp1 motif lone cebp motif
1 9 10 13 13 cebp motif bound igebp1 preb cell cell extract replaced nuclear factoril6beta nuclear factoril6betaigebp1 heterodimer plasmacytoma cell extract
0 4 4 5 5 finding reveal feature controlling pp52 promoter b cell provide foundation determining regulation promoter leukocyte lineage
0 7 7 8 8 previously established critical role transcription factor gata3 il5 promoter activation el4 cell express th1 th2type cytokine
0 8 8 3 3 whereas mutation gata3 site abolished antigen camp stimulated il5 promoter activation th2 cell ectopic expression gata3 th1 cell nonlymphoid nonil5producing cell line activated il5 promoter
0 8 8 9 9 whereas mutation gata3 site abolished antigen camp stimulated il5 promoter activation th2 cell ectopic expression gata3 th1 cell nonlymphoid nonil5producing cell line activated il5 promoter
0 8 8 9 9 whereas mutation gata3 site abolished antigen camp stimulated il5 promoter activation th2 cell ectopic expression gata3 th1 cell nonlymphoid nonil5producing cell line activated il5 promoter
1 9 9 6 8 report dnabinding activity primarily consisting classical nfkappa b heterodimer p50rela induced phagocytosing neutrophil
1 9 9 6 8 report dnabinding activity primarily consisting classical nfkappa b heterodimer p50rela induced phagocytosing neutrophil
1 9 9 9 9 report dnabinding activity primarily consisting classical nfkappa b heterodimer p50rela induced phagocytosing neutrophil
0 22 22 18 21 although nac reduced nuclear factorkappa b nfkappa b activation ec measured gelshift assay using oligonucleotide probe corresponding consensus nfkappa b binding site vcam1 gene vcamnfkappa b antioxidant appreciable effect oligomer corresponding consensus nfkappa b binding site eselectin gene eselectinnfkappa b used
0 36 36 38 39 although nac reduced nuclear factorkappa b nfkappa b activation ec measured gelshift assay using oligonucleotide probe corresponding consensus nfkappa b binding site vcam1 gene vcamnfkappa b antioxidant appreciable effect oligomer corresponding consensus nfkappa b binding site eselectin gene eselectinnfkappa b used
0 36 36 17 21 although nac reduced nuclear factorkappa b nfkappa b activation ec measured gelshift assay using oligonucleotide probe corresponding consensus nfkappa b binding site vcam1 gene vcamnfkappa b antioxidant appreciable effect oligomer corresponding consensus nfkappa b binding site eselectin gene eselectinnfkappa b used
0 36 36 17 21 although nac reduced nuclear factorkappa b nfkappa b activation ec measured gelshift assay using oligonucleotide probe corresponding consensus nfkappa b binding site vcam1 gene vcamnfkappa b antioxidant appreciable effect oligomer corresponding consensus nfkappa b binding site eselectin gene eselectinnfkappa b used
1 10 10 17 17 electrophoretic mobility shift assay increase mrna associated 5 10fold increase stat1containing dnabinding complex bind fc gammari promoter element
0 6 6 1 1 furthermore tyrosine phosphorylation stat1 tyrosine kinase jak1 jak2 enhanced significantly rgdadherent monocyte compared control cell
0 7 7 1 1 furthermore tyrosine phosphorylation stat1 tyrosine kinase jak1 jak2 enhanced significantly rgdadherent monocyte compared control cell
0 3 3 1 1 furthermore tyrosine phosphorylation stat1 tyrosine kinase jak1 jak2 enhanced significantly rgdadherent monocyte compared control cell
0 3 3 0 2 carboxylterminal cytoplasmic domain cd36 required oxidized lowdensity lipoprotein modulation nfkappab activity tumor necrosis factoralpha
0 12 12 9 12 also determined activation nfkappab dna binding activity required intact carboxylterminal cytoplasmic segment cd36
1 12 12 12 13 myelopoiesis includes development granulocytic monocytic lineage transcription factor several family active including aml1cbf beta cebp ets cmyb hox mzf1
1 12 13 12 13 myelopoiesis includes development granulocytic monocytic lineage transcription factor several family active including aml1cbf beta cebp ets cmyb hox mzf1
0 8 8 6 7 fusion splice 5 end 3q21 gene exon 2 evi1 gene event similar normal intergenic splicing mds1evi1 previously documented leukemia t321 t312 acute myelogenous leukemia 1evi1 fusion etv6evi1 fusion respectively occur
0 8 8 6 9 fusion splice 5 end 3q21 gene exon 2 evi1 gene event similar normal intergenic splicing mds1evi1 previously documented leukemia t321 t312 acute myelogenous leukemia 1evi1 fusion etv6evi1 fusion respectively occur
1 24 24 25 25 clinically relevant dose 25 mm acute ethanol treatment vitro increased nfkappa b binding activity monocyte preferential induction inhibitory p50p50 nfkappa brel homodimer resulted induction p65p50 heterodimer
1 18 18 25 25 clinically relevant dose 25 mm acute ethanol treatment vitro increased nfkappa b binding activity monocyte preferential induction inhibitory p50p50 nfkappa brel homodimer resulted induction p65p50 heterodimer
1 5 5 6 6 contrast lipopolysaccharide stimulation primarily induced p65p50 heterodimer shown result gene activation
0 7 7 1 2 four plike element required optimal transcription mouse il4 gene involvement distinct set nuclear factor activated cell activator protein1 family protein
0 8 8 2 3 previously identified p sequence critical regulatory element human il4 promoter
0 8 8 5 6 previously identified p sequence critical regulatory element human il4 promoter
0 8 8 9 9 previously identified p sequence critical regulatory element human il4 promoter
0 1 1 14 14 mouse il4 promoter five element homologous human p sequence designated conserved lymphokine element 0 cle0 p p2 p3 p4
0 1 1 17 17 mouse il4 promoter five element homologous human p sequence designated conserved lymphokine element 0 cle0 p p2 p3 p4
0 1 1 2 2 mouse il4 promoter five element homologous human p sequence designated conserved lymphokine element 0 cle0 p p2 p3 p4
0 3 3 7 9 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 4 4 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 16 16 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 8 9 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 18 18 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 4 4 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 17 17 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 16 16 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 14 14 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 3 3 4 4 transfection el4 cell il4 promoterreporter construct carrying mutated plike element showed four plike element cle0 p p2 p4 p3 required optimal activation il4 promoter
0 8 8 9 9 activity amyb b cell observed either artificial construct cmyc promoter used reporter
0 10 10 10 12 finally 110kda protein identified nucleus b cell line specifically bind amyb nterminal domain
0 10 10 1 2 cooperation binding site stat6 nf kappa brel il4induced upregulation human ige germline promoter
0 10 10 11 12 cooperation binding site stat6 nf kappa brel il4induced upregulation human ige germline promoter
0 10 12 8 9 electrophoretic mobility shift assay show nucleoprotein complex formed upstream site nf kappa b1 contains classical p50p65 heterodimer
1 15 15 5 6 electrophoretic mobility shift assay show nucleoprotein complex formed upstream site nf kappa b1 contains classical p50p65 heterodimer
1 15 15 5 6 electrophoretic mobility shift assay show nucleoprotein complex formed upstream site nf kappa b1 contains classical p50p65 heterodimer
1 15 15 16 16 electrophoretic mobility shift assay show nucleoprotein complex formed upstream site nf kappa b1 contains classical p50p65 heterodimer
1 15 15 16 16 electrophoretic mobility shift assay show nucleoprotein complex formed upstream site nf kappa b1 contains classical p50p65 heterodimer
0 3 5 1 2 complex proximal site nf kappa b2 appears composed p50 relb
0 11 11 8 9 addition combination nf kappa brel binding site stat6 response element conferred il4 inducibility heterologous minimal promoter individual site effect
0 11 11 2 6 addition combination nf kappa brel binding site stat6 response element conferred il4 inducibility heterologous minimal promoter individual site effect
0 11 11 13 15 addition combination nf kappa brel binding site stat6 response element conferred il4 inducibility heterologous minimal promoter individual site effect
1 3 5 6 7 available data suggest nf kappa b2 nucleoprotein complex may cooperate dnabound stat6 achieve il4dependent activation human ige germline gene
1 11 11 1 1 since ap1 part nfat complex conclude il7signaling pathway involved activation fo jun protein ap1 consists
1 10 10 1 1 since ap1 part nfat complex conclude il7signaling pathway involved activation fo jun protein ap1 consists
0 10 10 13 13 tax protein human tcell leukemia virus type 1 mediates transactivation csisplateletderived growth factorb promoter interaction zinc finger transcription factor sp1 ngfiaegr1
0 5 5 10 10 previous work identified essential site csispdgfb promoter taxresponsive element 1 tre1 necessary transactivation tax
0 5 5 6 6 previous work identified essential site csispdgfb promoter taxresponsive element 1 tre1 necessary transactivation tax
0 15 15 12 14 vitro transcription assay showed tax able significantly increase transcriptional activity template containing 257 74 region csispdgfb promoter
0 15 15 16 16 vitro transcription assay showed tax able significantly increase transcriptional activity template containing 257 74 region csispdgfb promoter
0 11 11 12 12 analysis tax mutant showed two mutant iexc29s iexl320g unable significantly transactivate csispdgfb promoter
0 4 4 18 19 furthermore deletion mutation analysis vcam1 promoter performed chloramphenicol acetyltransferase construct revealed tax trans activating vcam1 promoter via two nfkappab site present bp 72 57 vcam1 gene promoter required taxinduced expression adhesion molecule
0 4 4 18 19 furthermore deletion mutation analysis vcam1 promoter performed chloramphenicol acetyltransferase construct revealed tax trans activating vcam1 promoter via two nfkappab site present bp 72 57 vcam1 gene promoter required taxinduced expression adhesion molecule
0 4 4 5 5 furthermore deletion mutation analysis vcam1 promoter performed chloramphenicol acetyltransferase construct revealed tax trans activating vcam1 promoter via two nfkappab site present bp 72 57 vcam1 gene promoter required taxinduced expression adhesion molecule
0 4 4 5 5 furthermore deletion mutation analysis vcam1 promoter performed chloramphenicol acetyltransferase construct revealed tax trans activating vcam1 promoter via two nfkappab site present bp 72 57 vcam1 gene promoter required taxinduced expression adhesion molecule
0 4 4 5 5 furthermore deletion mutation analysis vcam1 promoter performed chloramphenicol acetyltransferase construct revealed tax trans activating vcam1 promoter via two nfkappab site present bp 72 57 vcam1 gene promoter required taxinduced expression adhesion molecule
0 11 11 12 12 inhibition occurred parallel activation cjun transactivating function expression reflected transfection experiment il2 promoter level involved inhibition nfkappabdriven reporter activation also nuclear factor activated cell nfat
0 9 9 2 4 mutational removal jnk phosphorylation site caused constitutive nuclear localization nfat4
1 21 21 17 20 hypoxic endothelium showed > 10fold increase sensitivity inhibitor proteasome activation combination hypoxia lp enhanced proteasomedependent cytoplasmictonuclear localization nuclear transcription factorkappa b p65 rel subunit
0 1 2 5 7 suspect cebp epsilon promoterenhancer contains retinoic acidresponse element directly stimulated retinoids
0 1 2 3 3 suspect cebp epsilon promoterenhancer contains retinoic acidresponse element directly stimulated retinoids
0 6 7 17 19 describe cloning characterization fulllength cdna encoding murine nfatc predicts protein conserved structural motif nfat family member including rel homology domain nfat homology domain nuclear translocation signal
0 6 6 7 9 mnfatc complexed ap1 bound specifically murine il2 nfat recognition sequence activated transcription cotransfected il2 promoter cos7 cell
1 0 2 8 9 interleukin1 receptor type il1ri associated protein thus forming complex system il1 exerts various signal
0 6 7 9 14 atf1 creb transactivate cell cycle regulated histone h4 gene distal nuclear matrix associated promoter element
0 5 6 11 13 promoter activity cell cycle regulated histone h4 gene regulated least four principal cisacting element mediate g1s phase control andor enhancement transcription cell cycle
0 12 12 5 6 sitedirected mutational study demonstrate site site iv together support atf1 crebinduced transactivation h4 promoter
0 12 12 0 0 sitedirected mutational study demonstrate site site iv together support atf1 crebinduced transactivation h4 promoter
0 12 12 13 13 sitedirected mutational study demonstrate site site iv together support atf1 crebinduced transactivation h4 promoter
0 7 8 13 14 thus data establish atfcreb factor functionally modulate histone h4 gene transcription distal proximal promoter element
1 3 3 5 6 cytokine induced assembly stat5a stat5b containing complex capable binding interferongamma activation sequence gas complex rapidly translocated within 1 min nucleus il2 il7treated cell
1 4 4 5 6 cytokine induced assembly stat5a stat5b containing complex capable binding interferongamma activation sequence gas complex rapidly translocated within 1 min nucleus il2 il7treated cell
0 7 7 5 5 il2 il7 equivalent ability induce tyrosine phosphorylation stat5a stat5b facilitate binding stats immobilized gas element
0 8 8 5 5 il2 il7 equivalent ability induce tyrosine phosphorylation stat5a stat5b facilitate binding stats immobilized gas element
0 8 11 4 6 crel p65 subunit bind upstream nfkappab site human granulocyte macrophagecolony stimulating factor promoter involved phorbol ester response 5637 cell
0 8 11 4 12 crel p65 subunit bind upstream nfkappab site human granulocyte macrophagecolony stimulating factor promoter involved phorbol ester response 5637 cell
0 8 11 12 12 crel p65 subunit bind upstream nfkappab site human granulocyte macrophagecolony stimulating factor promoter involved phorbol ester response 5637 cell
1 6 6 1 3 describe heterodimeric binding complex nfkappab subunit crel p65 identical one obtained using hivltrkappab site recognition sequence different one crel p50 observed nuclear extract mo tlymphoid htlvii infected cell
1 7 7 1 3 describe heterodimeric binding complex nfkappab subunit crel p65 identical one obtained using hivltrkappab site recognition sequence different one crel p50 observed nuclear extract mo tlymphoid htlvii infected cell
0 14 14 26 26 shown reverse transcriptionpolymerase chain reaction electrophoretic mobility shift assay respectively treatment csa lead decreased tf mrna expression reduced activation nfkappab transcription factor known contribute induction tf promotor human monocyte
1 4 4 13 13 surprisingly g285 sfv potent cd40 agonist rapidly crosslinked cd40 cell surface crosslink cd40ig solution
1 1 1 9 9 xpb xpd gene encode protein subunit general transcription factor tfiih involved nucleotide excision repair ner initiation mrna transcription rna polymerase ii
0 1 3 8 9 human g0g1 switch gene g0s2 potential nfatbinding site 5 flank encodes small basic potential phosphoprotein unknown function
0 1 3 6 7 human g0g1 switch gene g0s2 potential nfatbinding site 5 flank encodes small basic potential phosphoprotein unknown function
1 24 24 21 23 used reverse transcriptasepolymerase chain reaction examine fetal term neonatal cord blood mrna expression three transcription factor implicated tcell activation cjun cfo nf kappa b p50 subunit
0 6 6 7 7 quantitative experiment comparing binding transcription factor il2 promoter currently investigation
0 1 1 18 19 human il5 promoterenhancer luciferase gene construct transfected il5producing cell clone clearly transcribed stimulation indicating 515 base pair il5 gene segment upstream coding region sufficient respond activating signal human helper cell
0 5 5 6 6 nfkappa brel family member regulating icam1 promoter monocytic thp1 cell
0 4 6 0 1 kappa bsite identified promoter intercellular adhesion molecule1 icam1 gene involved regulation icam1 expression tumor necrosis factor alpha tnfalpha glucocorticoid
0 1 1 1 4 vitro icam1 kappa b site appeared bind rela crel homodimers well heterodimers nfkappa b1 weakly nfkappa b1 homodimers
1 12 13 11 13 vitro icam1 kappa b site appeared bind rela crel homodimers well heterodimers nfkappa b1 weakly nfkappa b1 homodimers
1 12 13 9 9 vitro icam1 kappa b site appeared bind rela crel homodimers well heterodimers nfkappa b1 weakly nfkappa b1 homodimers
1 7 7 9 9 vitro icam1 kappa b site appeared bind rela crel homodimers well heterodimers nfkappa b1 weakly nfkappa b1 homodimers
1 8 8 9 9 vitro icam1 kappa b site appeared bind rela crel homodimers well heterodimers nfkappa b1 weakly nfkappa b1 homodimers
0 10 10 10 13 monocytic thp1 cell tnfalpha induced two nuclear complex vitro bound icam1 kappa b site
0 8 8 9 10 second complex contained rela exhibited higher affinity towards icam1 kappa b hiv kappa b site
1 5 5 6 6 glucocorticoid receptor shown repress activity rela homodimer nfkappa b1rela heterodimer
1 5 5 9 9 glucocorticoid receptor shown repress activity rela homodimer nfkappa b1rela heterodimer
1 2 2 3 3 argue vivo rela homodimers likely play dominant role tnfalphainduced icam1 transcription monocytic cell
1 14 14 15 15 lp tolerance monocytesmacrophages three 3 cytosins required dna binding motif detection upregulated nfkappa b p50 homodimers
1 21 21 22 23 analysis binding protein employing 605 motif human tnf promoter ggggctgtccc revealed tolerant cell human monocytic cell line mono mac 6 predominance p50p50 nfkappa b
1 21 21 22 23 analysis binding protein employing 605 motif human tnf promoter ggggctgtccc revealed tolerant cell human monocytic cell line mono mac 6 predominance p50p50 nfkappa b
1 21 21 21 21 analysis binding protein employing 605 motif human tnf promoter ggggctgtccc revealed tolerant cell human monocytic cell line mono mac 6 predominance p50p50 nfkappa b
1 21 21 21 21 analysis binding protein employing 605 motif human tnf promoter ggggctgtccc revealed tolerant cell human monocytic cell line mono mac 6 predominance p50p50 nfkappa b
1 6 6 6 6 wild type motif give efficient binding p50p50 upregulated tolerant cell whereas mutant 3 g show hardly binding p50p50
1 6 6 6 6 wild type motif give efficient binding p50p50 upregulated tolerant cell whereas mutant 3 g show hardly binding p50p50
1 6 6 6 6 wild type motif give efficient binding p50p50 upregulated tolerant cell whereas mutant 3 g show hardly binding p50p50
0 2 4 5 6 conversely murine kappa light chain enhancer motif ggggactttccg efficiently bind nuclear p50p50 tolerant murine p388 macrophage
1 11 11 11 11 conversely murine kappa light chain enhancer motif ggggactttccg efficiently bind nuclear p50p50 tolerant murine p388 macrophage
1 11 11 11 11 conversely murine kappa light chain enhancer motif ggggactttccg efficiently bind nuclear p50p50 tolerant murine p388 macrophage
0 4 4 13 15 data show detection upregulated p50 homodimers lp tolerant cell dependent subtle difference sequence dna binding motif
0 2 2 8 11 temporal control igh gene expression developing b cell 3 locus control region
0 15 15 11 13 summarize importance igh 3lcr putative functional role igh gene expression compare 5lcr regulatory region human betaglobin locus
0 2 2 3 3 summarize importance igh 3lcr putative functional role igh gene expression compare 5lcr regulatory region human betaglobin locus
0 4 4 2 5 binding protein regulatory region il2 gene vitro stimulation il2mrna synthesis splenic tlymphocytes culture normal condition shown
1 2 2 1 1 induction interleukin12 p40 transcript cd40 ligation via activation nuclear factorkappab
0 2 2 7 12 sequence analysis p40 promoter region identified two potential nuclear factor nfkappab binding site conserved mouse human
0 2 2 3 4 sequence analysis p40 promoter region identified two potential nuclear factor nfkappab binding site conserved mouse human
0 19 19 6 8 electrophoretic mobility shift assay revealed potential nfkappab binding sequence located around 120 bp upstream transcription initiation site murine human p40 gene formed nfkappab complex nuclear extract daudi cell stimulated cd40 ligation
0 19 19 14 16 electrophoretic mobility shift assay revealed potential nfkappab binding sequence located around 120 bp upstream transcription initiation site murine human p40 gene formed nfkappab complex nuclear extract daudi cell stimulated cd40 ligation
0 15 15 2 4 result suggest nfkappab binding site located around 120 bp upstream transcription initiation site murine human p40 promoter region could important p40 induction cd40 ligation via activation nfkappab
0 15 15 15 17 result suggest nfkappab binding site located around 120 bp upstream transcription initiation site murine human p40 promoter region could important p40 induction cd40 ligation via activation nfkappab
0 1 1 12 12 crosslinking cd19 early human b lineage cell induces formation cd19vavphosphatidylinositol3 kinase complex tyrosine phosphorylation cd19 vav activation ra pathway
1 1 1 9 11 crosslinking cd19 early human b lineage cell induces formation cd19vavphosphatidylinositol3 kinase complex tyrosine phosphorylation cd19 vav activation ra pathway
1 12 12 12 12 u937 cell differentiated pma nonadherent culture shown express two fibrinogenbinding integrins predominately cd11bcd18 lesser extent cd11ccd18
1 12 12 12 12 u937 cell differentiated pma nonadherent culture shown express two fibrinogenbinding integrins predominately cd11bcd18 lesser extent cd11ccd18
1 15 15 15 15 u937 cell differentiated pma nonadherent culture shown express two fibrinogenbinding integrins predominately cd11bcd18 lesser extent cd11ccd18
1 12 12 15 15 u937 cell differentiated pma nonadherent culture shown express two fibrinogenbinding integrins predominately cd11bcd18 lesser extent cd11ccd18
1 10 10 10 10 conclude contact fibrinogenderived protein may contribute mononuclear phagocyte activation signaling cd11bcd18 resulting selective activation transcriptional regulatory factor including nfkappa b
1 10 10 10 10 conclude contact fibrinogenderived protein may contribute mononuclear phagocyte activation signaling cd11bcd18 resulting selective activation transcriptional regulatory factor including nfkappa b
0 4 4 16 17 one site similar activated tnfrii associating tnfrassociated factor traf1 traf2 second site similar tnfri associating tnfri death domain interacting protein tradd
0 0 1 4 4 ikappab alpha phosphorylation ser32 ser36 followed degradation nfkappab activation
0 0 1 3 3 ikappab alpha phosphorylation ser32 ser36 followed degradation nfkappab activation
0 6 7 3 3 tax expression promotes nterminal phosphorylation degradation ikappab alpha principal cytoplasmic inhibitor nfkappab
0 16 17 18 20 study demonstrate htlv1 tax activates recently identified cellular kinase ikappab kinase alpha ikkalpha ikkbeta normally phosphorylate ikappab alpha nterminal regulatory serine response tumor necrosis factor alpha tnfalpha interleukin1 il1 stimulation
0 13 13 11 12 pathway resulted induction transcription factor nfkappa b nfat protein binding cd28 response element il2 promoter
0 13 13 14 14 pathway resulted induction transcription factor nfkappa b nfat protein binding cd28 response element il2 promoter
0 13 13 14 14 increased level intracellular ca2 triggered activation p56lck craf1 unable induce binding transcription factor il2 promoter
0 3 3 4 4 cyclosporin aresistant transactivation il2 promoter requires activity okadaic acidsensitive serinethreonine phosphatase
0 3 3 4 4 transcription factor active il2 promoter differentially influenced upon downmodulation okadaic acidsensitive phosphatase transactivation octamer nfkappa b nf activated cell protein abrogated transactivation ap1 protein even enhanced
1 4 4 7 9 immunofluorescence study using ab rela p65 subunit nuclear factorkappa b revealed ino inhibited activation nuclear factorkappa b
0 13 13 8 8 using tax mutant fail activate either atf nfkappabdependent promoter different 5 truncation mutant e2f1 promoter show taxdependent transcriptional control e2f1 gene involves least part atf binding site located e2f1 promoter
0 13 13 8 8 using tax mutant fail activate either atf nfkappabdependent promoter different 5 truncation mutant e2f1 promoter show taxdependent transcriptional control e2f1 gene involves least part atf binding site located e2f1 promoter
1 9 9 8 8 6 14 patient lymphocyte displayed impaired ability translocate nfeb p65 rela following activation anticd3 il2
0 3 3 1 2 transcription minimal promoter nfil6 gene regulated crebatf sp1 protein u937 promonocytic cell
0 5 5 1 4 identified 104bp minimal promoter region nfil6 gene sufficient basal activationdependent induction transcription u937 cell
0 4 4 6 6 addition adpactivated platelet induced mcp1 icam1 promoterdependent transcription
0 5 5 6 6 addition adpactivated platelet induced mcp1 icam1 promoterdependent transcription
0 17 17 14 15 show function closely related protein distinguished vivo matching point mutation 5hs3 amino acid change zinc finger sp1 eklf
0 16 16 14 15 show function closely related protein distinguished vivo matching point mutation 5hs3 amino acid change zinc finger sp1 eklf
0 27 27 25 26 circumvent problem developed alternative procedure allowed u show neutrophil lp tnfalpha induce nfkappab dnabinding activity essentially consists p50rela dimer ifngamma promotes binding stat1 homodimers ifngamma response region fcgammari promoter
1 17 17 12 12 circumvent problem developed alternative procedure allowed u show neutrophil lp tnfalpha induce nfkappab dnabinding activity essentially consists p50rela dimer ifngamma promotes binding stat1 homodimers ifngamma response region fcgammari promoter
1 17 17 18 18 circumvent problem developed alternative procedure allowed u show neutrophil lp tnfalpha induce nfkappab dnabinding activity essentially consists p50rela dimer ifngamma promotes binding stat1 homodimers ifngamma response region fcgammari promoter
1 17 17 18 18 circumvent problem developed alternative procedure allowed u show neutrophil lp tnfalpha induce nfkappab dnabinding activity essentially consists p50rela dimer ifngamma promotes binding stat1 homodimers ifngamma response region fcgammari promoter
1 22 22 23 23 circumvent problem developed alternative procedure allowed u show neutrophil lp tnfalpha induce nfkappab dnabinding activity essentially consists p50rela dimer ifngamma promotes binding stat1 homodimers ifngamma response region fcgammari promoter
0 7 7 30 32 vitro study identify three essential element tataless blr1 core promoter confer cell type differentiationspecific expression b cell human mouse functional promoter region 36 respect transcription start site nfkappab motif 44 noncanonical octamer motif 157
0 7 7 27 28 vitro study identify three essential element tataless blr1 core promoter confer cell type differentiationspecific expression b cell human mouse functional promoter region 36 respect transcription start site nfkappab motif 44 noncanonical octamer motif 157
0 7 7 19 21 vitro study identify three essential element tataless blr1 core promoter confer cell type differentiationspecific expression b cell human mouse functional promoter region 36 respect transcription start site nfkappab motif 44 noncanonical octamer motif 157
0 7 7 8 9 vitro study identify three essential element tataless blr1 core promoter confer cell type differentiationspecific expression b cell human mouse functional promoter region 36 respect transcription start site nfkappab motif 44 noncanonical octamer motif 157
1 14 14 11 11 importance site confirmed vivo study genetargeted mouse deficient either oct2 bob1 nfkappab subunit p50 p52
1 2 2 2 2 mouse deficient p52nfkappab blr1 expression unaffected
0 0 0 1 1 betacasein promoter widely used monitor activation stat signal transducer activator transcription5 since stat5 originally found mediator prlinducible betacasein expression
0 1 1 9 11 il2induced betacasein expression enhanced dexamethasone synergistic effect dexamethasone requires sequence 155 193 betacasein promoter
0 1 1 13 13 il2induced betacasein expression enhanced dexamethasone synergistic effect dexamethasone requires sequence 155 193 betacasein promoter
0 7 7 15 17 expression active form ra rasg12v suppressed il2induced betacasein osm gene expression negative effect ra mediated region 105 193 betacasein promoter
0 7 7 19 19 expression active form ra rasg12v suppressed il2induced betacasein osm gene expression negative effect ra mediated region 105 193 betacasein promoter
0 20 20 12 12 apparent contradiction expression dominant negative form ra rasn17 also inhibited il2induced activation promoter containing minimal betacasein stat5 element well promoter ci osm
0 21 21 12 12 apparent contradiction expression dominant negative form ra rasn17 also inhibited il2induced activation promoter containing minimal betacasein stat5 element well promoter ci osm
0 12 12 13 13 addition rasg12v complemented signaling erythropoietin receptor mutant defective ra activation augmented activation betacasein promoter mutant erythropoietin receptor signaling suggesting possible role ra stat5mediated gene expression
0 0 0 7 8 raldh2 transcript tall however mostly initiated within second intron
0 2 2 6 7 stat3gamma derived stat3alpha limited proteolysis lack carboxylterminal portion stat3alpha
0 5 5 6 6 u937 cell transfected human fulllength il1beta promoter connected luciferase reporter gene submitted transcription assay northern blotting dna electrophoresis mobility gel shift assay
0 9 12 8 8 signaling pathway mediated tnf cytokinereceptor family target common ciselement ifn regulatory factor 1 promoter
0 9 12 13 13 signaling pathway mediated tnf cytokinereceptor family target common ciselement ifn regulatory factor 1 promoter
0 1 1 2 2 targeting irf1 gas confined activation via cd40 extends stimulus mimic cd40 signaling cascade like tnfalpha ebv
1 4 4 4 6 contrast induction stats cytokine irf1 gasbinding complex activated cd40 tnfalpha ebv contains rel protein specifically p50 p65
0 4 4 5 5 contrast induction stats cytokine irf1 gasbinding complex activated cd40 tnfalpha ebv contains rel protein specifically p50 p65
0 18 18 13 15 regulation nfkappa b ap1 nfat stat1 nuclear import lymphocyte noninvasive delivery peptide carrying nuclear localization sequence nfkappa b p50
0 18 18 11 18 regulation nfkappa b ap1 nfat stat1 nuclear import lymphocyte noninvasive delivery peptide carrying nuclear localization sequence nfkappa b p50
1 20 20 5 6 herein demonstrate inducible nuclear import nfkappa b ap1 nfat stat1 jurkat lymphocyte significantly inhibited cellpermeable peptide carrying nls nfkappa b p50 subunit
0 20 20 14 21 herein demonstrate inducible nuclear import nfkappa b ap1 nfat stat1 jurkat lymphocyte significantly inhibited cellpermeable peptide carrying nls nfkappa b p50 subunit
1 11 11 6 9 show inhibitory nls peptide interacts vitro cytoplasmic nls receptor complex comprised rch1importin karyopherinbeta heterodimer expressed jurkat cell
1 11 11 11 13 show inhibitory nls peptide interacts vitro cytoplasmic nls receptor complex comprised rch1importin karyopherinbeta heterodimer expressed jurkat cell
1 14 14 16 18 human intestinal epithelial cell inflammatory response amebic infection inhibited intraluminal administration antisense oligonucleotide human p65 subunit nuclear factor kappab role neutrophil tissue damage observed amebiasis studied depleting neutrophil scidhuint mouse
1 0 0 5 7 p50 p65 protein constituent prototypic nuclear factor kappab identified component dnaprotein complex antipeptide antibody gel supershift assay
1 0 0 10 11 p50 p65 protein constituent prototypic nuclear factor kappab identified component dnaprotein complex antipeptide antibody gel supershift assay
1 1 1 5 7 p50 p65 protein constituent prototypic nuclear factor kappab identified component dnaprotein complex antipeptide antibody gel supershift assay
1 1 1 10 11 p50 p65 protein constituent prototypic nuclear factor kappab identified component dnaprotein complex antipeptide antibody gel supershift assay
0 2 2 3 3 show activation il2 promoter tpl2 inhibited mutant signaling molecule inhibit mitogenactivated protein kinase mapk calcineurinnfat pathway promoted combination signaling molecule activate pathway
0 11 11 12 12 therefore conclude signal generated convergence mapk calcineurinnfat pathway necessary sufficient activation il2 promoter tpl2
0 1 1 2 2 activation il2 promoter nfatdriven minimal promoter shown depend signal transduced raf1
0 1 1 2 2 however il2 promoter whose activation tpl2 fully blocked dominant negative mutant mek1s218222a mek1mek2 inhibitor pd098059
0 1 1 2 2 activation il2 promoter nfatdriven minimal promoter tpl2 fully blocked dominant negative mutant nfat delta418 partially blocked calcineurin inhibitor cyclosporin suggesting tpl2mediated nfat activation control combination calcineurindependent independent pathway
0 3 3 4 4 stat6 inhibits human interleukin4 promoter activity cell
0 2 2 14 18 th2 cell il4 gene expression tightly controlled level transcription coordinated binding multiple transcription factor regulatory element proximal promoter region
0 11 11 15 18 nuclear factor activated cell nfat family member play critical role regulating il4 transcription interact five sequence termed p0 p4 il4 promoter
0 7 7 8 8 report stat6 interacts three binding site human il4 promoter electrophoretic mobility shift assay
0 10 10 7 7 show whereas multimerized response element germline ige promoter highly induced il4 stat6expressing jurkat cell intact human il4 promoter repressed similar condition
0 2 2 5 6 conclude function stat6 highly dependent promoter context factor promotes il4 gene expression indirect manner
0 16 16 9 12 cdna contains 546nucleotide nt open reading frame orf code carboxylterminal 180 amino acid aa recently identified fkhrl1 gene
0 16 16 2 6 cdna contains 546nucleotide nt open reading frame orf code carboxylterminal 180 amino acid aa recently identified fkhrl1 gene
0 16 17 1 2 restoration ccaat box 70 bp insertion eklf binding site 85 bp 95 bp promoter significantly increased delta globin gene expression haec
0 16 17 3 4 restoration ccaat box 70 bp insertion eklf binding site 85 bp 95 bp promoter significantly increased delta globin gene expression haec
0 16 17 13 13 restoration ccaat box 70 bp insertion eklf binding site 85 bp 95 bp promoter significantly increased delta globin gene expression haec
0 16 17 9 10 restoration ccaat box 70 bp insertion eklf binding site 85 bp 95 bp promoter significantly increased delta globin gene expression haec
0 10 10 8 9 result demonstrate altered ccaat box ccaac lack eklf binding site deltaglobin contribute low level expression haec model well
0 10 10 5 5 result demonstrate altered ccaat box ccaac lack eklf binding site deltaglobin contribute low level expression haec model well
0 10 10 3 4 result demonstrate altered ccaat box ccaac lack eklf binding site deltaglobin contribute low level expression haec model well
0 6 6 7 7 nuclear factor activated cell ap1 insufficient il2 promoter activation requirement cd28 upregulation reap
0 0 0 1 1 il2 promoter activation jurkat cell stimulated superantigen presented raji b cell requires cd28 activation
0 8 8 9 9 addition rctla4ig block cd28 binding ligand culture decreased il2 promoter activation >80
0 5 5 6 6 therefore activation nfat ap1 insufficient il2 promoter activation
0 3 3 4 4 thus requirement cd28 il2 promoter activation appears due reap nfat ap1 site
0 3 3 1 2 identified nfkappab site fasl promoter contributes regulation
0 3 3 4 4 identified nfkappab site fasl promoter contributes regulation
0 3 3 4 4 coexpression p65 rel fasl promoter enhanced activity coexpression ikappab dramatically inhibited inducible promoter activity
0 6 6 7 7 contrast transcription factor ap1 required activationinduced fasl promoter activity
0 6 6 10 10 contrast lpsmediated nuclear binding nuclear factorkappabrel tfspecific kappab site inhibited lysopc
1 7 7 9 9 demonstrate fusion protein composed cterminal hsp70 peptide p50 subunit nfkappab directed nucleus cell could bind dna specifically activated igkappa expression tnfalpha production
0 22 22 23 24 cd2 cd3 crosslinking increased binding nuclear protein radiolabelled cre oligonucleotide probe electrophoretic mobility shift assay suggesting lymphocyte activation enhances binding independently phosphorylation creb serine 133
0 2 3 4 5 previously identified fa ligand regulatory element flre fa ligand fasl promoter bind egr family protein demonstrated egr3 pilot egr1 ngfia krox24 tis8 zif268 induces transcription fasl
0 2 3 10 10 previously identified fa ligand regulatory element flre fa ligand fasl promoter bind egr family protein demonstrated egr3 pilot egr1 ngfia krox24 tis8 zif268 induces transcription fasl
0 12 12 13 13 detected vivo footprinting priming markedly increase activationdependent engagement p0 p1 nfatbinding element il4 promoter
0 6 6 7 7 moreover proximal p element essential optimal il4 promoter activity
0 6 6 7 7 increased expression wildtype nfat1 substantially increase il4 promoter activity unprimed cd4 cell suggesting nfat1 may limiting il4 gene expression cell type
0 7 7 8 8 furthermore truncated form nfat1 act dominantnegative reducing il4 promoter activity primed cd4 cell confirming importance endogenous nfat increased il4 gene expression effector cell
1 3 3 2 3 prevalent complex heterodimer p50p65